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ABSTRACT
The original 16-session model of Interpersonal Psychotherapy for Depression (IPT:
Klerman, Weissman, Rounsaville and Chevron, 1984) was adapted to an abbreviated 8-
session version (IPT-B) and initially applied to a single-case pilot study, prior to the present
randomised trial. The adaptation was carried out in response to the findings of Shapiro et al.
(1994) in which mildly to moderately depressed patients showed strong, positive outcomes,
regardless of whether they had received 8 or 16 sessions of either cognitive-behavioural or
psychodynamic-interpersonal psychotherapy. A total of 49 depressed patients were randomly
allocated to one of two groups: (1) IPT-B or (2) waiting list control. Patients in the IPT-B
group demonstrated a reduction of severity of depression at a higher rate than would be
expected to occur with the passage of time alone. There was no evidence however, of a
differential improvement in the perceived quality of interpersonal relationships. Secondary
analyses demonstrated that, when stratified for severity, severely depressed patients in the
IPT-B group exhibited greater improvement than those who were less severely depressed in
the same group. By two-month follow-up, 73% of all IPT-B patients made what was
considered to be a clinically significant improvement. The effectiveness of IPT-B was
witnessed by the NNT result of less than one, for both self-report and clinician-rated
clinically significant change. The economic evaluation extended these findings and
demonstrated the relative cost effectiveness of IPT-B as compared to an estimated standard
clinical practice of CBT. Implications of the results are discussed and further research with
IPT-B is suggested to determine whether (a) an extended follow up period will demonstrate
improvement in the quality of relationships; (b) it will outperform alternative active
treatments, such as 16 sessions of standard IPT, CBT and/or pharmacotherapy (c) other
patient characteristics will predict reliable change and/or severity of outcome.
CHAPTER 1.0
INTRODUCTION
An Adaptation of Interpersonal Psychotherapy for Depression within
Primary Care (IPT-Brief):





In 1990, depression was the fourth most important determinant of the global burden of
disease and the largest determinant of disability in the world (Murray & Lopez, 1994).
According to Andrews (2001) that burden of depression is not being reduced, partly because
too many people do not seek treatment and partly because efficacious treatments are not used
effectively (Andrews, Sanderson, Slade and Issakidis, 2000). Research conducted to date has
demonstrated that Interpersonal Psychotherapy for Depression (IPT, Klerman, Weissman,
Rounsaville and Chevron, 1984) is efficacious, both in terms of reducing depressive
symptoms and in extending the well interval in patients with recurrent illness (Elkin et al.,
1989; Frank et al. 1990). Studies that have been conducted to date have all used a standard
16-20 session model for treatment of the acute episode of depression. In an attempt to
examine the effective use of IPT, as suggested above, the present study sought to extend the
findings of Shapiro et al. (1994) whereby they established that both mildly and moderately
depressed patients had equivalent, strongly positive outcome regardless of whether thev
had been allocated 8 or 16 sessions of either cognitive-behavioural or psychodynamic-
interpersonal psychotherapy. The original 16-session model of IPT was adapted, in
adherence with the suggestions of Wilfley, Frank, Welch, Spurred and Rounsaville (1998),
to an 8-session model and tested within a single N case study. The positive results of the case
study indicated the present larger N study, in order to determine the effectiveness of the
abbreviated model, IPT-B, for depression within a Primary Care setting.
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1.2 BRIEF OVERVIEW OF THE DEVELOPMENT OF INTERPERSONAL
PSYCHOTHERAPY OF DEPRESSION (IPT)
Interpersonal Psychotherapy of Depression was originally developed in a research
framework as part of a clinical trial in the treatment of out-patients with depression. The
original authors of Interpersonal Psychotherapy of Depression (IPT), Klerman, Weissman,
Rounsaville and Chevron, (1984) state that IPT was not intended to be a new psychotherapy,
rather a collection of descriptions of the therapeutic concepts and techniques that clinicians
stated were most effective in their treatment of Depression. The authors state that their
original aim, when describing the concepts and techniques of what was to eventually become
IPT, was to ensure that therapists who were involved in delivering treatment during the New
Haven-Boston Collaborative Depression Project (1968) did so in a standardised manner.
This first efficacy study of IPT (Klerman, DiMascio, Weissman, Prusoff and Paykel, 1974;
Weissman, Klerman, Paykel, Prusoff and Hanson, 1974) was designed to examine several
treatment strategies for preventing relapse, following recovery from an acute episode of
depression, which had been originally treated with amitriptyline.
In 1984, IPT was described and operationally defined in Interpersonal Psychotherapy of
Depression (Klerman, et al. 1984).
"Our intent was not to develop a new psychotherapy, but to describe what we believed was
reasonable and current practice with depressed patients and might be considered for
inclusion under the rubric ofshort-term psychotherapy."
Klerman and Weissman (1993a) p4.
Since the original description, IPT has been demonstrated to be efficacious for depression, in
terms of reduction in depressive symptomatology and improvement in social functioning, in
both acute and continuation/maintenance treatment outcome studies (DiMascio et al., 1979;
Elkin et al., 1989; Frank et al., 1990; Klerman et al., 1974: Weissman et al. 1974, 1979).
Based upon the concept that depression occurs in an interpersonal context, IPT has two
overarching aims: (1) reduction of the symptoms of depression and (2) improvement of the
quality of interpersonal relationships.
The following section is structured as:
1. An overview of the theoretical background of IPT including a description of the origins
of the interpersonal approach to psychotherapy in general (Meyer, 1957 and Sullivan,
3
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1953) followed by the application of the interpersonal approach to depression through an
examination of Attachment Theory (Bowlby, 1969).
2. Examination of the empirical basis for an interpersonal approach to depression by firstly
describing the major research which has demonstrated an association between
interpersonal difficulties with depression and secondly through an examination of social
impairments as a consequence of depression.
1.3 THEORETICAL BACKGROUND OF INTERPERSONAL PSYCHOTHERAPY
OF DEPRESSION
IPT views depression as occurring in the interpersonal context, therefore the following
section describes the origins of such a viewpoint.
1.31 Origins ofan Interpersonal Approach to Psychotherapy: AdolfMeyer
The interpersonal approach to psychotherapy was originally founded in the US with Adolf
Meyer's 'psychobiological' approach to psychiatric illness (Meyer, 1957). Meyer (1957) used
the term 'psychobiology' to describe his work and theories, referring to the influence of
biological mechanisms upon behaviour. Meyer (1957) strongly influenced by Darwin,
perceived mental illness as an attempt by the individual to adapt to the changing
environment. Indeed, his concept of psychobiology modified the Darwinian principle of
biological adaptation to include the organism's adaptation to the ever-changing psychosocial
environment. He placed an emphasis on the patient's current psychosocial and interpersonal
experiences, in distinction to the psychoanalytic focus on the past and the intrapsychic
(Meyer, 1957). Meyer (1957) was interested in dynamic processes but critical of
psychoanalysis for focussing on the unconscious and inference before exploring the facts of
what the person's actual life experiences were and what he/she thought about them.
1.32 Harry Stack Sullivan and the Interpersonal Paradigm
Harry Stack Sullivan, one of AdolfMeyer's students, viewed psychiatry as follows:
"..the scientific study ofpeople and the processes that go on among them, rather than the
exclusive study ofthe mind, ofsociety or the brain."
Sullivan (1953) quoted in Klerman et al. (1984) p47
Sullivan popularised the term "interpersonal" as a balance to the then-dominant intrapsychic
approach (Sullivan, 1953). He presented the first major alternative to Freud's drive structural
model as he believed that classical Freudian Drive Theory was fundamentally flawed
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concerning human motivation, as it under-emphasised the larger social and cultural context
in accounting for development and psychopathology.
Sullivan therefore stands as the person who most clearly articulated the interpersonal
concept, defining Psychiatry as the field of interpersonal relations. With associates, Fromm-
Reichmann (1960) and Cohen et al. (1954), Sullivan developed a comprehensive and
consistent theory of the connections between psychiatric disorders and interpersonal
relations for the developing child in the family and for the adult in the multiple transactions
of life. Indeed, the interpersonal school is responsible for the emergence of family therapy.
In the interpersonal approach, the unit of observation and therapeutic intervention is the
primary social group, the immediate face-to-face involvement of the patient with one or
more significant others. The interpersonal approach is distinguished from social-psychiatric
approaches by the different social unit it focuses upon. Social psychiatric approaches focus
upon large units of society such as health care institutions, large scale macro social processes
such as urbanisation; the influence of social class, racial membership, ethnic background;
and historical, political, and economic forces. In contrast, the interpersonal approach is most
concerned with the individual's closest relationships, most notably family relationships: in
the family of origin and in the family of procreation, love relationships, friendship patterns
(particularly in adolescence and young adulthood) work relations and neighbourhood or
community relationships (Klerman et al. 1984).
The roles of major interest to interpersonal psychotherapy occur within the nuclear family
(as parent, child, sibling, spouse), the extended family, the friendship group, the work
situation (as supervisor, supervisee or peer) and the neighbourhood or community.
The interpersonal approach views the relationship between social roles and psychopathology
as occurring in 2 ways:
1. Conflict in social roles can serve as antecedents for clinical psychopathology
2. One of the consequences of mental illness may be an impairment of the individual's
capacity to perform social roles.
Although the interpersonal school was initially based on the work of HS Sullivan, it soon
came to include some of the theories of the neo Freudians, Frieda Fromm-Reichmann, Erich
Fromm and Karen Florney. Indeed, the work of Frieda Fromm-Reichmann and Mabel Blake
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Cohen (Cohen, Baker, Cohen, Fromm-Reichmann and Weigert, 1954) provides additional
support for the focus of a psychosocial and interpersonal context associated with the onset of
mood episodes in their treatment ofmanic depressive illness.
Sullivan (1953) was also passionate about the benefit of psychoanalysis for therapists as a
tool to help the therapist understand the complexity of interpersonal meaning however, the
role of personal analysis is not addressed in IPT. Sullivan (1953) stated that people are
motivated by "needs" separable into one of two categories: (1) satisfaction and/or (2)
security (absence of anxiety), both of which may be met in an interpersonal context.
Sullivan (1953) presented an interesting theory of anxiety in which he claimed that an infant
discovers himself or his sense of self in relationship with his object (initially, usually the
mother). Some of the earliest interactions with the mother will produce anxiety, others will
provide care and comfort. From the earliest interaction, the infant will strive to avoid anxiety
and gain security and so will avoid interactions that produce anxiety. Sullivan, who believed
that relationship patterns repeat themselves throughout the life course, stated that the self
consisted ofme-you patterns based on experiences that avoid anxiety and facilitate security.
The IPT emphasis on the interpersonal and social factors in the understanding and treatment
of depression also draws on the work of many other clinicians, especially Fromm-
Reichmann (1960), Cohen et al. (1954) and Arieti and Bemporad (1978). Becker (1974) and
Chodoff (1970) also emphasised the social roots of depression and the need to attend to the
interpersonal aspects of the disorder. Frank (1973) applied an interpersonal conceptualisation
to psychotherapy, stressing mastery of current interpersonal situations as an important
component for success in outcome.
1.33 The Interpersonal Approach to Depression: Attachment Theory
Attachment Theory, as developed by Bowlby (1969), provides a major theoretical source for
understanding depression in an interpersonal context and is central to Interpersonal
Psychotherapy for Depression, as it views the need for human relationships, particularly
emotional bonds, as a major force on human development.
Bowlby (1982) suggested that there is an instinctive propensity to form strong affectional
bonds to preferred others and that an unwilling separation from or loss of those bonds leads
to various forms of emotional distress including anxiety, anger, despair, depression, and
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emotional detachment. Bowlby (1969) also suggested that by ensuring a close proximity to
the (mother) primary caregiver these bonds promote no less than survival of the species.
Bowlby's (1969) work has been extended by Rutter (1972) to show that the child's
relationship with others besides the mother can also create attachment bonds and that
disruption of these bonds can contribute to the onset of depression. Bowlby's (1969) early
writings were understood to mean that there was a biological need to develop a selective
attachment with just one person and that the quality of that relationship differed from all
others. According to Rutter (1995) what has become clear over time is that there are very
definite hierarchies in selective attachments and that it is usual for children to develop
selective attachments with a small number of people who are closely involved in child care.
Bowlby (1977) also suggested that many forms of psychopathology are the result of an
inability to form or maintain emotional bonds. On the basis of this argument, he suggested a
system of psychotherapy that emphasised the connections between early attachment bonds
with parental figures and current relational patterns with significant others and stated that
Psychotherapy should help the patient examine current interpersonal relationships and
understand how they have developed from experiences with attachment figures in childhood,
adolescence, and adulthood.
Bowlby (1988) stated that although the capacity for developmental change diminishes with
age, change continues throughout the life cycle so that changes for better or worse are
always possible and it is this persisting potential for change that gives opportunities for
effective therapy.
Parker (1978) describes effective psychotherapy as similar to optimal parenting. Ideal
psychotherapy, according to Parker (1978), should combine caring with non-possessive
warmth and should provide, as part of the interpersonal therapeutic relationship, a cognitive
explanation of distortions of past relationships. The concept of attachment bonds provides a
strong theoretical basis for understanding the interpersonal context of depression and for
developing psychotherapeutic strategies to correct the distortions produced by faulty
attachments in childhood (Bowlby, 1977). As Rutter (1995) suggests though, we are still far
from an understanding of the development of relationships and of the ways in which
distortions in relationships play a role in psychopathology. Attachment theory has been
hugely helpful in bringing about progress in both areas however, it must be recognised that
attachment is not the whole of relationships.
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1.4 EMPIRICAL BASIS FOR AN INTERPERSONAL APPROACH TO
DEPRESSION
Empirical research has demonstrated an association between interpersonal difficulties in the
current social environment with clinical depression (Brown and Harris, 1989; Henderson,
Byrne and Duncan-Jones, 1981). Indeed, a number of psychosocial variables have been
demonstrated as being associated with the onset and course of depression, for example,
inadequate social attachments, lack of social support and stressful life events and ongoing
difficulties (Brown and Harris, 1989).
Several longitudinal studies have focused on the psychosocial and interpersonal
consequences of depression demonstrating that various social impairments are a
consequence of depression and also that impairments in social functioning often persist long
after the symptoms have decreased.
1.41 Inadequate SocialAttachments, Lack ofSocial Support and Depression
Brown and Harris (1978) first reported that a significant proportion of depressed females
from a community survey of women living in London, had experienced a provoking agent
(i.e. a severe event and/or major ongoing difficulties) of etiological importance. Furthermore,
they defined "vulnerability factors" of depression, such as the lack of a confiding or intimate
relationship and the presence of several young children in the home. These vulnerability
factors were perceived to contribute to depression only in the presence of a provoking agent.
Brown and Harris (1978) suggested that the vulnerability factors were not capable of
producing depression in their own right but increased the risk in the presence of a provoking
agent. In a further London study in Islington (Brown, Andrews, Harris, Adler & Bridge,
1986), low self esteem and poor social support acted as vulnerability factors.
The importance of the presence of a buffer against depression originated from the work of
Brown and Harris (1978). Indeed, these studies suggested that social support is a powerful
moderating variable in the prevention of depression. Individuals may be protected from
adverse consequences through the stress-buffering effects provided by supportive
relationships. Intimacy has been proposed as an important component of care-eliciting and
supportive interpersonal relations (Brown and Harris, 1978). Research on this aspect of
attachment bonding in relationship to the development of depression was reported by Brown,
Harris, and Copeland (1977) who stated that the presence of an intimate and confiding
relationship with a man, usually the spouse, was a strong protection against the development
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of a depression in the face of life stress. The crucial aspect of social bonds seems to be, not
their availability, but how adequate they are perceived to be when one is under stress.
Henderson (1979) confirmed the clinical association between weak social bonds and
depression, recognising that "close personal relations" provide opportunities for intimacy,
nurturance, validation of self-worth and a sense of connectedness with others. Henderson,
Byrne and Duncan-Jones (1981) discussed the relevance of the perceived adequacy (versus
availability) of social bonds in terms of the power to reduce the risk of depression, especially
when someone is facing a distressing situation. The conclusion in the longitudinal study was
as follows:
"The actual availability of social relationships probably has little to do with the causes of
neurosis. The perceived adequacy with which others meet the individual's requirements,
especially under adversity, seems much more important. "
Henderson et al. (1981) p 197
Interestingly, the authors of IPT have suggested that the symptoms of depression may be
viewed as being care-eliciting behaviour which may indeed be adaptive as:
"...they emerge when persons consider themselves deficient in care, concern and interest
from others. These studies suggest that adequate social relationships may indeed play an
important role in recovery from and in the prophylaxis ofdepressive episodes, particularly
in the presence ofadversity. "
[Herman et al. (1984) p59
Brugha (1995) has reviewed theoretical and research aspects of social support and
psychiatric disorder, and also the history of social support, stating that it began to influence
studies of clinical disorders in the 1970s. Brugha (1995) argues that it is likely that good
social support acts as a buffer against the effects of life events and has an independent
protective effect.
1.42 Stressful Life Events andDepression
A major influence on the work of life events lay in the views of Adolph Meyer (1957) who
introduced the life chart as a way of charting life history, psychiatric and physical illnesses
and stressful circumstances, and he emphasised that various life events within common
experience could be an important part of the aetiology of a disorder (Meyer, 1951). There are
challenges which face studies of life events such as: (1) obtaining reliable and valid
information; (2) elimination of events that are consequences of illness; (3) quantification of
9
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stress. However, since the early work, a number of interviews have been used in life events
research which take account of these challenges e.g. The Bedford College Interview (Brown
and Harris, 1978), the Interview for Recent Life Events (Paykel, 1997) and the PERI
(Psychiatric Epidemiology Research Interview) Life Events Scale (Dohrenend, Krasnoff,
Askenasy and Dohrenwend, 1978). The first studies involved comprehensive interviews for
events and making comparisons with control samples from the general population. Indeed,
Paykel et al. (1969) found that in the 6 months following a stressful life event, there was a 6
fold increase in the risk of developing depression and that exits of persons from the social
network occurred more frequently in the 6 month period prior to the onset of depression.
Brown and Harris (1989) stated that the majority of stressors, preceding depression, involved
a degree of loss and disappointment. They described loss as involving a broad range of
experiences:
"...from literal departures ofpersons ... to losses of cherished ideas about oneself, one's
roles, or other people's relationships with one."
Brown and Harris (1989) p449
Brown, Harris and Hepworth (1994) have extended this work and state that the common
denominator of the depressogenic life stress involves not only loss but also humiliation (e.g.
loss of status) and/or entrapment (e.g. caught up in a poor marriage or job).
In terms of depression, issues have been bound up with older debates about classification and
endogenous versus reactive depression. In general, the separation of the two groups has not
survived well (Paykel, Rao & Taylor, 1984). Depressions vary in the extent to which they
are preceded by life stress, but this does not relate well to symptoms pattern. It may be that a
group of recurrent severe depressives have less stress (Brown et al. 1994; Frank, Anderson,
Reynolds, Rietnour & Kupfer, 1994). There have also been studies of the impact of events
on depressive outcome. The more recent studies of Brown and co-workers indicate that
positive classes of events, such as those which neutralise previous events and 'fresh start'
events improve outcome, in those in the milder range of depression (Brown et al. 1994;
Brown and Moran, 1994). Stressful events appear to lessen the likelihood of improvement
and increase relapse, but not in severe recurrent samples (Paykel, Cooper, Ramana and
Hayhurst, 1996). 'Fresh start' events have been reported to demonstrate similar effects in a
new sample from a trial of befriending, with new severe stressors having an adverse effect
(Harris, Brown & Robinson, 1999).
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Perhaps one of the most exciting developments in the field of life events is the growing
research into the examination of genetic elements in the generation of events (Paykel, 2001).
"Once specific genes contributing to psychiatric disorders have been identified by molecular
genetic methods, they provide vulnerability factors to test against effects of life events and
event genesis... this is likely to take many years yet."
Paykel, (2001) p 147
Zlotnick, Shea, Pilonis, Elkin and Ryan (1996) reported that despite differential prevalence
rates of major depression for men and women, their findings did not support a different
process in outcome of illness for men and women; life events and social support were related
to severity of depressive symptoms of both genders.
1.43 Marriage - Adult Needfor Human Attachment?
There is controversy about whether chronic marital difficulties are antecedents or
consequences of depressive episodes (Briscoe and Smith, 1973). Despite this controversy,
numerous studies have shown that chronic marital dissatisfaction and discord are
significantly associated with clinical depression and that chronic marital turmoil is just as
likely to precipitate a depressive episode as is the complete dissolution of the marriage
(Pearlin and Lieberman, 1979). Those who are divorced have significantly higher levels of
depression than either the continuously married or the never married (Blazer et al, 1994;
Smith and Weissman, 1992).
"...the actual or threatened disruption of the marital attachment through disputes,
separation, or divorce is one of the most common and serious disruptions of attachment in
adulthood and is often related to the occurrence ofdepression ."
Klerman et al. (1984) p60
According to Hinchliffe, Hooper and Roberts (1978) marriage serves as the society's
response to the individual adult's need for human attachment, as discussed earlier. Ideally,
the social and legal contract provides a secure economic and social base for rearing children
and creates an opportunity for each partner's needs for mutual care, concern, and affection to
be expressed within the stability and security of a committed relationship (Hinchliffe,
Hooper and Roberts, 1978). Therefore, the actual or threatened disruption of the marital
attachment through disputes, separation or divorce is one of the most common and serious
disruptions of attachment in adulthood and therefore is often related to the onset of
depression (Klerman et al, 1984). Not only does the marital relationship have a high
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correlation with and etiological implications for the onset of depression, its effects on
patients' responsiveness to treatment and the maintenance of treatment gains have also been
demonstrated (Rounsaville, Weissman, Prusoff and Hercet-Barob, 1979; Rounsaville,
Prusoff and Weissman, 1980).
1.44 InterpersonalDifficulties as a Consequence ofDepression
Consideration for the impact of depression on the individual's interpersonal relations and the
consequences of the depression for the patient's marriage, family, work and community
activities must also be given. There has been a substantial body of evidence which has
documented the adverse side effects of depression on the individual's social environment
(Wells et al. 1989).
There is strong support for the use of an interpersonal approach to the understanding and
treatment of depression (Frank and Spanier, 1995). It is widely accepted that antecedent life
events and long-term stressors, particularly those involving loss, disappointment,
humiliation, and/or entrapment, are important in the onset and course of depression (Frank
and Spanier, 1995). Studies cited above, also demonstrate that close personal relations and
satisfactory social supports are important in the prevention of depression and that disruption
of these attachments plays a significant role in the development of depression. Also, it would
appear that persistent deficits in social adjustment are a serious consequence of depressive
episodes, as they seem to increase the patient's vulnerability to a recurrence of depression by
the likelihood of leading to loss-related life events and ongoing adversities (e.g. chronic
marital dissatisfaction, loss of social supports including both personal relationships and
general supports).
Given the above overview, IPT focuses on the improvement in the quality of the patient's
current social network and mastery of social roles, thereby fostering a facilitation of recovery
and reduction in the potential vulnerability to a recurrence of depressive symptomatology.
IPT is therefore interested in the patient's social relationships in all key areas or domains that
are important to providing a sense of self-worth. In order to achieve this, there is an
awareness of all social influences and life stressors. IPT emphasises all the social concepts
while remaining focused on the role of the interpersonal relationships as a vehicle to promote
satisfaction and improve the quality of relationships. In turn, IPT aims to reduce the
symptoms of depression and other forms of disorder.
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1.5 DESCRIPTION OF IPT
The following section is a detailed description of IPT, as outlined by Klerman et al. (1984)
including: the three phases; four problem areas; goals and strategies; techniques, therapeutic
stance; overall characteristics of IPT as compared with CBT and an examination of the
major differences between IPT, CBT and Psychodynamic psychotherapy.
Although IPT is one of the most well-studied brief therapies, many clinicians, it is argued
(Ablon & Jones, 1999) seem to have difficulty when asked to describe what such a treatment
entails. A review of the literature reveals what in theory should occur in IPT. Based on the
interpersonal theories of Meyer (1957), Sullivan (1953), and others, IPT is focused on the
relationship between mood and interpersonal events. The rationale avoids suggesting
whether untoward psychosocial events cause depression or vice versa; indeed for clinical
purposes, the authors state that causality may not matter.
As discussed above, IPT is informed by Bowlby's attachment theory (1982) and recognises
the profound impact of early developmental experiences and unconscious mental processes
(i.e. intrapsychic wishes and conflicts) on later patterns of interpersonal relationships. The
clinician focuses on the current social roles and interpersonal relations (Klerman et al. 1984).
The salient therapeutic points are that patients learn to link their current mood with current
interpersonal contacts and to recognise that by appropriately addressing interpersonal
situations, they may simultaneously improve both their relationships and their depressed
state (Klerman et al. 1984).
The focus on 'current relational dilemmas' is based on the assumption that early childhood
experiences will be reflected in current patterns of interpersonal relating and in the patient's
current social roles.
The interpersonal approach was originally applied specifically to the understanding of
clinical depression, which is considered to have three component processes (Klerman et al.
1984):
1. symptom function
2. social and interpersonal relations
3. personality and character problems
13
CHAPTER 1: INTRODUCTION
IPT intervenes in the first two levels of these three processes and facilitates recovery of the
acute depression by relieving the depressive symptoms and helping the patient develop more
effective strategies for dealing with current interpersonal problems associated with the onset
of symptoms.
Whilst IPT recognises the role of genetic, biochemical, developmental and personality
factors in the causation of and vulnerability to depression, it is interesting to note that
personality is not a focus. An exception to this general approach is that of IPT for
Borderline Personality Disorder (Angus and Gillies 1994) but even here, the Personality
Disorder is not confronted directly. Although personality is not a focus, it is believed to
affect several aspects of treatment such as predicting psychotherapeutic outcome, altering the
patient-therapist relationship and may also be a determinant of the patient's recurrent
interpersonal problems.
In IPT, clinical depression is viewed as occurring within an interpersonal context and
according to Klerman et al, (1984) psychotherapeutic interventions directed at the
interpersonal context will facilitate the patients' recovery from the acute episode and
possibly have preventative effects against relapse and recurrence. IPT has been
conceptualised at three levels: (1) strategies; (2) techniques; (3) therapeutic stance. The
strategies and goals of IPT, as described in Table 2.0 occur in three phases of treatment:
initial, intermediate and final phase.
1.51 Initial Phase ofIPT Treatment
The initial phase includes the psychiatric history, diagnostic evaluation and delivery
according to standard criteria (e.g. DSM-IV criteria. APA, 1994., Appendix 1.0) and sets the
framework for treatment. The patient is also given the "sick role" (Parsons, 1951) which
may excuse him/her from overwhelming social obligations, but at the same time makes an
explicit requirement for the patient to work in treatment to recover full function. Far from
being a negative role assigned to the patient, society it seems, is willing to legitimise
sickness as long as the patient follows culturally determined conventions of being ill, such as
trying to regain health as quickly as possible, or accepting medical help in overcoming the
illness (Christopoulos, 2001). Perhaps one of the major criticisms of the sick role is that as
cultural paradigms and norms of illness shift over time, the socially defined parameters of
what it means to be sick change, and therefore the sick role will also change within IPT. The
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question which then arises, is how contemporary research will be compared with research
carried out in future generations, if the sick role will ultimately evolve.
A further criticism of the sick role focuses on the self-evident conclusion that the sick role
and subsequent behaviour (of the patient) is an 'eye-of-the-beholder phenomenon'
(Blackwell, 1992) and that too often the eye is that of the physician and in the current case,
the eye of the IPT therapist. However, it is argued here that the assignment of the sick role
with the diagnosis of depression serve to 'normalise' the patient's experience and
demonstrate that the therapist and patient are talking about the same illness. It also
demonstrates the possibilities for recovery and allows the therapist to hold the positive
stance, as advocated by the IPT model (Klerman et al. 1984). The assignment of the sick role
is illustrated through an in-depth analysis of a single case presentation (Appendix 2.0) and is
argued that it allowed IPT-B to be what was considered to be a 'successful' treatment. A
second, 'unsuccessful' case is also presented, interestingly with a lady who was unable to
relinquish her adopted sick role, which had proved to be an adaptive role since early
childhood but was one which was beginning to "strain the social contract" (Christopoulos,
2001 p93).
Those who argue against the sick role may do so from the perspective that assignment of
such will eventually "lead to a shift in preference crway from participation" (Salole, 1997
pi349). However, some would argue that people do not consciously choose to play the sick
role once they become a patient. Indeed, Stiggelbout and Kiebert (1997) argue that being a
patient is enough to make some behave in a less active way than they might have foreseen
for themselves when healthy. These authors argue that the sick role is adopted
subconsciously and therefore would be adopted, regardless of the model of therapy being
employed. However, implicit in the assignment of the sick role within IPT, is the assumption
that ultimately, the patient will take responsibility and the therapist will begin to minimise
the sick role, whilst encouraging active participation and eventually independent
competence.
A key feature of this time-limited, manualised, antidepressant treatment is that it approaches
depression as a clinical disorder. According to Klerman et al. (1984) this legitimises the
patient's assumption of the sick role, therefore allows the patient to accept help to overcome
the illness (Christopoulos, 2001); this places IPT within the broad definition of the medical
model. This is perceived as a positive although rather contentious stance, especially amongst
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non-medical IPT practitioners. Despite the controversy that surrounds the application of the
medical model, it is argued here that because of the medical model stance and the
assignment of the sick role, the patient is able to legitimise their illness and, by definition, try
to regain their health as quickly as possible (Christopoulos, 2001).
The psychiatric history includes the interpersonal inventory, a unique element to IPT,
which involves a review of the patient's current social functioning and close relationships.
The inventory provides a rich picture of the interpersonal world of the patient, including the
relationship patterns, mutual expectations and reciprocal nature of each relationship. The
review provides a social framework for understanding the social and interpersonal context of
the onset and maintenance of the depressive symptoms and defines the focus of the treatment
and interestingly, answers the recent call for routine assessment of patients' support networks
(Harris, 2001).
During this phase, the patient is educated with regards to depression through an explicit
discussion of the diagnosis and expectations of treatment from the patient's perspective. The
therapist offers an interpersonal formulation, which links the depressive symptoms to the
patient's interpersonal situation within the framework of one of the four focal areas
commonly associated with depression: (1) grief; (2) interpersonal role disputes; (3) role
transitions; (4) interpersonal deficits, as described in Table 1.0 below. The major goals of
IPT are achieved by ascertaining with the patient which of the four types of problems
described was associated with the onset of the presenting episode of depression and by
working collaboratively with the patient to renegotiate interpersonal difficulties associated




Grief Grief is defined as complicated bereavement following the death of a loved
one. The therapist's major role is one of facilitation of the mourning process




Role Disputes are defined as a conflict with a significant other: a spouse, co¬
worker, close friend, other family member etc. The therapist helps the patient to
explore the relationship, nature of the dispute and the options to resolve it.
Role Transition This focal area includes any change in life status, for example, a job promotion,
graduation, beginning or ending of a relationship. The patient is encouraged to
deal with the change by recognising positive and negative aspects of the new




This problem area defines the patient as significantly lacking in social skills,
resulting in problems in initiating or sustaining relationships.
Table 1.0 The Four Identified Problem Areas as described by Klerman et al. (1984)
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1.52 Intermediate Phase ofIPT Treatment
Once the major problem area has been identified, a treatment contract is defined and the
intermediate phase begins which utilises strategies and goals for each problem area, as




As outlined by Klerman et al. (1984)
|§ .goals
•
Grief 1. Review depressive symptoms.
2. Relate depressive symptoms to death of
significant other.
3. Reconstruct the patient's relationship with the
deceased.
4. Describe the sequence and consequences of
events just prior to, during, and after the death.
5. Explore associated feelings (negative as well as
positive).
6. Consider possible ways of becoming involved
with others.
1. Facilitate the mourning
process.
2. Help the patient re¬
establish interest and
relationships to substitute
for what has been lost
Role
Transitions
1. Review depressive symptoms
2. Relate depressive symptoms to difficulty in
coping with recent life change
3. Review positive and negative aspects of old and
new roles
4. Explore feeling about what is lost
5. Explore feelings about the change itself
6. Explore opportunities in new role
7. Realistically evaluate what is lost Encourage
appropriate release of affect
8. Encourage development of social support system
and of new skills called for in new role.
1. Mourning and
acceptance of the loss of
the old role.
2. Help the patient to
regard the new role as
more positive.
3. Restore self-esteem by
developing a sense of
mastery regarding demands
of the new roles.
Interpersonal
Dispute
1. Review depressive symptoms.
2. Relate depressive symptoms' onset to overt or
covert dispute with significant other and with
whom patient is currently involved.
3. Determine stage of dispute: Renegotiation,
Impasse or Dissolution
4. Understand how nonreciprocal role expectations
relate to dispute:
5. Are there parallels in other relationships?
6. How is the dispute perpetuated?
1. Identify dispute.
2. Choose plan of action.
3. Modify expectations or
faulty communication to




1. Review depressive symptoms
2. Relate depressive symptoms to problems of social
isolation or unfulfillment
3. Review past significant relationships including
their negative and positive aspects.
4. Explore repetitive patterns in relationships
5. Discuss patient's positive and negative feelings
about therapist and seek parallels in other
relationships.
1. Reduce the patient's
social isolation.
2. Encourage formation of
new relationships
Table 2.0 Strategies and Goals of IPT Treatment as described by Klerman et al. (1984)
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1.53 Final Phase ofIPT Treatment
During the final phase of treatment, the patient in IPT is encouraged to recognise and
consolidate therapeutic gains, recognise their independent competence and develop methods
of identifying and countering depressive symptoms, should they recur in the future. As in
other time-limited therapies, there is an explicit discussion of termination with an
acknowledgement that it is potentially a time of grieving, as the patient prepares to terminate
the relationship with the therapist.
Perhaps one of the unique characteristics of IPT is in terms of its explicit discussion of
termination at the start of therapy. Indeed, from the first session, there is an explicit count
down to the end, with the final sessions being described, not only as a time for potential
grieving, but also as a useful tool to model a 'successful' ending of a relationship.
As an acute treatment, IPT consists of 16 sessions of once-a-week outpatient treatment; as a
monthly maintenance treatment, it may continue for years.
1.54 Techniques ofIPT
The IPT manual specifies techniques which incorporate psychodynamically orientated
therapies (e.g. exploration, clarification of affect) and cognitive behavioural therapies (e.g.
behaviour change techniques, testing perceptions and performance through interpersonal
contact). Other techniques specified by the authors include reassurance, clarification,
improving communication and decision analysis. As such, IPT is not necessarily considered
to be unique in terms of the techniques that it employs although the strategies are considered
to be distinctive (Klerman et al. 1984). The manual distinguishes IPT from alternative
psychotherapeutic treatments and explicitly targets the patient's Axis I disorder as opposed
to attempting character change.
1.55 Therapeutic Stance in IPT as Compared to CBT
The role of the therapist in IPT is one of active patient advocate and not neutral commentator
as in psychoanalysis and one in which a hopeful, supportive, active stance is taken. As
transference is not facilitated, the therapeutic relationship is conceptualised to be based in
reality, as are the patient's perceptions of interpersonal problems outside of therapy. Perhaps
the major distinction between IPT and cognitive behavioural therapy (CBT: Beck, Rush,
Shaw, and Emery, 1979) lies within this concept, whereby the cognitive behavioural
therapist may consider the patient's perception of interpersonal problems to be biased by
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cognitive distortions rather than based in reality. The unit of observation and the target of
intervention in IPT is face-to-face interaction with significant others.
Many of the procedures and techniques of IPT therefore share those of other
psychotherapies. Important common elements include attempts to help the patient gain a
sense of mastery, combat social isolation, restore a sense of social belonging and find
meaning in their lives. Table 3.0 summarises the overall characteristics of IPT and the more
common specific and non-specific factors between IPT and CBT, which was chosen as the
main comparator as:
"Depression may be treated effectively with cognitive therapy or interpersonal therapy. CBT
and IPT effectively reduce symptoms ofdepression."
Treatment Choice in Psychological Therapies and Counselling, (Dept. of Health, 2001 p3-4)
Overall characteristics of IPT
III; ;§} j |ii:| ||! i !|i : ' § -
Common non-specific factors
of IPT and CBT
More specific factors between
IPT and CBT
Time limited, not long term Helping the patient to feel
understood
Time-limited
Focused not open ended Framework for understanding Manualised
Current not past interpersonal
relationships
Providing hope and optimism Here and now focus
Interpersonal not intrapsychic Psychoeducation Structured (although CBT is
considered to be more
structured than IPT through the




■ Mobilisation ofpatient to
increased activity
" Link ofmood to activity and
reaction to events
■ Testing alternative solutions




Personality recognised but not
the focus
Both IPT and CBT can be
combined with antidepressant
medication
Goals of self-assertion and
mastery are similar
The ultimate goals of new skills
for prophylaxis are the same
Table 3.0: Overall Characteristics of IPT and the more Common Specific and Non-specific
Factors between IPT and CBT.
1.56Major Differences between IPT and CBT
A major difference amongst the many schools of psychotherapy is in their conceptualisation
of the causes of the patient's problems as lying in the remote past, the immediate past or in
the present. IPT also differs from other approaches in the particular techniques it uses and in
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its overall strategies (Table 2.0). Table 4.0 outlines the major differences between IPT and
CBT in the treatment of depression.
■ % Wi- CBT
IPT is informed by Bowlby's attachment theory
(1982) and recognises the profound impact of
early developmental experiences and unconscious
mental processes (i.e. intrapsychic wishes and
conflicts) on later patterns of interpersonal
relationships.
CBT is based on an underlying theoretical
rationale that an individual's affect and behaviour
are largely determined by the way in which he
structures the world (Beck, 1976). Cognitions are
based on assumptions developed from previous
experiences.
The patient's perception of interpersonal problems
is viewed as being based in reality.
The patient's perception of interpersonal problems
is viewed as biased by cognitive distortions rather
than based in reality.
Focus on affect Focus on "hot" cognitions (thoughts with strong
associated affects)
No attempt to uncover distorted thoughts
systematically.
Attempt to systematically uncover distorted
thoughts (negative automatic thoughts,
conditional and unconditional beliefs) through the
use of techniques such as Socratic questioning.
No homework (although this does appear in
adaptations i.e. IPC and IPT-B - described in
greater detail).
Homework assignments ("a significant vehicle
from which data which disconfirm many negative
thoughts and beliefs can be obtained. ..shift the
focus of therapyfrom subjective, abstract
conceptualisations to more objective, realistic,
and detailed accounts." Beck et al. (1979) p272.
No attempt to help the patient to develop
alternative thought patterns through prescribed
practice. Therapist calls attention to distorted
thinking in relation to significant others
Attempts are made to help the patient to develop
alternative thought patterns through prescribed
practice.
Goal is to change the relationship patterns rather
than associated depressive cognitions (recognised
as depressive symptoms) and thereby alter affect.
Goal is to alter the depressive cognitions and
behaviour and thereby alter affect.
Table 4.0: Major Differences between IPT and CBT
1.57 IPT and Psychodynamic Psychotherapy
Although the essential features of a psychodynamic and IPT approach differ i.e. the focus on
unconscious mental processes versus the focus on social roles and interpersonal interactions,
IPT not only shares some techniques (as described earlier) but also some aspects of dynamic
psychotherapy (Hughes, 1999). Both approaches are concerned with the whole life span,
and both consider early experience and persistent personality patterns to be of importance. In
understanding human transactions, however, the IPT therapist focuses on interpersonal
relations whereas the psychodynamic therapist is concerned with object relations. The IPT
therapist helps the patient see how their present way of relating to other people and
expectations of relationships may have contributed to their depression. Although IPT
recognises the patient's past as being of significance, it does not explore the past. The IPT
therapist is active both in identifying problem areas and working with the patient in finding
alternative strategies to deal with depression in the future.
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1.6 OUTCOME RESEARCH: A Brief Review of the Literature
The following section is a review of the outcome research to date, including the efficacy of
IPT as an acute treatment for depression in which the original analysis and subsequent
reanalyses of the NIMH TDCRP (Elkin et al. 1989) data are described in detail. Research has
demonstrated that IPT is efficacious, both in terms of reducing depressive symptoms and in
extending the well interval in patients with recurrent illness (Elkin et cil 1989; Frank et al.
1990).
1.61 Efficacy of IPT as an Acute Treatmentfor Depression
The first test of efficacy of IPT as an acute antidepressant treatment was a four-cell, sixteen
week randomised trial of IPT, amitriptyline (AMI), their combination and a non-scheduled
control group treatment for eighty-one out-patients with Major Depression (DiMascio et al.,
1979; Weissman et al. 1979). The non-scheduled treatment assigned patients a psychiatrist
who could be contacted if required but there were no regular treatment sessions scheduled.
There were no significant differences between IPT and medication in terms of a reduction of
symptoms at the end of treatment, both treatments were more effective than the control
treatment and combined treatment was more effective than either treatment alone (DiMascio
et al., 1979; Weissman et al. 1979). In a one-year naturalistic follow-up study (Weissman,
Kierman, Prusoff, Sholomskas and Padin, 1981) it was found that patients who had received
IPT, either alone or in combination, developed significantly better psychosocial functioning
by the time of the 1-year follow-up than the medication or treatment control patients. This
effect on social functioning was not found for AMI alone and had not been evident for IPT at
the end of the 16-week trial (Weissman et al. 1981). Many patients across treatments
reported requiring additional treatment over the follow-up year, a fact now recognised in
many studies that include a maintenance phase, including the present study albeit rather
shortened due to time restrictions.
The National Institute of Mental Health Treatment of Depression Collaborative Research
Program (NIMH-TDCRP; Elkin et al. 1989) strongly supported the efficacy of IPT for the
acute treatment of depression in out-patients. This study, one of the most ambitious acute
treatment studies to date, randomly assigned 250 depressed out-patients across 3 research
sites with four treatment conditions i.e., 3 (research sites) x 4 (treatment conditions) factorial
design with patients randomly assigned to 16 weeks of either:
1. Cognitive Behaviour Therapy (CBT; Beck, Rush, Shaw, & Emery, 1979)
2. Interpersonal Psychotherapy (IPT)
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3. Imipramine plus Clinical Management (IMI-CM)
4. Pill-placebo plus Clinical Management (PLA-CM)
Manuals were used to define each treatment and independent adherence monitors rated tapes
of sessions to ensure that therapists delivered the treatment according to the manual (Elkin et
al. 1989). Imipramine and placebo were each accompanied by Clinical Management (CM).
The results demonstrated that most subjects completed at least 15 weeks or 12 treatment
sessions, with IPT having the lowest attrition rate among the treatments (Elkin et al. 1989).
The mildly depressed out-patients improved in all the treatments with no overall difference.
The results however did demonstrate differences amongst the more severely depressed out¬
patients; IMI-CM demonstrated the most rapid response and consistently superior to placebo.
IPT was comparable to IMI-CM on several outcome measures and showed a mean outcome
superior to placebo. CBT demonstrated an intermediate level of improvement and was not
superior to placebo for this group.
There has been controversy with regards to the approach to data analysis and as a result,
there have been numerous reanalyses of the NIMH-TDCRP efficacy data (e.g. DeRubeis,
Gelfand, Tang, & Simons, 1999; Gibbons et al., 1993; Klein & Ross, 1993; Kung & Elkin,
2000; Zuroff et al. 2000). The reanalysis by Klein & Ross showed more distinct differences
in efficacy among treatments, especially with the more severely depressed patients. These
authors reported that medication was superior to psychotherapy; IPT and CBT were superior
to placebo (particularly with the severely depressed); the efficacy of IPT was reported to be
superior to CBT among patients with severe illness. The reanalysis is fairly consistent with
results reported by Elkin et al. (1989) but sharpens differences among treatments. There has
however been controversy regarding the reanalyses, as an example, comments have been
made regarding the competency of the CBT therapists across all sites involved in the
TDCRP and suggestions that the competency differences would account for the differences
found between CBT and IPT (Shaw et al. 1999). Indeed, Shaw et al. (1999) examined the
relationship of therapist competence to the outcome of CBT and provided support for the
relationship of therapist competence to the reduction of depressive sympomatology. These
findings only relate to those patients receiving CBT but do suggest that more positive results
might have been obtained for CBT condition in the TDCRP had the therapists maintained a
highly competent level of performance on more cases (Shaw et al, 1999).
22
CHAPTER 1: INTRODUCTION
Gibbons et al. (1993) further analysed the data and concluded from their reanalysis that
across the 16-week course of treatment, patients in all groups (including PLA-CM), showed
considerable improvement. These authors also reported that IMI-CM demonstrated a faster
rate of improvement in comparison to IPT and CBT through the 12-week evaluation.
However, this difference is no longer significant at 16 weeks. Therefore, across 16 weeks of
treatment, IPT and CBT were not significantly inferior to IMI-CM, in alleviating depressive
symptoms although they appear to be slower in their rate of response. These authors also
reported that there is little support for the specificity of treatment effects between the two
psychotherapies, IPT versus CBT. Elkin (1994) suggests that the relative lack of differences
among the treatment may be due to the good outcome for the PLA-CM condition, especially
with less severely depressed patients.
In an 18-month naturalistic follow-up study of the TDCRP data, Shea et al. (1992) reported
that the recurrence rate for major depression was high even with acute treatment and
therefore that short-term IPT and CBT does not have enduring effects in many cases and so
cannot be considered to be effective. Recovery was defined by the presence of minimal or
no symptoms following the end of treatment and sustained during follow-up. Of the subjects
who had acutely remitted, 30 percent of CBT, 26 percent of IPT, 19 percent of IMI and 20
percent of placebo subjects remained in remission during that time span. At the end of the 16
weeks, among remitters, relapse over the 18-month follow-up period was 36 percent for
CBT, 33 percent for IPT, 50 percent for IMI and 33 percent for placebo. It is important to
note, however that data from the MTRD study from Frank et al. (1990) were not available
when Shea et al. (1992) made their conclusions with regards to the effectiveness of
treatments. On further examination of this study, however, the analyses were limited to
dichotomous diagnostic criteria of recovery and relapse which have several limitations:
1. They restrict the evaluation of finer distinctions such as degrees of symptomatic,
functional and phenomenological change;
2. Using dichotomous criteria rather than continuous variables, requires substantially
larger sample to achieve statistical power.
3. Threshold values for defining recovery and relapse are somewhat arbitrary (Blatt,
Zuroff, Bondi, & Sanislow, 2000).
Despite the limitations of use of dichotomous criteria of recovery and relapse to assess
therapeutic gain, Shea et al. (1992) found substantial differences at follow up among
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treatment conditions. The percentage of patients defined as "fully recovered" among the total
sample who began treatment was higher in the two psychotherapy conditions than in the two
medication conditions, suggesting better outcome at follow-up in both psychotherapy
conditions (Shea et al. 1992).
Agosti and Stewart (1998) further analysed the TDCRP data for those patients who
responded to treatment and subsequently "recovered" in order to compare their social
functioning and symptoms with that of community samples. They concluded that the two
groups (recovered versus community sample) were indistinguishable, suggesting that
patients who benefit from treatment and recover from major depression can expect to
achieve a normal level of functioning and symptomatology, however, they did not identify
which arm of the study the 'recovered' individuals came from. If we apply the definition of
Shea et al. (1992) of "fully recovered", a higher percentage came from the two
psychotherapy conditions and therefore it would appear that the conclusions of Agosti and
Stewart (1998) are applicable to the two psychotherapy conditions to a greater extent than to
the medication conditions.
Blatt et al. (2000) recently analysed the TDCRP data stating that they considered that it was
premature to draw conclusions about the relative efficacy of IMI-CM (as Elkin 1994: Klein
and Ross, 1993) until a comprehensive assessment was conducted at termination and follow-
up on the broad range of measures available (including evaluation of symptoms, functional
capacities and reports by patients about their satisfaction with the treatment they received
and the impact on their lives, particularly after a substantial period following termination).
They concluded that analyses of the various measures of therapeutic gain during treatment,
at termination and at 18-month follow up indicate that medication (IMI-CM) results in a
significant reduction in symptoms at mid-treatment (eighth week) in comparison to CBT and
IPT, as well as placebo (e.g. Klein and Ross, 1993), but this relative advantage for
medication is markedly diminished at termination (e.g. Shea et al., 1992; Watkins et al.
1993). The significantly greater reduction of symptoms at mid-treatment in the active
medication condition (IMI-CM) has led in the past, to a number of investigators (e.g., Elkin
et al, 1985, 1989, 1995, 1996; Klein and Ross, 1993) to conclude that medication was more
effective than CBT and PLA-CM and somewhat more effective than IPT in the brief
outpatient treatment of major depression, especially for more severely depressed patients.
The three active treatments however, were not significantly different at termination in Blatt
et al.(2000) study using the ratings by therapists and patients at termination.
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Blatt et al. (2000) also concluded that at 18-month follow-up, patients reported significantly
greater overall satisfaction with treatment and patients in both IPT and CBT reported
significantly more constructive effects on life adjustment than the patients in the two
medication conditions did. Patients in the two psychotherapy conditions thought that
treatment had significantly greater effects on helping them to establish better interpersonal
relationships, to cope with those relationships more effectively and to recognise more fully
their symptoms of depression than patients in the IMI-CM and PLA-CM.
It is possible, of course, to place different interpretations on the results of Blatt et al. (2000).
As an example, it may be the consequence of cognitive dissonance because of more effort
involved in psychotherapy than in medication. Blatt et al. (2000) study highlights the
important question of having an exclusive focus on symptom reduction to evaluate
therapeutic gain, as discussed earlier. Blatt et al. (2000) report consistent and significant
differences among treatment groups in the effects of treatment of life adjustment at follow-
up.
The research evidence therefore suggests that IPT and CBT are effective acute treatments for
depression. Based on measures of therapeutic gain, IPT appears to generate greater overall
satisfaction than IMI-CM or PLA-CM and appears to have a greater effect on life adjustment
than either pharmacotherapy or placebo (Blatt et al. 2000).
In an attempt to make a useful application of all the outcome research, as described for the
NIMH TDCRP above, Ogles, Lambert and Sawyer (1995) evaluated the clinical
significance of the results. They reported that a substantial number of patients who received
treatment for depression made reliable improvements and had post-treatment scores that fell
within a functional distribution (as defined by Jacobson and Truax, 1991). They also
reported that there were no differences in clinical significance rates among the treatment
groups for measures of depressive symptoms but when considering general improvement,
treatments did differ. When the completer sample were examined (as described later), the
highest proportion of patients who met criteria for clinically significant change came from
the IPT group (85 percent of the total).
1.62 Efficacy ofIPT as aMaintenance Treatmentfor Depression (IPT-M)
The MTRD study was a 3-year randomised outcome trial in depressed patients with a clear
history of repeated episodes of depression (Frank et al. 1990). Patients were randomised to
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IPT-M with maintenance pharmacotherapy (imipramine), combination pharmacotherapy/
psychotherapy, and a control group. IPT-M was designed specifically to maintain recovery
and reduce vulnerability to future episodes by improving social adjustment. All subjects
received treatment from the acute episode of depression with a combination of IPT and
imipramine and were continued on that combination until they had sustained a state of
remission defined as having a HRSD score as less than or equal to 7 for 20 weeks. After
achieving that status, patients were randomly assigned to one of five maintenance treatments:
(1) IPT-M alone; (2) IPT-M with placebo tablet; (3) IPT-M with imipramine; (4) medication
clinic visits with imipramine or (5) medication clinic visits with placebo tablets.
The study demonstrated that when patients received a combination of pharmacotherapy and
IPT, those who continued to receive IPT on a monthly basis following drug discontinuation,
remained well significantly longer than those who did not. Frank et al. (1990) reported that
this result demonstrated a clinically significant and meaningful effect for IPT-M. Frank et al.
(1991) provided a follow-up report from this study, which established the value of
maintenance treatment in the prevention of recurrence of major depression and found IPT-M
to have significant prophylactic capacity, even when used at a very low dose.
Therefore, from the results of the MTRD study (Frank et al. 1990) and the NIMH
Collaborative Study (Elkin et al. 1989) it can be clearly stated that the performance of IPT in
the treatment of clinical depression, consistently surpasses no treatment and placebo therapy
in both acute and maintenance treatment of outpatients with depression.
1.7 WHY IS IPT EFFECTIVE?
The following section attempts to answer the question of why IPT might be effective through
examination of research conducted to date involving: patient predictors; therapist factors; the
therapeutic alliance and perfectionism.
Through the numerous outcome studies, as outlined above (Elkin et al. 1989; Frank et al.
1990), IPT has been demonstrated to be effective. Outcome studies, however, do not reveal
how the treatment works or how patients recover from an acute episode of depression or how
protection from a recurrence of symptoms may occur. A brief review of the major findings
demonstrates that the following factors may be particularly salient in answering the question




In an analysis of the TDCRP data, Sotsky et al. (1991) found that patients with a low
baseline level of social dysfunction responded well to 1PT whereas those with severe social
deficits responded less well to IPT. Patients with greater symptom severity and difficulty in
concentrating responded poorly to CBT (Sotsky et al. 1991). Furthermore, Sotsky argued
that high initial severity of depression and impairment of functioning predicted superior
response to IPT and to IMF This is an extremely important point therapeutically, as in
Primary Care, patients may be referred specifically for IPT, if the General Practitioner
perceives there to be interpersonal deficits and yet the research conducted by Sotsky et al.
(1991) quite clearly demonstrates that HIGH social dysfunction predicts a poorer response
to IPT.
As discussed earlier, not only does the marital relationship have a high correlation with and
etiological implications for the onset of depression; its effects on patients' responsiveness to
treatment and the maintenance of treatment gains have also been demonstrated (Rounsaville,
Weissman, Prusoff and Hercet-Barob, 1979; Rounsaville, Prusoff and Weissman, 1980).
Kung and Elkin (2000) recently examined the impact of marital adjustment on depressed
married patients in the context of individual treatment (using the NIMH TDCRP dataset).
Their results indicated that patients' level of marital adjustment at termination and the extent
of marital improvement over the course of treatment significantly predicted treatment
outcome at follow-up in terms of both depressive symptoms and social functioning. Marital
adjustment at intake was not a significant predictor of depressive symptomatology at
termination and follow up. However, more relevant to the present discussion, neither
treatment modality (IPT or CBT) nor the interaction between treatment and pre-treatment
marital adjustment significantly predicted the outcome measures, including marital
adjustment at termination or follow-up.
1.72 Therapist Factors
Frank, Kupfer, Wagner, McEachran & Cornes (1991) discovered that the ability of the
therapist to keep sessions focused on interpersonal issues was significantly correlated with
prevention of relapse in their maintenance study of IPT for recurrent depression. Frank et al.
(1991) reported that the patients who received monthly IPT with a high interpersonal
specificity survived a mean two years before depression recurred whereas those patients who
received therapy with a low interpersonal focus were afforded only 5 months of protection
before relapse. In the present study, this finding was acknowledged, all therapy sessions
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were audio-taped and adherence to the present adaptation of IPT was rated by an
experienced IPT therapist (KC).
1.73 Therapeutic Alliance andPerfectionism
More recently, Zuroff et al. (2000) re-examined the TDCRP dataset for the relationship
among perfectionism, perceived relationship quality, and the therapeutic alliance. These
authors demonstrated that (a) the patient contribution to the alliance and the perceived
quality of the therapeutic relationship were independent predictors of outcome, (b)
perfectionistic patients demonstrated smaller increases in the Patient Alliance factor over the
course of treatment and (c) the negative relation between perfectionism and outcome was
explained by perfectionistic patients' failure to develop stronger therapeutic alliances. The
authors found no evidence that the results were moderated by treatment condition. Therefore,
the roles of perfectionism and the therapeutic alliance were not demonstrably different in the
CBT or IPT groups. The study could be criticised for the measure of perfectionism used, the
Perfectionism sub-scale of the DAS. It would also be interesting to determine whether
similar results would have been obtained if the perspective of the patient, therapist and
observer had all been utilised.
Therefore, from the above, it can be concluded that IPT is equivalent in efficacy to well
controlled pharmacotherapy in bringing about a remission of depressive symptoms and has
been adapted to other disorders and to alternative formats as is discussed below.
1.8 ADAPTATIONS OF IPT
The following section is dedicated to a description of the various forms of adaptations of
IPT, many of which are still in their infancy, with only pilot data available to suggest
whether the adapted format is feasible. Where available, efficacy data has been included in
the description.
1.81 IPT andMoodDisorders
In terms of mood disorders, IPT has been adapted for Recurrent Major Depression (IPT-M)
and Dysthymic Disorder (IPT-D). IPT-M is a monthly maintenance form of IPT (Frank,
1991) which differs from acute IPT in that it is scheduled to continue once a month, for 3
years; the aim is to delay or prevent relapse. Therapists and patients can choose to shift
amongst the four focus areas, rather than adhering to a particular focus (Frank, 1991). The
study conducted by Frank et al. (1991) demonstrated that even in an extremely high risk
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group, a monthly dosage of IPT-M provides an average of a year and a half of protection
against recurrence.
IPT-D was developed by Markowitz (1998) for dysthymic disorder and was considered to be
important for several reasons including the observation that approximately half of those
diagnosed with dysthymic disorder, do not respond to antidepressant medications
(Markowitz, 1994). IPT-D was developed to confront the interpersonal difficulties that are so
prominently a part of the disorder and to help patients to develop their social skills whilst
alleviating their tenacious mood disorder. In this adaptation, patients are encouraged to re-
conceptualise what they have seen as their lifelong character flaws as ego-dystonic, chronic
mood-dependent symptoms as chronic "state" rather than "trait". There is no efficacy data as
yet from clinical trials although there are trials underway for IPT-D (Steiner et al. 1998).
Pilot data has been reported as being positive, in terms of reducing symptoms of depression,
and has been associated with significant economic savings in direct use of health care and
social services in the US (Steiner et al. 1998).
IPT has been adapted for different groups of patients presenting with Major Depression such
as: older adults (Reynolds et al. 1999); adolescents (Moreau, Mufson, Weissman and
Klerman, 1991; Mufson, Weissman, Moreau and Garfinkel, 1999;); medically ill (Stuart &
Cole, 1996); ante and post-partum (Stuart, 1999) and HIV (Markowitz, Klerman & Perry,
1993). Some of the research, which has adapted IPT, has adapted the manual in order to meet
the psychosocial needs and problem areas of specific populations. As an example, Mufson,
Moreau, Weissman and Klerman (1993) modified IPT to incorporate adolescent
developmental issues (IPT-A) and added a fifth problem area of the single-parent family, an
interpersonal situation found frequently among adolescents (Appendix 3.0 for specialised
manuals).
1.82 Use of IPT in Other DiagnosticAreas
Following the demonstration that IPT is effective in the treatment of mood disorders, the
therapy has been expanded to other diagnostic areas such as the following:
1.821 Eating Disorders
■ Bulimia Nervosa
Fairburn et al. (1991, 1993, 1995) altered IPT for two studies of bulimic patients. The
research demonstrated that IPT had long-term benefits, which were comparable to CBT and
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superior to a behavioural control condition. Although the patients in the CBT group showed
initial advantages (Fairburn et al. 1991), overtime patients in CBT and IPT made equivalent
and substantial changes across all symptom domains (Fairburn et al. 1993). At one-year
follow-up, IPT and CBT demonstrated equal efficacy, with each superior to BT. In the first
trial of IPT for bulimia nervosa, there was no significant adaptation of the original model of
IPT and eating problems were not addressed in the therapy (Fairburn, 1993). The bulimia
nervosa was diagnosed as a medical illness and then linked to an interpersonal problem area
in a formulation.
■ Anorexia Nervosa
McKenzie, Bulik, McKenzie, Luty and Jordan (2000) have developed IPT for outpatients
with a diagnosis of anorexia nervosa, in a similar way to Fairburn et al. (1995) for bulimia
nervosa, as described above. The four problem areas and IPT strategies remain unchanged in
IPT for anorexia nervosa; to date there is no efficacy data available.
■ Binge Eating Disorder
Wilfley et al. (1993) have adapted IPT for Binge Eating disordered patients in a group
format. In their initial study, Wilfley et al. (1993) demonstrated that group treatment using
either CBT or IPT was more effective than a waiting list control, in terms of reducing the
binge eating. Results were sustained at a one-year follow-up.
1.822 Substance Related Disorders
IPT cannot be claimed to efficacious in treating patients with substance misuse problems or
substance dependence. There have been two trials to date with substance abusers, both of
which failed to demonstrate efficacy. The first trial was conducted by Rounsaville, Glazer,
Wilber, Weissman and Kleber (1983) who found recruitment difficulties and high dropout
rates. Symptomatic improvement was not specific to IPT when compared to standard
treatment for opiate users on methadone maintenance (Rounsaville et al. 1983). In a separate
trial Carroll, Rounsaville, and Gawin (1991) discovered that 12 weeks of IPT was ineffective
or marginally worse than Behavioural Therapy (relapse prevention) for cocaine abusers




Modification of IPT is currently being conducted for Social Phobia by Lipsitz et al. (in
press). IPT is also being modified for Panic Disorder but as yet there is no efficacy data
(Weissman, Markowitz and Klerman, 2000).
1.83 IPT in other Formats
The actual format of IPT has also been altered i.e. from individual psychotherapy to a group
format (Wilfley, Frank, Welch, Spurrell and Rounsaville, 1998). Interestingly, until Wilfley
et al. (1998) proposed a set of questions to act as a template for making adaptations of
manualised treatments, no research literature or formal guidelines existed.
"...our questions and our solutions are generalisable and will be useful to other clinical
researchers undertaking the process ofadaptation. "
Wilfley etal. (1998) p380
Other formats include IPT by telephone (Donnelly et al. in Weissman, Markowitz &
Klerman, 2000) however, the authors report the limitations of such an approach and suggest
that the efficacy is pending. A patient guide has also been developed (Weissman, 1995)
which includes worksheets and is presented in a user-friendly manner; the authors again
report that there is no efficacy data for use of such a manual.
Conjoint IPT for depressed patients with marital disputes (IPT-CM) has been developed by
Foley (1990). Results from a pilot study of IPT-CM (IPT versus IPT-CM) demonstrated that
both groups of patients improved equally in symptoms and in social adjustment but those
who received IPT-CM showed greater improvements in marital adjustment and affectional
expression than did patients receiving IPT. The results from this pilot study however should
be read with caution due to the nature of the design, for example, the small sample size, the
lack of no-treatment control group, and the absence of an alternative psychotherapy of
proven efficacy.
IPT has also been adapted to a form known as Interpersonal Counselling (IPC, Klerman et
al., 1987; Weissman, 1993), a brief treatment (six 30 minute sessions) focused on the
patient's current psychosocial functioning and administered by health care professionals
(usually nurses.) IPC as a manual has not been published, however, the authors permitted
comparison of the IPC manual with the current adaptation (IPT-B) for the present study. IPC
was designed for distressed primary care patients who do not meet syndromal criteria for
psychiatric disorders. IPC was first tested with medical patients with stress symptoms
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(Klerman et ah, 1987; Weissman, 1993) demonstrating that when compared to a waiting list
condition, the difference in symptom severity post treatment was highly significant. The
authors therefore stated that IPC was a feasible intervention with patients presenting to
Primary Care with symptoms of distress and could be delivered by non-mental health nurse
practitioners.
1.84 Summary
1PT is a system of brief focal psychotherapy that has incorporated the theoretical positions of
Meyer, Sullivan and Bowlby as well as the empirical evidence linking differences in the
immediate social environment with the onset of depression. The IPT approach to
understanding and treating depression integrates the psychoanalytic perspective, which
emphasises childhood experiences with the cognitive behavioural perspective, with its
emphasis on current psychosocial stressors and ongoing difficulties. IPT has been adapted
and used successfully within different disorders and across different treatment modalities.
1.9 CONTEXT FOR THE PRESENT STUDY
The following section describes the context for the present study with an outline of the main
research questions, aims and hypotheses.
Within Primary Care (in Fife, Scotland) patients treated for depression are seen for an
average of 6-8 sessions, mainly using the Cognitive Behavioural Model for Depression
(Beck et al. 1979). As stated, IPT is a manualised treatment (Klerman et al. 1984) and calls
for 16 sessions, usually taken over 20 weeks. If therapists are to remain true to the model,
does that therefore restrict its use within Primary Care as patients are, on average, only seen
for 6-8 sessions? If IPT can be used in a briefer format to fit in with current practice does it
retain its efficacy?
It is interesting to note that one session per week for 12-20 weeks has become an industry
standard for the "short-term" psychotherapy of depression, however there is little empirical
evidence to support this particular format of therapy, regardless of the theoretical model
being employed. Indeed, Shapiro et al. (1994) have demonstrated that both mildly and
moderately depressed clients had equivalent, strongly positive outcome regardless of
whether they had been allocated 8 or 16 sessions of either cognitive-behavioural or
psychodynamic-interpersonal psychotherapy, however, this same standard has NOT been
applied to the adaptation of IPT.
32
CHAPTER 1: INTRODUCTION
1.91 Primary Care Guidelines for Major Depression
In recent years there have been efforts made to establish criteria against which the status of
psychological interventions is measured (Chambless, Baker, Baucom, Beutler, and Calhoun,
1998; Woody & Sanderson, 1998). In the UK, the intention is to devise clinical guidelines
and training and accreditation protocols, which are increasingly consistent with the evidence
base (Department of Health, 1998). The grading of evidence to be apportioned to each study
is based on the efficacy paradigm, which holds the randomised-controlled trial as its gold
standard. In 1996, NHS Strategic Review, Psychotherapy Services in England, set out a
programme for co-ordinated, evidence based, comprehensive, safe and equitable provision of
psychotherapy and pointed to the gap between these ideals and reality. The department of
Health recently (February 2001) published the 'Treatment Choice in Psychological
Therapies and Counselling Evidence Based Clinical Practice Guidelines' in which
recommendations were made with reference to the treatment of depression stating:
'Depression may be treated effectively with cognitive therapy or interpersonal therapy. A
number of other brief structured therapies for depression may be of benefit, such as
psychodynamic therapy ...CBT and IPT effectively reduce symptoms ofdepression' (p2)
The above statement was weighted according to Level A criteria, i.e. 'Based on consistent
finding in a majority of studies in high quality systematic reviews or evidence from high
quality studies' (pi). However, no indication was given as to how many sessions would be
effective and for what degree of severity of depression.
The American Psychiatric Association have recently revised their treatment guidelines for
the treatment of major depression (American Psychiatric Association, 2000) and become
more influenced and driven by the empirical literature. In an evaluation of the scientific basis
for the guidelines, it is noted that the efficacy of cognitive behaviour therapy and
interpersonal psychotherapy have been particularly well documented by the research
literature. The guidelines were influenced by more than 80 controlled trials of cognitive
behaviour therapies which were generally reported to be superior to minimal treatment
controls and at least as effective as other interventions to which they were compared (Gaffan,
Tsaousis & Kemp-Wheeler, 1995). The US guidelines also state that although interpersonal
psychotherapy has been tested in a smaller number of studies, it has consistently
outperformed control conditions and done at least as well as other interventions (Jarrett &
Rush, 1994; Rush and Thase, 1999).
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The US guidelines are organised into 3 parts with the first part being an overview of the
major treatment recommendations for acute treatment (resolution of symptoms),
continuation treatment (prevention of relapse) and maintenance treatment (prevention of
recurrence). The second part contains information on the nature of depression, including its
diagnosis and distribution in the population. There is also a review of the published literature
regarding the available treatments for depression with separate sections on drugs and
psychotherapy and combined treatment. The final part of the guidelines describes where
more research is needed to guide clinical decisions regarding treatment.
The guidelines do include recommendations for the selection of the initial modality of
treatment to be influenced by factors such as symptom severity and patient preference. It
further advises that at least some psychosocial interventions can be considered as the sole
treatment for patients with mild to moderate depression, but that medications or ECT should
be provided for patients with moderate to severe disorders. The guidelines also state that
preference should be given to those psychosocial interventions that have been shown to be
effective and notes that efficacy has been particularly well documented for cognitive
behaviour therapy and interpersonal psychotherapy.
It is interesting to note that the guidelines recommend assessing the adequacy of response
within 4 to 8 weeks and either altering or changing the nature of treatment in the event that
the response is less than complete but offers little direct guidance for the practice of the
psychosocial interventions.
Neurolink1 recently published the "Depression Guidelines: Recognition and Management in
General Practice. "The purpose of such is to provide GPs, and other healthcare professionals
in Primary Care, with key information points in order to improve the recognition of
depression and facilitate better management. Neurolink Guidelines state IPT to be "as
effective as CBT in mild to moderate depression ...it requires the same amount of time as
CBT" (p23). The Guidelines also state that CBT involves 8-16 hours and suggests studies
that demonstrate that mild depression responds in 6-8 sessions. The Guidelines, however, do
not cite any reference for this statement.
' Neurolink is an independent board of mental health experts supported by an educational grant from
Wyeth Laboratories since 1995.
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1.92 The SecondSheffield Study (Shapiro et al. 1994)
In a study of 117 depressed clients, stratified for severity, who completed 8 or 16 sessions of
manualised treatment, Shapiro et al. (1994) demonstrated an equal effectiveness when
comparing a cognitive-behavioural (CB) intervention versus psychodynamic-interpersonal
psychotherapy (PI), irrespective of the severity of depression or duration of treatment. The
authors reported that there was no overall advantage of 16 sessions treatment over 8 sessions
except in those presenting with relatively severe depression, who improved substantially
more after 16 sessions.
Shapiro et al. (1994) provided the present study with justification to determine whether 8
sessions of Interpersonal Psychotherapy for Depression (IPT) was effective in terms of
reducing the presenting symptoms of depression and improving the quality of interpersonal
relationships when compared to a waiting list control group.
Taking the above into account, the overarching research question was as follows:
Can Interpersonal Psychotherapy of Depression (IPT) be adapted to be briefer (IPT-B)
within a Primary Care setting and still remain effective in terms of reducing the symptoms
ofdepression and improving the quality of interpersonal relationships?
1.93 Research Questions
1. Compared to waiting list control, does IPT-B for depression produce significant
improvement in depressive symptomatology?
2. Compared to waiting list control, does IPT-B for depression produce improved quality of
interpersonal relationships?
3. Compared to waiting list control, does IPT-B for depression remain effective over time?
1.94 Aims andHypotheses of the Present Study
1. To determine whether IPT-B is effective in reducing the symptoms of depression
when compared to waiting list control.
Research Hypothesis 1: The adapted version of IPT to IPT-B is effective in reducing the
symptoms ofdepression when compared to waiting list control.
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2. To determine whether IPT-B is effective in improving the quality of interpersonal
relationships when compared to waiting list control.
Research Hypothesis 2: The adapted version of IPT to IPT-B is effective in improving the
quality of interpersonal relationships when compared to waiting list control.
3. To determine whether IPT-B is effective over time (using the same criteria for
effectiveness i.e. reduction for symptoms of depression and improvement of quality
of interpersonal relationships) when compared to waiting list control.
Research Hypothesis (3a): The adapted version of IPT to IPT-B is effective over time (10
weeks and 20 weeks post Baseline Assessment) in terms ofreducing symptoms ofdepression
and (3b): improving the quality of interpersonal relationships when compared to waiting list
control.
1.95 The Stages of the Present Study
1. Adaptation of IPT to IPT-B (adhering to the suggestions of Wilfley et al. 1998).
2. Development of the IPT-B Manual according to Klerman et al. (2000; Appendix 4.0).
3. Tested out on a Single Case Study (Appendix 5.0) in which results demonstrated an
overall considerable improvement in terms ofa reduction in symptoms ofdepression and an
improvement in the quality of interpersonal relationships over the course of treatment.
4. The results from the Single Case study provided justification for conducting the present 2
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Figure 1.0 Design of the Present Study.




An Adaptation of Interpersonal Psychotherapy for Depression within
Primary Care (IPT-Brief):




2.1 ADAPTATION OF IPT TO IPT-B: Brief overview of the process from single case
study to the present experimental v's control group design.
The present study aimed to determine whether a briefer version of Interpersonal
Psychotherapy for Depression (IPT-B) is effective in reducing symptoms of depression and
improving the quality of interpersonal relationships in patients presenting to Primary Care
with Major Depressive Disorder (MDD). In order to achieve these aims, it was necessary to
determine whether IPT could be adapted to a briefer version i.e. IPT to IPT-B and then to
determine whether the new brief version was effective in achieving the same aims within a
single case. As a preliminary step to the present study, a pilot study was conducted, which
involved the adaptation process (the original model of IPT to IPT-B) and application
utilising a single-case study design. The preliminary stage was consistent with advice
provided by the original authors of IPT. Indeed, the most recently published book by
Weissman et al. (2000) devotes a section on "How to Develop a Treatment manual." Even
though that advice was published a year after the original pilot study, the present study does
adhere to the recommendations. (Appendix 4.0 describes the steps as suggested by
Weissman et al. (2000) and the present author's response). A detailed description of the
preliminary stage of the study, the single-case pilot study, is provided in Appendix 5.0.
2.11 The Intervention used: Adaptation ofIPT to IPT-B
In adapting an individual treatment to an alternative format (i.e. IPT to IPT-B), the central
consideration was how best to preserve the hypothesised curative elements of the
manualised treatment whilst accommodating to the constraints imposed and opportunities
provided by the changed time limits (Wilflcy et al. 1998).
Wilfley et al. (1998) suggest that the elements which presumably constitute the active
ingredients must be identified. A consideration must also be made as to how the altered
therapeutic time may affect the delivery. Wilfley et al. (1998), in their discussion of the
provision of a standardised format for adapting manualised treatments2, suggest that the
following questions should be asked:
2
Wilfley et al., (1998) presented a paper on their adaptation of IPT from individual treatment to group treatment
and from MDD to BED. The questions posed in this section relate to their adaptation across modalities, i.e. from
individual treatment to group treatment.
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1. What are the effective change processes of the individual treatment and how will they
be preserved in the alteredformat?
2. How are the therapist and patient roles characterised in the individual treatment and
how will they be maintained in the [new]format?
3. What are the techniques of the individual treatment and how will they be delivered in a
[shortened] format?
The questions raised above were all taken into consideration when examining the differences
and similarities and subsequent adaptation of IPT to IPT-B (Appendix 6.0 and 6.1).
The adapted format of IPT to IPC (Interpersonal Counselling, Weissman, 1993) was used as
a comparison in both the pilot study and the present study, as IPC is the closest in style and
format to the abbreviated IPT-B model. IPC has not yet been published but the author
(Weissman, M.M.) kindly allowed comparisons to be made under the conditions that IPC
would not be copied, revised or renamed. Due to the restrictions, only general comparisons
appear in the current paper, however, detailed comparisons were made in order to adhere to
Wilfley's suggestions as noted above (Appendix 6.2).
Although the single-case pilot study had a number of attractive features, such as being
conducted fairly quickly and within routine clinical practice, the results of such a design can
be criticised for the potential difficulty of generalisation to a broader clinical population. The
results of the single-case pilot study, however, provided valuable justification for exploring
the abbreviated model of IPT further. The contrast of the waiting list control group was
required in order to be clear that any demonstrated benefits could be attributed to the
intervention. There are however criticisms of the present approach, which includes a control
group, as outlined in Chapter 4.0: Discussion.
2.2 FROM SINGLE CASE TO LARGER N PRESENT STUDY
2.21 PresentDesign
"The art of outcome research design becomes one of creative compromises based upon
explicit understanding of the implications ofthe choices made."
Shapiro (1989) p 164
The present study employed a randomised 2-group experimental versus control pretest-
posttest design: IPT-B Treatment versus waiting list control group. In 1997, Wampold
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highlighted the distinction between efficacy studies and effectiveness studies. The former
applies to:
"..well-controlled outcome research in which treatment groups are compared either to
control groups and/or to other treatment groups under experimental conditions. "
(Wampold, 1997 p22)
Effectiveness studies on the other hand assess:
. whether patients benefit from psychotherapeutic treatments under the conditions found in
settings where psychotherapy is actually administered by practitioners. Effectiveness studies
are essentially an assessment ofoutcomes ofpsychotherapy in uncontrolledfield settings "
(Wampold, 1997 p22)
In order to ensure that internal validity3 is achieved within an efficacy study, techniques
rarely used in clinical practice are employed including the following:
1. studying highly selected, diagnostically homogenous patient populations;
2. randomisation of patients into treatments;
3. employment of extensive monitoring of patients' progress
The above techniques however, may also pose a threat to external validity, i.e. the extent to
which we can infer that the causal relationship can be generalised.
The bridge between research trials and routine treatment is even more difficult to span
because of the vicissitudes of biology and individual psychological differences in treatment
response (Roth and Fonagy, 1996). As psychotherapy is a highly complex process, any
number of interacting factors could be significant to outcome but the priority of the present
research was to show an underlying causal relationship between improvement and
intervention (IPT-B). Realistic controls therefore were employed with regards to:




Referrals for the present study came from three Clinical Psychologists attached to five
Primary Care Out-Patient practices in West Fife. All patients who were referred to the
3 The extent to which a causal relationship can be inferred among variables, or where the absence of a
relationship implies the absence of cause.
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Department of Clinical Psychology, with a possible primary diagnosis of depression, were
referred to the study and assessed by the present author to determine their eligibility for
inclusion in the current study.
2.23 Entry Criteria
The sample was specified in terms of the inclusion and exclusion criteria, known collectively
as the entry criteria as follows:
1. Informed consenting adults between 18 and 65 years.
2. All participants who met the following criteria:
■ DSM-IV Diagnostic Criteria for Major Depressive Disorder as judged by the Structured
Clinical Interview for DSM-IV (SCID: First, Spitzer, Gibbon and Williams, 1997).
■ Diagnosis of depression as rated by Revised Hamilton Rating Scale for Depression
(RHRSD) and the Beck Depression Inventory-II (BDI-II). Severity was defined in terms
of cut-off scores on the pre-screening instruments.
" No depressive disorder severe enough to require immediate treatment.
3. All Participants considered depressive symptoms as their main problem.
4. All Participants were willing to accept random allocation including the Waiting List for
Treatment as Usual condition.
5. No evidence of organic mental disorder, schizophrenia, alcohol or drug dependence.
6. Concurrent Axis-II personality disorder was not a reason for exclusion unless the
personality disorder was clearly the primary problem.
7. Concurrent Axis-I anxiety diagnosis was not a reason for exclusion unless the anxiety
disorder was clearly the primary problem.
8. Participants who did not fulfil the entry criteria or who dropped out after randomisation
were offered treatment as usual at the Clinical Psychology Department.
9. Participants prescribed antidepressant medication agreed to remain on a stable regimen
throughout the duration of the study.
10. Participants who met selection criteria and agreed to enter the trial were assigned at
random, using the sealed envelope technique, to one of 2 conditions:
A. Immediate start IPT-B (treatment group) Patients were offered a series of
appointments to begin immediately post assessment with 2 follow-up appointments at end of
treatment and 2 months post end of treatment.
B. Waiting List for Treatment as Usual (control group) within the Clinical
Psychology Department. Patients were replaced on the waiting list where they had come off
and waited for the same amount of time for treatment as usual within the Department.
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Patients in this condition were given 2 follow-up assessment appointments at 2 and 4 months
post baseline assessment. Patients in this group would not have had any contact with the
Clinical Psychologist due to normal waiting times but would have been free to contact their
GP for any routine care.
Patients in both groups were asked to maintain a diary over the course of the study to
determine contact with any other professional, in order to minimise effects from any external
source.
2.24 The Issue ofBlinding
In many clinical trials of treatment, where there is some subjectivity in both disorder
definition and quantification of response, it is necessary to make the assessment of response
as objective as possible. In practice, this is helped by masking or blinding the assessor to the
identity of the allocated treatment. The current trial made no attempt to disguise the nature or
form of treatment to the patient and due to the design limitation (assessor and therapist being
the current author) group allocation was open to the assessor.
2.25 Randomisation
On entry to the trial, patients were allocated a trial number, which served as a unique
identifier on all records. The present trial utilised the sealed envelope technique (Gore,
1981) in which each envelope contained a card labelled with the same information as the
corresponding envelope together with the identity of the treatment allocated. Envelopes were
kept and opened in strictly increasing order of the serial numbers in each group; only one
envelope was used per patient and was opened only after the decision to randomise
treatment.
2.26 Measures ofOutcome
Morley's Assessment-Evaluation Funnel (Morley, 1989:Appendix 7.0) was used to
prospectively assess participants in both groups, at specified intervals, using multiple
measures of outcome appropriate to the disorder and to the goals of the treatment method
(Shapiro et al. 1994).
2.261: Structured Clinical Interview and Revised Hamilton Rating Scalefor Depression
In order to satisfy the demand for a standardised diagnostic measure and objective measure
(Shapiro et al. 1994) the Structured Clinical Interview for DSM-IV (SCID, First et al..
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1997) and the Revised Hamilton Rating Scale for Depression (RHRSD, Warren 1994)
were employed. Both versions of the RHRSD were used i.e. the Clinician Rating Form
(RHRSD-CV) and Self-Report Problem Inventory (RHRSD-PI). The total score on both
versions of the scale reflects the severity of depression and allows a confirmation or
disconfirmation of a diagnosis of Major Depressive Disorder. The RHRSD takes the form of
a clinical interview whilst the problem inventory is a self-report booklet which takes
approximately 15 minutes for the patient to complete, evaluating symptoms in the same
domains as the clinician-rated scales but in a true/false format. The problem inventory has a
reading age of approximately 11 years.
The original Hamilton scale (Hamilton, 1960) has often been reported to be the most
sensitive scale for measuring response to treatment and is probably the most widely used
scale in research on depression for describing levels of severity in different groups, to ensure
an adequate matching or to measure improvements in trials on treatment4. In order to retain
the relationship of the RHRSD to the research which has already been conducted on the
original Hamilton Scale, the RHRSD is constructed around the 17 original items. Items
which have been added to the revised version are as follows: three items relating to the
cardinal diagnostic indicators of depression plus five items designed to assess the
significance of symptoms in the area of social functioning.
The internal consistency of the RHRSD, as reflected by Cronbach's alpha, for the Clinician
Rating Form has been reported as 0.79 for the verification sample and 0.81 for the Self-
Report Problem Inventory (Warren, 1994). The level of reliability for each format of the
scale is reported as being consistent, with estimates of internal consistency ranging from 0.45
to 0.95 (Hedlung and Vieweg, 1979). The interrater reliability has been reported as being
high, ranging from 0.52 to 0.96 (Hedlung and Vieweg, 1979).
Warren (1994) reports that a posttreatment RHRSD Total Score of 10 or less or a decrease
by more than one-third in the initial severity level of the RHRSD Total Score is considered
to represent successful treatment response over the short term. The reduction in the RHRSD
Total Score must be maintained over the course of 6 months or more before an individual
can be considered to have recovered.
4 Zitman, Mennen, Griez and Hooper (1989) present a report in which they state that fewer than half of the
researchers whose published research they examined had actually used the form of the rating scale to which they
referred their readers. Out of 50 research centres, these authors could not identify two that had used exactly the
same version of the scale.
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2.262 Beck Depression Inventory-II
In order to satisfy the demand to be as specific as possible to the treatment being evaluated
and for self-report measures (Shapiro et al. 1994) the following measures were employed:
The Beck Depression Inventory II (Beck et al. 1996). The BDI-II consists of 21 items,
which assesses the intensity of depression in both clinical and normal clients. Each of the 21
items is arranged with a choice of 4 statements in increasing order of severity about a
particular symptom of depression. Each item is rated on a 4-point scale ranging from 0 to 3.
The maximum score is 63. The scale includes items which update the older version (BDI,
Beck et al. 1961) to the current diagnostic criteria of DSM-IV (APA, 1994). The older
version was based on the past 7 days, however, in line with DSM-IV, the time frame for the
BDI-II has been increased to the past 2 weeks. According to the authors of the BDI-II, this
version shows improved clinical sensitivity with a reliability of the BDI-II being higher than
the BDI (Coefficient Alpha = 0.92 for BDI-II and 0.86 for BDI; Beck, Steer and Brown,
1996).
2.263 World Health Organisation Quality OfLife Scale -Brefversion
The World Health Organisation Quality of Life Scale (WHOQOL Group, 1996). The
measure of quality of life responds not only to one of the overarching aims of IPT-B but also
as a response to the call for data on quality of life (Gladis, Gosch, Dishuk, and Crits-
Christoph, 1999). In their review of the controversies and evidence in empirically supported
psychological interventions, Chambless and Ollendick (2001) suggest that quality of life
measures will become the central outcome measure in future trials.
The WHOQOL-Bref was used to establish baseline scores and to examine changes in quality
of life over the course of the IPT-B Treatment. Quality of life is defined as follows:
"Individuals' perceptions of their position in life in the context of the culture and value
systems in which they live and in relation to their goals, expectations, standards and
concerns."
World Health Organisation (1996)
The WHOQOL is a generic quality of life measure and the abbreviated version the
WHOQOL-BREF provides a valid and reliable alternative to the lengthier WHOQOL-IOO.
The pilot study utilised the abbreviated version of the WHOQOL-IOO.
Since the pilot study was conducted in 1999, further research on the WHOQOL has been
reported by O'Carroll, Smith, Couston, Cossar and Hayes (2000) who state that the
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WHOQOL-BREF is useful in evaluating quality of life improvement following therapeutic
interventions. The 26-item questionnaire, derived from the 100-item parent WHOQOL-lOO,
covers 4 domains of Physical Capacity, Psychological, Social Relationships and
Environment. The Social Relationships domain was of primary interest in the present study
to examine perceived improvement in interpersonal relationships. O'Carroll et al. (2000)
suggest that the WHOQOL-BREF can reliably measure changes following therapeutic
interventions and that there is adequate test-retest reliability when assessed on a clinical
sample. These authors state that the WHOQOL-BREF therefore is satisfactorily responsive
to clinically meaningful change for the Physical, Psychological and Environmental domains
but there is a significant reduction in sensitivity to change on the Social dimension.
2.264 Significant Others Scale (B)
Significant Others Scale-B version: SOS (Power, Champion and Aris, 1988) assesses four
emotional and four practical social support functions in significant others. SOS(B) is a
version which allows the patient to select key individuals to be rated. Each rating has the
actual level of support received and the ideal level of support plus the discrepancy between
the two. Ratings are made on a seven-point rating scale where 1 equals 'never' and 7 equals
'always'. The scale takes approximately 10 minutes to complete and raw scores are obtained
for each type of support. Raw scores are summed across individuals to give separate
measures of emotional support and practical support. Total scores are then divided by the
number of individuals rated to give a mean for each type of support in each area. Power et al.
(1988) reported that the SOS has a satisfactory reliability and validity with test-retest
reliability over a six-month period ranging from 0.73 to 0.83 across the four summary
support scores.
2.265 Summary ofMeasures used in the Present Study
The present study therefore employed a combination of the following (Shapiro et al. 1994):
1. Objective measures (by the principle investigator)
2. Self-report measures
3. Standardised diagnostic and symptomatic measures
4. Measures as specific as possible to the treatment being evaluated
During treatment, individual targets were assessed using the following:
1. Beck Depression Inventory II (Beck, 1996).
2. Diary to assess any external contributors to differences (Appendix 9.0).
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For the Treatment group, immediately post session, the following questionnaires were
completed by the therapist (Rounsaville et al. 1986) for all patients.
1. Checklist and Rating Form: either initial sessions or termination (Appendix 10.0).
2. Therapist Strategy Form and Focus Rating Form (Appendix 10.1).
3. Process Rating Form (Appendix 10.2).
4. Overall Therapy Rating Form (Appendix 10.3).
Roth and Fonagy (1996) point out that the reduction of outcomes to a series of scores may be
unsatisfactory, as it undoubtedly fails to capture the complexity of the therapeutic work.
They argue that as the majority of current measures do not capture the subtleties of
individual presentations or the significance of particular changes to particular patients that
there is merit in the objection. For this reason, the current study includes case material for
two patients: IK, for whom the intervention IPT-B was deemed to be 'successful'; LN in
which IPT-B was deemed to be 'unsuccessful' according to pre-trial criteria described for
success, utilising RHRSD (both versions) and BDI-II as the main outcome measures.
2.27 The Manualsfor the Present Study
In an attempt to specify treatment purity (i.e. the extent to which a treatment is homogeneous
across sessions, whilst being consistent with a specified model), four manuals were
developed according to the suggestions raised by Wilfley et al. (1998) and in agreement with
Myrna Weissman, as original author of IPT. The manuals, reproduced from the original pilot
study, specify ways in which a therapist should behave within a particular treatment mode
and in response to particular clinical situations. Three manuals were devised for the current
study, each corresponding to a different focus area, as described earlier (Appendix 11.0).
"Manuals should not be cookbooks that stifle spontaneity. On the other hand, they must
provide guidelines sufficient that different therapists tend to respond in similar ways to key
therapeutic situations. A properly designed manual offers therapists reassurance that the
therapy has been carefully thought out and defined, has coherence, and addresses problems
that ma)> arise for the patient and therapist. It should contribute to the therapist's confidence
in the treatment, which can in turn be imbued to the patient."
Weissman et al. (2000) p387
Roth and Fonagy (1996) suggest that a treatment guideline should include patient
presentations that may be the 'exception to the rule' but that the advantages for widening a
protocol have to be balanced against the possibility that directives are diluted to the point
where they become inappropriately broad and flexible. The manuals developed for the
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present study provide session-by-session guidelines with added flexibility for formulation
within one of four focus areas as described earlier (Kendall, Chu, Gifford, Hayes and Nauta,
1998). According to Chambless and Ollendick (2001), the better manuals are richly
elaborated with examples of dialogue illustrating application of the procedures and with
descriptions of courses of action to take when problems arise in treatment. The present
manuals attempted to take this advice on board and provide examples of dialogue (Appendix
11.0). According to Chambless and Ollendick (2001), treatment manuals are necessary to
provide an operational definition of the intervention under study, because very different
procedures may fall under the general rubric of, for example, IPT. In terms of generalisable
knowledge, which is at the very heart of the present study, Chambless and Ollendick (2001)
state that it is meaningless to say that a treatment works without being able to say what the
treatment is.
2.28 Therapist Training
According to Margison and McGrath (1989), good design requires therapists to be trained in
order to maintain treatment consistency. In the current trial, only one therapist, trained in
Interpersonal Psychotherapy for Depression, utilised the manuals as specified. Indeed, the
treatment manuals, together with adherence monitoring, improved the interpretation of the
results of the current study. Adherence to the model was monitored, both by the present
author and by an independent rater (KC), through audiotaped sessions and use of rating
forms (Appendices 10.0-10.3).
2.29 Follow-up Data
The success of the intervention, IPT-B, was measured by its ability to improve patient
functioning and to maintain that improvement after therapy ended. According to Roth and
Fonagy (1996), the length of follow-up required to demonstrate a clinical effect is governed
by the natural history of a disorder, which will suggest both the probability of relapse and the
usual length of time between episodes. Therapeutic efficacy can only be demonstrated in the
context of both factors. However, there is an important consideration to make when deciding
how long the follow-up period should be, as the longer a patient is followed up, the more
difficult it is to ascribe change to the original treatment. Therefore, whilst the results of very
prolonged follow-up may be desirable, they may be difficult to interpret. In the present
study, the length of follow-up was dictated according to the strict timetable imposed, and




Time HBaseline; Time 2:End-of-Treatment and Time 3:2-month follow-up.
Waiting List Control Group:
Time 1: Baseline; Time 2: 2-months post-baseline and Time 3: 4-months post-baseline.
Times of the control group correspond to the timing of reassessment of the treatment group.
2.30 The Issue ofAttrition
The present study aimed to report on the basis of an "intention-to-treat" sample, including all
participants who entered into the trial, regardless of whether they completed treatment
(Chambless and Ollendick, 2001) as well as presenting separate data for those completing all
therapy. Outcome data analyses were therefore conducted on two samples of patients:
1. The Intention to Treat sample included all patients who entered treatment and completed
baseline assessment and at least 3 sessions of IPT-B.
2. The completer sample included all patients who completed 8 sessions of IPT-B and all
assessment sessions.
According to Elkin et al. (1989) the completer analysis will best reflect treatment effects for
those patients who have received a full course of treatment. The results of the Intention to
Treat analysis may be considered an estimate of the overall performance of a treatment
programme, including its ability to retain patients in treatment. Data on both samples is
included to provide the most complete and accurate representation of the findings.
2.31 Clinical and Statistical Significance
In psychotherapeutic trials, it is conventional to report the statistical significance of
differences between treatments in terms of a confidence level ofp < 0.05 or <0.01. However,
as Sterne and Smith (2001) state, the null hypothesis may be rejected at relatively high levels
of statistical significance without simultaneously demonstrating that the finding is worthy of
clinical attention. The demonstration of statistical effects may not be equivalent to a
clinically significant therapeutic change and therefore a number of strategies have been used
to detect this; Jacobson and Truax (1991) suggest criteria for the evaluation of clinically
significant changes in psychotherapy. Definition and subsequent application of the criteria





It is essential in any health outcome research that the study has sufficient power to detect
treatment effects (discussed in Chapter 3.0:Results). In order to minimise threat to the
external validity of the research the following were adhered to (Dar, Serlin and Omer, 1994):
1. Planned rather than post hoc statistical decisions.
2. Reduced use of multivariate techniques.
3. Avoidance of the use of stepwise statistical procedures.
Power analyses were used prospectively during the design stage to confirm the sample size
required (N=25 in each group for a large effect, Clark-Carter, 1997).
2.33 Analysis ofData
Overall statistical analyses were carried out using the Statistical Package for Social Sciences
for Windows, Version 10. Variables were compared using ANOVA, T-Tests and Simple
Regression for predictor analysis. Reliable clinical change was assessed utilising criteria as
defined by Jacobson and Truax (1991) and Warren's criteria for the definition of successful
treatment was applied to the severity of depression outcome data. Effect size was used as a
measure of improvement and the summary of effects was calculated, in terms of the number
needed to treat.
2.34 Economic Evaluation
An economic evaluation was conducted alongside the study in order to examine the cost
effectiveness of IPT-B as compared to routine clinical practice (12-20 weeks CBT). This was
carried out in accordance with guidelines for health technology assessment, as required by
both the National Institute for Clinical Excellence (NICE) and the Health Technology Board
for Scotland (HTBS).
A cost effectiveness analysis was carried out from the perspective of the NHSScotland.
Conduct of the analysis was according to published guidelines (Drummond, O'Brien,
Stoddart and Torrance 1986). The summary measure was cost per successfully treated
patient. The outcome measure of successfully treated patient was defined as a patient whose
BDI score was <9, as used by Elkin et al. (1989) in the NIMH Study.
For comparative purposes, an estimate of the relative cost effectiveness of routine clinical
practice was made; a prospective study is now indicated following the results of the main
study. As with all economic evaluations a number of assumptions were made, thus a
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sensitivity analysis was carried out to investigate the impact of the main assumption (number
of routine clinical practice CBT sessions is 18) on the cost effectiveness results.
2.35 Collection ofResource Use Data
In order to calculate the costs associated with the two different models of therapy, it is
necessary to collect data concerning the use of health care resources in the delivery of these
interventions. An attempt was made to collect resource data using patient diaries (Appendix
9.0) however it was found that participants in the study, regardless of group allocation, failed
to comply with completing the diary information. Concerns about compliance with paper
diaries are widespread and indeed the validity of using this method has recently been called
into question (Stone, Shiffman, Schwartz, Broderick and Hufford, 2002).
In economic evaluation, it is good practice to compare the experimental intervention with
standard clinical practice; due to the constraints of the study, it was not possible to
prospectively collect resource use and outcome data concerning standard clinical practice.
Therefore, published data were used to estimate the relative cost effectiveness ofCBT (Elkin
et al. 1989).
The cost calculations were based on Clinical Psychologist-patient contact time for both the
study data and the standard clinical practice comparator. It should be noted that the IPT-B
sessions were in fact delivered in the present study by a Trainee Clinical Psychologist
qualified in IPT. A median number of 18 sessions of CBT were delivered by either a
Psychologist or a Psychiatrist in the NIMH study (Elkin et al. 1989). Calculations are based
on CBT being delivered by a Community Clinical Psychologist, as it is the relevant
comparison in the Primary Care setting. The NIMH study reported that 16-20 sessions of
CBT were delivered, the effect of this minimum and maximum number of sessions was
explored in sensitivity analysis. The comparator intervention of IPT-B was costed at 8
sessions per patient. The net cost per patient contact with a community clinical psychologist
(Scottish Health Service Costs, 2001) includes the direct costs of staff time plus allocated
costs (such as administration, cleaning, rent, rates etc.).
The other area of resource consumption that may impact on results is the use of
antidepressant medication. As information concerning antidepressant useage was not
available for the study patients (due to failure to complete resource use diaries) the effect of
the most extreme scenario was tested in sensitivity analysis of the base case results. This
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involved the addition of antidepressant drug costs to the cost of treating all IPT-B patients as
compared to the treatment costs alone for all CBT patients (i.e. assuming that all IPT-B
patients were receiving antidepressants whilst none of the CBT patients were). A further
assumption that was made was that the cost of Seroxat 20mg daily (British National
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3.0 PROCESS OF DATA ANALYSIS
The process of data analysis was carried out and reported in the following phases:
1. Description of the samples (intention-to-treat and completer)
2. Exploratory data analysis prior to statistical analysis
3. Confirmatory statistical outcome analyses related to the main hypotheses in two stages
as these relate to the overarching aims of IPT-B: (1) to reduce the symptoms of
depression and (2) to improve the quality of interpersonal relationships
m SEVERITY OF DEPRESSION
■ Primary analyses related to main hypotheses 1 and 3(a)
Mixed Factorial Design RepeatedMeasures ANOVA
■ Effect size as a measure of improvement: samples stratified for severity
■ Clinical significance
Jacobson's Reliable Change Index (Jacobson and Truax, 1991)
■ Overall impression of improvement
Warren (1994)
■ Secondary analyses
Simple Regression for Predictor Analyses
121 QUALITY OF INTERPERSONAL RELATIONSHIPS
Primary analyses related to main hypotheses 2 and 3(b)
Mixed Factorial Design RepeatedMeasures ANOVA
Secondary Analyses
Mixed Factorial Design RepeatedMeasures ANOVA
The remaining section of this chapter present results for the economic evaluation of IPT-B as
compared to an estimated CBT.
CHAPTERS: RESULTS
3.1 DESCRIPTION OF THE SAMPLES
3.11 Patient Characteristics
As discussed earlier, the present study aimed to report on the basis of an 'intention-to-treat'
sample, including all participants who entered into the trial, regardless of whether they
completed treatment (Chambless and Ollendick, 2001) as well as presenting separate data for
those completing all therapy. Outcome data analyses were therefore conducted on two
samples of patients: (1) The intention-to-treat sample included all patients who entered
treatment and completed at least 3 sessions of IPT-B. (2) The completer sample included all
patients who completed 8 sessions of IPT-B.
According to Elkin et al. (1989) the completer analysis will best reflect treatment effects for
those patients who have received a full course of treatment. The results of the intention-to-
treat analysis may be considered an estimate of the overall performance of a treatment
programme, including its ability to retain patients in treatment. Unless otherwise stated, data
on both samples is provided to give the most complete and accurate representation of the
findings.
A total of 81 patients were referred to the study, 58 (71.6 percent of total referred) of whom
were fully assessed using the battery of questionnaires and Structured Clinical Interview.
Twenty three (28.4 percent) patients were offered at least 2 assessment appointments and
failed to attend. Nine (11.1 percent) patients were referred who did not reach inclusion
criteria or were inappropriate. Table 5.0 describes the two samples of patients considered for
statistical analyses. The total number of patients entered into the study following full
assessment was 49 (60.5 percent of original number referred to the study). Total numbers of










M W D Se Si
Treatment:
Completer
14(16) 35.76 63.3 2 10.2 4.1 20.4 36.7 percent
Treatment:
Intent to Treat
26 (23) 35.73 61 3.8 11.5 7.7 15.4 42.2 percent
M= married/cohabiting; W= widowed; D= Divorced, Se= Separated; Si = Single













IT 2 (2 month
follow up)
IPT - B 26 22 21 21
Waiting List
Control
23 N/A 20 19
Table 6.0: Total Participant Numbers
3.12 Early Terminator Group
Because differential dropout can introduce bias in the results and affect interpretation of
findings, comparisons of those patients who completed treatment with those who did not on
the major demographic and clinical variables obtained before treatment were conducted. No
significant differences were found between the early terminator group and the completer
sample on any demographic or baseline major outcome measure (BD1-II; RHRSD-CV or
RHRSD-PI). Compared to the completer sample, the early terminators were younger (mean
age 29) but there were no significant differences found in age between the two groups (t(24) =
1.21, n.s,p=0.24)5
5 The lack of statistical difference between the early terminator group and the completer group may have been
due to a very small number of early terminators. Effect size was found to be 0.64. In order to achieve power of
0.8, 45 participants in each group would be required to detect a significant difference with the moderate effect
size obtained (Clark-Carter, 1997).
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3.2 EXPLORATORY DATA ANALYSIS PRIOR TO STATISTICAL ANALYSIS
3.21 Statistical Power, Effect Size and Significance Level
Statistical power, defined as the probability of avoiding a Type II error (Power = 1-6) was set
at 0.8. Clark-Carter (1997) argues that this is a reasonable level of power to aim for i.e. the
probability of making a Type II error (6) is 1-power = 0.2. Power analyses were used
prospectively during the design stage for ANOVA, to confirm the sample size required
(n=25 in each group for a large effect). The effect size, independent of sample size, is stated
for each result reported, to allow for future comparisons of the data. Ho was rejected if the p-
value was less than a 0.05.
Prior to conducting any statistical test, an appropriate exploration of the data set was
undertaken in order to ascertain the suitability for the specified test. As the performance of a
statistical test presupposes that certain assumptions about the data are correct, the
assumptions underlying the model of each test conducted were examined and adhered to.
3.22 InitialAnalyses Prior to the Principal Analyses
A one way ANOVA revealed no significant differences between the treatment group and the
control group at baseline for the major outcome measures, for either of the sample
populations: BDI-II: F(i,47)=l.43; n.s. p=0.24\ Eta squard=0.3; RHRSD-CV: F (i,47)=0.06;




3.3 CONFIRMATORY STATISTICAL OUTCOME ANALYSES
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Results are described according to the above outcome measures. Table 7.0 presents means
and SDs for the three outcome measures, in each of the two samples.
TREA 1 MEN I CONTROL
N Mean (SD) N Mean (SD)
IXTFXTfOX TO rnFATSAMPLE in ,
BDI-II
Baseline 26 27.73 (11.97) 23 31.70(11.14)
End of Treatment 26 15.12 (11.87) 23 24.22 (12.09)
2 Month Follow up 26 13.04 (11.23) 23 23.65 (13.42)
Hamilton Clinician Version
Baseline 26 17.88 (6.64) 23 17.43 (6.54)
End of Treatment 26 9.77 (6.85) 23 14.65 (9.15)
2 Month Follow up 26 9.04 (6.59) 23 14.30(9.04)
Hamilton Patient Version
Baseline 26 22.65 (8.02) 23 22.52 (6.85)
End of Treatment 26 15.69 (9.75) 23 19.83 (9.89)
2 Month Follow up 26 13.54 (10.39) 23 18.65 (11.38)
■
, COMPI ETER SAMPLE
BDI-II
Baseline 14 26.93 (13.10) 16 33.44(11.53)
End ofTreatment 14 14.71 (13.48) 16 24.63 (11.93)
2 Month Follow up 14 10.86(1 1.93) 16 23.81 (13.86)
Hamilton Clinician Version
Baseline 14 18.29 (7.18) 16 18.56 (6.24)
End of Treatment










Baseline 14 22.21 (8.76) 16 23.31 (6.94)
End ofTreatment 14 12.29 (8.86) 16 20.75 (9.42)
2 Month Follow up 14 8.29 (8.11) 16 19.06 (11.73)





3.31 Primary Analyses Related to Main Hypotheses 1 and 3(a)
2x(3) Mixed Factorial Desigti RepeatedMeasures ANOVA
For all 2x(3) Mixed Factorial Design Repeated Measures ANOVAs described below, any
reported unplanned pairwise multiple comparisons (which followed the significant
interaction) employed the Bonferroni method6 with a significance level set at 0.02. For all
analyses: Time l=baseline; Time 2=end-of-treatment; Time 3=2-month follow up.
The following analyses relate to Research Hypotheses 1 and 3(a) as follows:
■ Research Hypothesis 1: The adapted version of IPT to IPT-B is effective in
reducing the symptoms of depression when compared to waiting list control.
■ Research Hypothesis 3(a): The adapted version of IPT to IPT-B is effective over
time in terms of reducing symptoms of depression when compared to waiting list
control.
3.311 Outcome Measure 1: BDI-1Iwith Intention-to-Treat Sample
The main effect of time was significant F(2,94)=40.23; p<0.01; Eta squared=0.5 and there
was clearly a significant difference in performance between the two groups of patients
F(l,47)=6.80; p<0.01\ Eta squared=0.2. The interaction Group x Time was also significant
F(2,94)=3.161; p<0.05; Eta squared=0.1. Graph 1.0 shows that although both groups report
reduced symptoms of depression over time, the difference between Time 1 and 3 for the
treatment group was greater t(25)=5.94; p<0.01; d=l .3; than it was for the control group
t( 15)=3.08; p<0.01\ d=4.97.
6 The Bonferroni method was used to adjust the significance level by dividing the per family
significance level of 0.05 by 3 (3 possible comparisons, the Bonferroni corrected T Tests are required
to show significance beyond the 0.02 level). This more stringent criterion helps reduce the risk of











Graph 1.0: Time of assessment (l=baseline; 2=end; 3=follow up) of BDI-U across two groups of
patients within the Intention-to-Treat Sample
3.312 Outcome Measure 1: BD1-II with Completer Sample
As for the previous sample, the main effect of time was significant F(2,56)=29.64; p<0.01;
Eta squared=0.5 and there was a significant difference in performance between the two
groups of patients F(l,28)=3.56; pO. 05: Eta squared=0.2. The interaction Group x Time for
the Completer sample, however was not significant F(2,56)=1.64; n.s. p=0.20; Eta
squared=0.05. Graph 2.0 shows that both groups report reduced symptoms of depression
over time but the treatment group continue to report a decrease in depressive symptoms
(from Time 2 to Time 3 t(13)=2.28; n.s; p 0.04', d=0.3, whereas die control group do not
t(15)=0.57; n.s,p=0.57; d=0.07).
TIME
Graph 2.0: Time of assessment (l=baseline; 2=end; 3=follow up) of BDI-1I across two groups of




3.313 Outcome Measure 2: RHRSD-CV with Intention-to-Treat Sample
The main effect of time was significant F(2,94)=26.33; p<0.01; Eta squared^O.4 but there
was not a significant difference in performance between the two groups of patients
F(l,47)=2.98; n.s. p=0.91; Eta squared=0.6. The interaction Group x Time is significant
F(2,94)=6.12; p f).01: Eta squared=0.1. Graph 3.0 shows that although both groups report
reduced symptoms of depression overtime, it is clear that a similar result as for the BDI-II is
obtained, in that the difference between Time 1 and 3 for the treatment group t(25)=5.34;
p<0.01; d= 1.3, is greater than it is for the control group t(22)=2.14; n.s. p 0. 04: d=0.5.
TIME
Graph 3.0: Time of assessment (l=baseline; 2=end; 3=foIIow up) of RHRSD-CV across two
groups of patients within the Intention-to-Treat Sample
3.314 Outcome Measure 2: RHRSD-CVwith Completer Sample
Examination of the results for the Completer Sample indicate a similar pattern as described
above, with a significant Time effect F(2,56)=28.66; p<0.01; Eta squared=0.5; a significant
TIME
Graph 4.0: Time of assessment (l=baseline; 2=end; 3=follow up) of RHRSD-CV across two




interaction between Time and Group F(2,56)=8.83; p<0.01; Eta squared=0.2 but for this
sample a significant difference between the groups was obtained F(l,28)=5.76; p=0.02; Eta
squared=0.2, as shown in Graph 4.0. Although both groups report reduced symptoms of
depression over time, the difference between Time 1 and 3 for the treatment group was
greater t(13)=6.82; p<0.01\ d=2.40, than it was for the control group t( 15)—1.75; n.s;
p=0.10; d= 0.6 (Graph 4.0).
3.315 Outcome Measure 3: RHRSD-PI with Intention-to-Treat Sample
The main effect of time was significant F(2,94)=20.63; p<0.01: Eta squared=0.3 but there
was no significant difference between the groups F(l,47)=1.56; n.s; p=0.22; Eta
squared=0.03. Tire interaction Group x Time, was significant F(2,94)=3.53; p=0.03\ Eta
squared=0.7. Graph 5.0 shows that although both groups report reduced symptoms of
depression over time, it was clear that the difference between Time 1 and 3 for the treatment
group was greater t(25)=4.70; p<0.01; d=0.9, than it was for the control group t(22)=2.43;
n.s; p=0.02,d=0.6.
TIME
Graph 5.0: Time of assessment (l=baseline; 2=end; 3=foIIow up) of RHRSD-PI across two
groups of patients within the Intention-to-Treat Sample
3.316 Outcome Measure 3: RHRSD-PI with Completer Sample
Examination of the results for the Completer Sample indicate a similar pattern as described
above, for the Intention-to-Treat Sample, with a significant time effect F(2,56)=21.90;
p<0.01; Eta squared=0.4 a significant interaction between Time and Group F(2,56)=6.47;
p<0.01; Eta squared=0.2 but for this sample, a significant difference between the groups
was obtained as shown in Graph 6.0, F(l,28)=5.40; p=0.02; Eta squared=0.2. Graph 6.0




that the difference between Time 1 and 3 for the treatment group was greater
t(13)=5.4;p<0.01; d=1.6than it is for the control group t(15)=2.04; n.s; p=0.06;d=0.6.
TIME
Graph 6.0: Time of assessment (l=baseline; 2=end; 3=foIlow up) of RHRSD-PI across two
groups of patients within the Completer Sample
3.317 Summary ofAnalysis ofPrimary Severity ofDepression Outcome Measures
The general direction of results was similar in all analyses and for both samples. Over time,
both treatment and control groups (in both samples) reported decreased symptoms of
depression but the difference between baseline and 2-month-follow up was generally greater
in the treatment group than in the control group, indicating a significant improvement in




3.4 EFFECT SIZE with SEVERITY OF DEPRESSION
As a measure of improvement (in terms of severity of depressive symptoms) expressed as an
effect size, for the IPT-B treatment group, depressed patients from both samples, showed a
substantial improvement using the major outcome measures of BDI-II, RHRSD-CV and
RHRSD-PI. Tables 8.0 and 9.0 show that for both samples, large effect sizes were obtained


























BDI-II 27.73 11.97 15.12 1.05 13.04 1.22
RHRSD
CV
17.88 6.64 9.77 1.22 9.04 1.33
RHRSD
PI
22.65 8.02 15.69 0.87 13.54 1.14
























BDI-II 26.93 13.10 14.71 0.93 10.86 1.41
RHRSD -
CV
18.29 7.18 7.36 1.52 6.00 1.79
RHRSD
PI
22.21 8.76 12.29 1.13 8.29 1.79
Table 9.0: Effect Sizes for Completer Sample at the End-of-treatment and at Follow Up
3.41 Exploratory Analyses Using Initial Severity ofDepression and Effect Size
By design, the patient sample included a fairly wide range of depression, however it has
previously been suggested that the initial level of severity is associated with outcome of
treatment (e.g. Elkin et al. 1989) and this was indeed found within the present study. The
samples therefore were divided into those presenting with less severe symptoms of
depression at baseline and those presenting with more severe symptoms. These analyses
were considered to be exploratory, as the design did not include stratification on this
variable. Severity was defined using the Clinician Rated version of the RHRSD and a score
of >20. Tables 10.0 and 11.0 show that in both samples, patients presenting with more severe




those with less severe symptoms; the improvement increasing with time from end-of-






























BDI-1I 33.46 33.46 10.19 10.19 19.15 19.64 1.40 1.36 15.85 14.44 1.73 1.88
RHRSD -
CV
23.31 23.31 3.25 3.25 12.00 10.36 3.48 3.98 10.23 7.78 4.02 4.78
RHRSD -
PI
26.38 26.38 7.72 7.72 17.69 15.00 1.12 1.47 14.54 9.33 1.53 2.21
Table 10.0: Effect Sizes for Patients Presenting with Severe Depression at baseline (RHRSD>20)
Intent = Intention-to-Treat Sample






























BDI-II 25.13 25.13 12.37 12.37 11.69 10.83 1.08 1.16 10.94 8.86 1.15 1.32
RHRSD -
CV
13.88 13.88 4.81 4.81 9.00 6.42 1.01 1.55 8.94 5.00 1.03 1.85
RHRSD -
PI
20.94 20.94 8.93 8.93 15.44 11.50 0.62 1.06 14.00 8.29 0.77 1.42
Table 11.0: Effect Sizes for Patients Presenting with Less Severe Depression at Baseline
(RHRSD<20) Intent = Intention-to-Treat Sample




3.5 CLINICAL SIGNIFICANCE OF RESEARCH FINDINGS
The clinical significance of research findings is an important issue and one that is often
neglected (Ogles, Lambert and Sawyer, 1995). The present study therefore sought not only
to present statistical significance for group means, but also the variety of individual
responses to treatment and the practical meaningfulness of individual change. Jacobson and
Truax (1991) have proposed two criteria for assessing clinical change: (1) patients who
receive treatment should move from a theoretical dysfunctional population to a functional
population as a result of treatment and (2) the change must be reliable. Movement into the
functional distribution is determined by establishing a cut-off score beyond which patients
are considered to be more similar to the functional group than the dysfunctional group. The
criterion chosen to represent clinically significant change was Criterion C:
"The level offunctioning subsequent to therapy places that client closer to the mean of the
functional population than it does to the mean ofthe dysfunctional population. "
Jacobson and Truax (1991) pi3: Criterion C
It is based on the relative likelihood of a particular score ending up in dysfunctional versus
functional population distributions. Clinically significant change would be inferred when a
post-treatment score falls within the functional population on the variable of interest. When
the score satisfies this criterion, it is statistically more likely to be drawn from the functional
than from the dysfunctional population.
Reliability is determined by calculating a reliable change index (RCI), which if greater than
1.96, suggests that the pre-to post-treatment change is not a product of random fluctuations
in test scores. If the patient meets both criteria, the pre to post treatment change is identified
as clinically significant (Jacobson and Truax, 1991).
The outcome measures selected for evaluating clinical significance in both samples, were the
BDI-II, RHRSD-CV and RHRSD-PI. Reliability estimates were obtained from published
studies or test manuals (e.g. the BDI-II (Beck, Steer and Brown, 1996)), the Revised
Hamilton Rating Scale for Depression (RHRSD-CV and PI; Warren, 1994).
Descriptive statistics for a functional population were obtained from normative samples




in the IPT-B treatment group demonstrated reliable change on all three major measures of



























































































































Tablel2.0: Evaluation of Clinically Significant Change in Two Sample Populations
Intent = Intention-to-Treat Sample
Comp = Completer Sample
BDI-II = Beck Depression Inventory-Il
RHRSD-CV = Revised Hamilton Rating Scale for Depression - Clinician Version
RHRSD-PI = Revised Rating Scale for Depression - Self Rated Problem Inventory.
RCI>1.96 represents the number of individual who reliably improved. Clinically significant change represents clinically
significant change using Jacobson's criteria of "the level offunctioning subsequent to therapy places that client closer to the
mean of thefunctionalpopulation than it does to the mean of the dysfunctionalpopulation" (Jacobson and Truax, 1991) using
SoMl + SIMo
C= So +SI
Deterioration represents the number of patients who reliably deteriorated.
Initial Score decreased by > 1/3 or - <10 at post treatment represent criteria according to Warren (1994) to define successful
treatment on the RHRSD
An interesting observation from the data presented in Table 12.0 is that the greatest change
was demonstrated through self-report on the RHRSD-PI whereby 73 percent of patients
made what is considered as a clinically significant change by 2-month follow up. In the
IPT-B treatment group, all initial changes observed at the end-of-treatment were maintained




3.6 OVERALL IMPRESSION OF IMPROVEMENT: WARREN (1994)
Warren (1994) suggests that one method of defining successful treatment is through the
observation that at follow up, the RHRSD score will have decreased by 1/3 in its initial
severity or equal to less than 10 at post treatment (0-6 months). Application of Warren's
criteria to the results of the full study reveals that at the end-of-treatment, 58 percent of the
IPT-B treatment group reached criteria for success on the RHRSD Clinician Rated version
whilst 65 percent reached criteria for success by 2 month follow-up. This result clearly
demonstrates patient improvement status over time, especially when compared to only 39
percent of the waiting list control group reaching criteria for success by 2 month follow-up.
For the Self-Rated version of the same scale, 54 percent of the IPT-B treatment group
reached Warren's (1994) criteria for success by 2 month follow-up, compared to only 39
percent of the waiting list control group. By Warren's (1994) criteria, IPT-B can certainly be
defined as a successful treatment for the majority of patients presenting to Primary Care in
the present study and certainly more successful in terms of reduction of symptoms of
depression than the waiting list control Group.
3.61 Summary ofEffects ofIPT-B compared to Waiting List Control
In order to examine the effects of IPT-B in terms of the likely benefit that an individual
patient can expect, the relative risk reduction, the absolute risk reduction, and the number
needed to treat were calculated as detailed in Table 13.0 (Greenhalgh, 1997):
CALCULATING THE "BOTTOM LINE" EFFECTS ON AN
INTERVENTION
Outcome Event = Clinically Significant Change
BDI-II RHRSD-CV BDI-II RHRSD-CV BDI-II RHRSD-CV
Group Yes No Total
Control Group a. 9 11 b. 14 12 a.+b=23 a.+b=23
Experimental
Group
c. 17 17 d. 9 9 c.+d=26 c.+d=26
Table 13.0: The "Bottom Line" Effects on IPT-B
Control event rate (CER)=risk of outcome event in control group=a/(a+b)
Experimental event rate (EER)=risk of outcome event in experimental group=c/(c+d)
Relative risk reduction (RRR)=(CER-EER)/CER
Absolute risk reduction (ARR)=CER-EER




Results demonstrated that when clinically significant change (Jacobson and Truax, 1991) on
the BDI-II was used as outcome event, the number needed to treat (NNT) was 0.74. This
result shows that less than one patient is needed to treat with 1PT-B, to achieve one
successful outcome. The same result is achieved when using the clinician rated scale of the
RHRSD, i.e. NNT = 0.83, therefore less than one patient is NNT with 1PT-B to achieve one
successful outcome.
3.7 SECONDARY ANALYSES ASSOCIATED WITH SEVERITY OF DEPRESSION
3.71 Can One Predict Reliable Change?
In order to explore whether any of the patient characteristics within the present study could
predict reliable change, in terms of severity of depressive symptoms following therapy,
scatterplots were examined for linear relationships. These analyses must be considered
exploratory, since the design did not include prediction of patient characteristics related to
outcome. The only patient characteristic to demonstrate a linear relationship with outcome,
was that of initial severity of depression (r=0.58; n=26; p<0.01) which has previously been
reported in the literature as being of importance in terms of prediction of outcome, (e.g.
Elkin et al., 1989; Simons, Lustman and Wetzel, 1985; Woody, McLellan, and Luborsky,
1984).
Simple 2-variable regressions were carried out to determine whether initial severity of
depression could predict Reliable Change following therapy, as measured by Reliable
Change Index (Jacobson and Truax, 1991). As illustrated in Figure 2.0, a significant model
emerged (Fi,24= 12.3 70,/? =0.002). Adjusted R square = 0.313. Baseline BDI-II is therefore
a significant predictor of Reliable Change (Beta = 0.583; p=0.02). Therefore the regression





Reliable Change Index BDI-II 2 month follow up
Figure 2.0: Scatterplot of BDI-II Baseline against Reliable Change Index of BDI-II
A further Regression was carried out using RHRSD-Clinician Version as the outcome
measure to determine whether baseline RHRSD could reliably predict change, as illustrated
in Figure 3.0., a significant model emerged (Fi,24= 10.17, p =0.004). Adjusted R square =
0.268. Therefore, the only significant predictor of Reliable Change following therapy, using
RHRSD as the outcome measure, was RHRSD taken at baseline (Beta = 0.503; p=0.005).
The regression equation is Y' = 0.149X-0.70, where X=baseline RHRSD Score.
Results for two major outcome measures (BDI-II and RHRSD) demonstrate that the only
predictors of Reliable Change (after IPT-B) were their respective baseline measures.
Reliable Change Index RHRSD-CV 2 month follow up




Examination of Figures 2.0 and 3.0 demonstrate that as baseline severity increases, so too
does the change over therapy, as measured by the Reliable Change Index (Jacobson and
Truax, 1991). Therefore, those who are more severely depressed at baseline can expect most
change using self-report or clinician rated scales.
3.72 Can Severity ofDepression at Baseline Predict Severity of Outcome?
The same process, as described above, was carried out for severity of outcome using two
major outcome measures (l)BDI-II as the self-report measure (as illustrated in Figure 4.0)
and (2)RHRSD as the Clinician Rated outcome measure. Final 2-month follow-up scores
were used as the outcome and initial severity of depression was used as the predictor
variable.
3.721 Can Self-Report Predict Severity ofOutcome?
The model which emerged was significant (Fi,24=4.898, />=0.037). Adjusted R square =
0.135. Self-Report at baseline was a significant predictor of severity of outcome. Beta =
0.412;p-0.031). The regression equation is: Y-0.386X+2.32.
BDI Follow up
Figure 4.0: Scatterplot of BDI-II Baseline against BDI-II Follow up
3. 722 Can Clinician Rating Predict Severity ofOutcome?
For the clinician-rated outcome measure, RHRSD-CV, the model which emerged was not
significant (Ft.24=0.831, n.s. p=0.371). Baseline RHRSD-CV did not significantly predict
severity of outcome as measured by the same method: Beta = 0.183; />=0.371. The model
emerged as not significant which may have been due to the fact that the test had insufficient




would be necessary, for the given effect size, to achieve power of 0.8. The number of
participants was 26, after analysis using simple regression with 1 predictor variable, effect
size was found to be R2= 0.03. Using tables as supplied by Clark-Carter (1997), the test,
therefore, only had an estimated power of 0.152 (which is very small according to Cohen,
1988). In order to achieve the desired power of 0.8, approximately 390 participants would be
required. This large sample size underlines the finding that Clinician Rating on the RHRSD
cannot predict the severity of outcome and therefore should not be used for this purpose.
Therefore, one can predict reliable change from a measure of baseline severity of
depression but only the BDI-II can predict severity of outcome from its baseline measure.
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3.8 CONFIRMATORY STATISTICAL OUTCOME ANALYSES
(2) QUALITY OF INTERPERSONAL RELATIONSHIPS
Primary quality of interpersonal relationships outcome measures for both samples of patients
include:
(1) SOS (emotional and practical support)
(2) WHOQOL-Bref (social relationships domain)
Results are described according to the above outcome measures. Table 14.0 presents means















































Table 14.0: Means and SDs for the Outcome Measures SOS in each of the Two Samples.
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3.81 Primary Analyses Related toMain Hypothesis 2 and 3(h)
2x(3) Mixed Factorial Design RepeatedMeasures ANOVA
The following analyses relate to Research Hypotheses 2 and 3(b) as follows:
■ Research Hypothesis 2: Tire adapted version of IPT to 1PT-B is effective in
improving the quality of interpersonal relationships when compared to waiting list
control
• Research Hypothesis 3(b): The adapted version of IPT to IPT-B is effective over
time in terms of improving the quality of interpersonal relationships when compared
to waiting list control.
3.811 Outcome Measure 4: SOS: Emotional Support with Intention-to-Treat Sample
When the discrepancy between the ideal emotional support and the actual emotional support
was examined, the main effect of time was significant F(2,94)=4.07; p0.02; Eta squared=0.1
TIME
Graph 7.0: Time of assessment (l=baseline; 2=end; 3=follow up) of SOSDE across two groups of
patients within the Intention-to-Treat Sample
Graph 7.0 clearly shows that within the treatment group, the discrepancy between the ideal
and actual emotional support decreases over time from baseline to 2-month follow up,
confirmed through employment of the Bonferroni post-hoc test t(25)=2.37; n.s; p= 0.02.
d=0.4. No significant difference was observed for the control group over the same time
period, t(22)=1.02, n.s;p=0.32; d=0.2. No significant differences emerged between the
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groups F(l,47)=0.03, n.s; p=0.86: Eta squared=0.001 or as an interaction between Time and
Group F(2,94)=0.53, n.s;p=0.59; Eta squared= 0.01.
3.812 Outcome Measure 4: Significant Others Scale: Emotional Support with Completer
Sample
The same pattern of results was obtained for the Completer sample as described for the
previous Intention-to-Treat sample. The main effect of time was significant F(2,54)=3.83;
p=0.03; Eta squared=0.1. No significant differences emerged between the groups
F(l,27)=1.16, n.s; p=0.29; Eta squared=0.04 or as an interaction between Time and Group
F(2,54)= 1.20, n.s;p=0.31; Eta squared=0.04.
3.813 Outcome Measure 4: Significant Others Scale: Practical Support with Intention-to-
Treat Sample
A similar pattern of results as those obtained for emotional support was obtained for
practical support and within both samples. Tire main effect of time was significant
F(2,94)=5.42: p<0.01; Eta squared=0.1. No significant differences emerged between the
groups F(l,47)=l .98, n.s; p=0.17: Eta squared=0.04 or as an interaction between Time and
Group F(2,94)=0.34; n.s;p=0.71; Eta squared=0.01, as shown in Graph 8.0.
Graph 8.0: Time of assessment (l=baseline; 2=end; 3=folIow up) of SOSDP across two groups of
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3.814 Outcome Measure 4: Significant Others Scale: Practical Support with Completer
Sample
The main effect of time was significant F(2,54)=4.54: p<0.01; Eta squared=0.1. No
significant differences emerged between the groups F( 1,27)=0.12, n.s; p=0.75; Eta
squared<0.01, or as an interaction between Time and Group F(2,54)=0.53; n.s; p=0.59; Eta
squared=0.02.
3.815 Outcome Measure 5: World Health Organisation Quality ofLife Scale - Bref Version
The WEIOQOL-Bref measures the perceived quality of life within four domains:
Psychological, Social Relationships, Physical Capacity and Environmental. The results are
reported initially for the Social Domain, as they relate to the main hypotheses (2) and 3(b).
Results for the remaining 3 domains are reported as secondary analyses. Table 15.0 presents
means and SDs for the outcome measure WEIOQOL-Bref for each of the four domains, in

























































































Table 15.0: Means and SDs for the WHOQOL Outcome Measures in each of the Two Samples.
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3.816 Domain 1: Social Relationships
Intention-to-Treat and Completer Samples
For both the Intention-to-Treat and the Completer samples, only the main effect of time was
significant F(2,94)=10.35; p<0.01; Eta squared=0.2 and F(2,52)=7.54; p<0.01; Eta
squared=0.2 respectively.
3.817 Secondary Analysisfor Domain 2 -Psychological: Intention-to-Treat Sample
The main effect of time was significant F(2,94)=19.80; p<0.01; Eta squared=0.3 and there
was also a significant difference between the two groups F(l,47)=3.80; p<0.05; Eta
squared=0.1. The interaction Group x Time, however was not significant F(2,94)=l .00; n.s;
p=0.37; Eta squared=0.02. Graph 9.0 shows that both groups report improved quality of life
within the Psychological domain and post hoc analyses confirmed a significant difference
between Time 1 and 3 for the treatment group t(25)=3.88; p<0.01, d=0.8 and significant
difference between Time 1 and 3 for the control group t(22)=3.49;p<0.01; d=0.6.
TIME
Graph 9.0: Time of assessment (l=baseline; 2=end; 3=follow up) of WHOQOL across two
groups of patients within the Intention-to-Treat Sample: Psychological Domain
3.818 Secondary Analysisfor Domain 2 -Psychological: Completer Sample
Tire main effect of time was significant F(2,54)=24.14; p<0.01; Eta squared=0.5. The
interaction Group x Time was also significant F(2,54)=4.43; p=0.01; Eta squared=0.1 and
there was a clear difference in performance between the two groups ofpatients F(l,27)=9.43;












Graph 10.0: Time of assessment (l=baseline; 2=end; 3=follow up) of WHOQOL across two
groups of patients within the Completer Sample: Psychological Domain
Although both groups report increased perceived quality of life within the Psychological
Domain over time, the difference between Time 1 and 3 for the treatment group was greater
t(13)=4.75; p<0.01; d=1.4than it was for the control group t(14)=4.32;p<0.01; d=0.9.
3.819 Secondary Analysis for Domain 3: Environment
Intention-to-Treat and Completer Samples
For the Intention-to-Treat sample only the main effect of time was significant F(2,94)=3.95;
p=0.02; Eta squared=0.8. For the Completer sample, the main effect of time was significant
F(2,54)=4.44; p=0.02; Eta squared=0.1. Tire interaction Group x Time was also significant
F(2,54)=3.79; p=0.03; Eta squared-0.1 and there was a clear difference in performance
between the two groups of patients F(l,27)=7.65; p=0.01; Eta squared=0.2.
3.820 Secondary Analysis for Domain 4.Physical Capacity
Intention-to-Treat and Completer Samples
For both the Intention-to-Treat and the Completer samples, the main effect of time was
significant F(2,94)=13.60; p<0.01; Eta squared=0.2, and F(2,52)= 17.51; p<0.0l; Eta
squared=0.4, respectively. A significant difference in performance between the two groups
was also observed for the Intention-to-Treat and Completer samples F(l,47)=11.74; p<0.01;





3.91 Clinical Psychologist Cost
The cost per patient contact with a Clinical Psychologist is reported to be £77 (Scottish
Health Service Costs, 2001). A course of 18 sessions of Clinical Psychologist time, for
example with CBT, is calculated to cost £1386 whereas a course of 8 sessions, for example
with IPT-B, is calculated to cost £616.
3.92 Antidepressant drug cost
The cost per month for antidepressant useage can be calculated from the BNF (BNF 43) drug
acquisition cost for Seroxat 20mg of £17.76 for 30 tablets. It is necessary to deduct from this
7 percent of the cost to reflect the discounting reduction imposed by health boards when
reimbursing community pharmacists and to add the dispensing fee paid to the community
pharmacist of 95p per item dispensed.
The drug cost alone should also have the cost of a GP consultation at £7.30 added to it
(Graham and McGregor, 1997) uprated from 1995/96 to 2000/01 using the BMA Health
Service Cost Index (Personal Communication, BMA Health policy and Economic Research
Unit, London).
Monthly drug cost = (17.76 - 7 percent)+0.95+7.3 = £24.77 per patient
Outcomes are measured at 4 months therefore 4 x 24.77 was added to the IPT-B costs
(£99.08 per patient) in the sensitivity analysis
3.93 Outcomes of Therapy
The outcomes of therapy are defined as the cost per successfully treated patient, i.e. BDI < 9.
From the intention-to-treat Group of 59 patients receiving CBT (standard clinical practice) in
the NIMH study (Elkin et al. 1989), a successful end point was reached in 29 cases (49
percent). From the intention-to-treat Group of 26 patients receiving IPT-B in the present
study, a successful end point was reached at follow up in 12 cases (46 percent).
3.94 Cost Effectiveness
Cost effectiveness was calculated as the following:
CBT cost = 1386x59/29 = £2820 per successfully treated patient





The number of CBT sessions required was varied from 16-20 under sensitivity analysis to
explore the impact on the cost effectiveness of CBT. A minimum of 16 CBT sessions will
cost £1232, therefore the cost effectiveness is calculated as 1232x59/29 = £2506 per
successfully treated patient. A maximum of 20 CBT sessions will cost £1540, therefore the
cost effectiveness is calculated as 1540x59/29 = £3133 per successfully treated patient. This
illustrates a significant cost saving with IPT-B can be realised when compared to the full
quoted range of CBT sessions. In order to explore the impact of antidepressant drug useage
on the cost results an extreme scenario whereby all IPT-B patients were in receipt of Seroxat
20mg daily for 4 months and no CBT patients were in receipt of antidepessants over the
same time period was costed and added to the base case treatment costs:
IPT-B cost = (616+99)x26/12 = £1549 per successfully treated patient. Thus the cost
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4.0 SUMMARY OF THE MAIN FINDINGS
Results obtained from this study demonstrate that IPT-B leads to a reduction of symptoms of
depression at a rate higher than that occurring with the passage of time (control group). IPT-
B does not, however lead to an improvement in the quality of interpersonal relationships
over the short duration of treatment or two-month follow up. Exploratory analyses of effect
size (for reduction of symptom severity) demonstrated that all patients showed substantial
improvement, whilst when stratified for initial severity, severely depressed patients showed
greater improvement after IPT-B treatment than those who were less severely depressed. The
greatest change, in terms of symptom reduction, was demonstrated through self-report
RHRSD, whereby 73 percent of IPT-B patients made what is considered to be clinically
significant change by two-month follow up. Sixty five percent of the IPT-B group reached
Warren's (1994) criteria for success on the clinician version of the RHRSD, compared to
only 39 percent in the control group. The effectiveness of IPT-B is also witnessed by the
NNT results of 0.74 according to clinically significant change in BDI-II and 0.83 according
to clinically significant change in RHRSD-CV. The economic evaluation extended these
findings and demonstrated the relative cost effectiveness of IPT-B compared to an estimated
standard clinical practice of CBT. The only patient characteristic to predict reliable change
and severity of outcome was that of initial severity of depression. In the future, IPT-B should
be tested to determine whether (a) an extended follow up period will demonstrate
improvement in the quality of relationships; (b) it will outperform alternative active
treatments, such as 16 sessions of standard IPT, CBT and/or pharmacotherapy (c) other
patient characteristics will predict reliable change and/or severity of outcome.
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4.1 INTERPRETATION OF RESULTS
The interpretation presented here will explicate the implications of the analyses in three
parts, the first two of which relate to the overarching aims of IPT-B: (1) to reduce the
symptoms of depression and (2) to improve the quality of interpersonal relationships
PART m: SEVERITY OF DEPRESSION
■ Primary Analyses as related to:
Hypothesis 1: The adapted version of IPT to IPT-B is effective in reducing the symptoms of
depression when compared to waiting list control.
Hypothesis 3(a): The adapted version of IPT to IPT-B is effective over time in terms of
reducing symptoms ofdepression when compared to waiting list control.
■ Effect size as a measure of improvement: sample stratified for severity
■ Clinical significance
■ Overall impression of improvement
■ Secondary analyses
■ Implications of the main findings of severity of depression for service delivery
PART (2V QUALITY OF INTERPERSONAL RELATIONSHIPS
■ Primary Analyses as related to:
Research Hypothesis 2: The adapted version of IPT to IPT B is effective in improving the
quality of interpersonal relationships when compared to waiting list control.
Research Hypothesis 3(b): The adapted version of IPT to IPT-B is effective over time in









■ Strengths and weaknesses of the study
■ Generalisation of the results
" Limitations of the present study and psychotherapy research in general
■ Implications of the main findings in the larger scientific and professional context
■ Recommendation for future research
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PARTm
4.2 SEVERITY OF DEPRESSION: PRIMARY ANALYSES as related to
HYPOTHESES 1 AND 3(a)
The following section offers an interpretation of the findings of the primary analyses as
related to the main hypotheses: 1 and 3(a) with regards to severity of depression using




4.21 Severity ofDepression Outcome Measures: Hypotheses 1 and 3(a)
Table 16.0 presents the main outcome measures, within each of the sample populations, to






1: The adapted version of IPT to IPT-B is
effective in reducing the symptoms of






3(a): The adapted version of IPT to IPT-B is
effective over time in terms of reducing







Tabic 16.0: Outcome Measures to Endorse Hypothesis 1 and/or 3(a)
The following conclusions can be drawn from Table 16.0:
■ Within the completer sample,7 employment of both clinician-rated severity of depression
(RHRSD-CV) and patient-rated severity of depression (RHRSD-PI & BDI-II) outcome
measures confirmed both research hypotheses 1 and 3(a).
■ Within the intention-to-treat sample,8 employment of one patient-rated measure of
severity of depression (BDI-II) confirmed hypothesis 1. Employment of both clinician-
7
According to Elkin et al. (1989) the completer analysis will best reflect treatment effects for those
patients who received a full course of treatment.
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rated severity of depression (RHRSD-CV) and patient-rated severity of depression
(RHRSD-PI & BDI-II) outcome measures confirmed research hypothesis 3(a).
Examination of the above findings allows the conclusion to be drawn that the adapted
version of IPT to IPT-B is effective, in terms of reducing the symptoms of depression, when
compared to waiting list control and remains so over time. However, Oakes (1986) has
argued that statistical significance (used to draw the above conclusion) in itself, does not
yield a great deal of rich information. As the overarching purpose of the present study was to
estimate the effect of the IPT-B intervention, it was perceived that traditional statistical
testing alone was not sufficient. Cohen (1990) has argued that a sufficiently large sample
size and reliable assessment procedure, will result in a statistically significant result, for even
trivial effects (Cohen, 1990). The fact that a treatment effect is statistically significant, as
described above, reveals little about the magnitude of the effect and therefore effect size
estimates were employed, to supplement the traditional statistics and provide a richer
understanding of the treatment effects obtained.
4.3 EFFECT SIZE AND SEVERITY OF DEPRESSIVE SYMPTOMS
Prior to stratification of the samples, the effect size measures illustrated a substantial
improvement in both sample populations, over all three main outcome measures (BDI-II;
RHRSD-CV and RHRSD-PI). Large effect sizes were obtained (Cohen, 1988) all of which
increased over time and which augmented the judgement that not only does IPT-B lead to a
reduction of symptoms of depression at a rate higher than that occurring with the passage of
time, patients in that group demonstrate a substantial improvement.
When the samples were stratified by initial severity of depression, the results indicated that
severely depressed patients demonstrated greater improvement than those who presented
with less severe symptoms of depression, on all major measures of outcome. This finding is
consistent with results obtained for the regression analyses, conducted in the present study
and similar to the results reported by Brown, Schulberg and Prigerson (2000) in their study
of Primary Care patients in the US, whereby lower depressive symptom severity at 8-months
was associated with higher baseline functioning (higher depressive symptom severity at
follow-up was associated with lower baseline functioning in the present study).
8 Results of the intention-to-treat analysis may be considered an estimate of the overall performance of
a treatment programme, including its ability to retain patients in treatment.
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Brown et al. (2000) also reported that less severely depressed patients (baseline HRSD<19)
prescribed nortriptyline, improved more rapidly during the initial 3 months of treatment than
clinically similar patients provided with IPT. Both IPT and nortriptyline were comparably
effective in treating major depression among severely depressed patients (HRSD>20).
Comparisons with Brown et al. (2000) will only be made in light of the inherent differences
between the US and the UK health services, the clinical sample and only when a
pharmacotherapy arm is included in a trial with IPT-B in the future. A question is raised by
this finding though, in terms of the rate of therapeutic change: would IPT-B have an effect,
as rapid as that observed with nortriptyline (in less severely depressed patients) in the initial
stages of treatment, if the patient is aware of the imposed brief time-limit as in IPT-B, i.e.
would the rate of therapeutic change be accelerated? Perhaps one of the reasons for the
differential early effects in Brown's study was that in the IPT group, patients knew that they
had approximately 20 sessions and therefore change could take longer, as has previously
been suggested by Eckert (1993).
Therefore, perhaps one of the reasons for the observed changes, of substantial effect, in the
present study, despite such a short intervention period, is precisely because of the explicitly
imposed brief time-limit. It is suggested that perhaps the shorter time-limits may change the
impact of the sessions processes on the patients. The only way to determine this would be to
observe the temporal patterns of session impact on patients across different treatments and
examine whether these patterns show evidence of acceleration in the 8-session treatments as
compared with 16 session treatments; this is discussed further with regards to extending the
present study.
The effect size measures suggest the relevance in the future of stratifying the sample at the
outset, as there were quite clear differences between those who were severely depressed at
baseline and those who were less severely depressed, in terms of the effect of IPT-B.
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4.4 EXAMINATION OF CLINICAL SIGNIFICANCE IN TERMS OF SEVERITY OF
DEPRESSION
One problem with the above effect sizes is that they compare differences in mean scores
against the standard deviations of the groups, rather than against any absolute standard. The
presence of a large effect size therefore does not guarantee that a result is clinically
significant. Shapiro, Barkham, Hardy, and Morrison (1990) suggest that indices of clinical
significance should be incorporated into studies where clinical change is being assessed and
therefore were applied to the present study.
It is interesting to note that the clinical significance of research findings has been neglected
until fairly recently. Indeed, in the NIMH TDCRP study, the clinical significance of client
change was considered by determining the number of patients "who met a predefined level of
clinical recovery" (Elkin et al. 1989, p974) but the reliability of the change was not
considered. The method used by Elkin et al. (1989) did not consider the possibility of
reliable deterioration during treatment for some individuals. Ogles et al. (1995) addressed
these issues and reanalysed the data from the NIMH study and applied the Jacobson method
(Jacobson and Truax, 1991) to the TDCRP data stating that a relatively large number of
patients who received treatment for depression made reliable improvements. As in the
present study, the reports were not limited to the patient's self-report of current symptoms of
depression but were also evident to a clinician and on self-report measures of diverse
psychological symptoms. One of the benefits of the Jacobson method is that it allows one to
certify that changes are reliable and indeed, a relatively large number of patients receiving
IPT-B made reliable improvements, in terms of severity of symptoms, from baseline to two
month follow up. The present findings suggest that IPT-B for Major Depressive Disorder in
Primary Care can result in clinically meaningful changes in a relatively short period of time
and those changes can be maintained and even increase over a two-month follow up.
It is also interesting to examine the reliable changes that took place within the waiting list
control group, which were not surprising given the results from the NIMH study. A
substantial number of patients in the placebo-clinical management group met criteria for
meaningful improvement (i.e. as a direct comparison, 62 percent of all patients on BDI for
NIMH as compared to 39 percent for BDI-II in the present study). When considering each of
the main severity of depressive symptom outcome measures, the two groups differed. IPT-B
had a higher proportion of patients who met the criteria for clinically significant change
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across all 3 measures (66 percent, 73 percent and 64 percent for RHRSD-CV, RHRSD-PI
and BDI-II respectively) whereas the control group had a lower proportion (50 percent, 55
percent, and 40 percent for each measure respectively).
4.41 Reliable Deterioration in terms ofSeverity ofDepressive Symptoms
Whereas a number of clients experienced reliable changes for the worse in the NIMH
TDCRP only one patient (in both samples) in the IPT-B treatment group experienced reliable
deterioration. The potential negative outcomes that occur during psychotherapy are well
documented (Lambert, Shapiro and Bergin, 1986) and findings in the present study suggest
smaller proportions of negative change, e.g. 4 percent on both self report measures but no
reliable deterioration was detected using clinician rating of change.
4.42 The Issue ofDiscordance amongMultipleMeasures ofOutcome
Discordance among multiple measures of outcome is not a new phenomenon but has been a
problem for researchers for many years (Lambert et al. 1986). Various instruments used in
outcome research may create large differences in improvement rates or treatment success
(Ogles, Lambert, Weight and Payne, 1990) and indeed, instruments completed by different
parties involved in the treatment often have divergent views of success (Pilkonis, Imber,
Lewis and Rubinsky, 1984). One potential problem of measurement concordance involves
the possibility that patients will be identified as functional at pre-treatment (Saunders,
Howard and Newman, 1988), i.e. they may reach the level required on one instrument as
cutoff for inclusion but not on another. Inclusion criteria are detailed in Chapter 3.0 and
included the diagnosis of Major Depressive Disorder according to DSM-IV criteria (APA,
1994). However, three patients had a baseline score on the BDI-II in the functional range
(BDI-II < 12). Because of floor effects, these patients had little chance of making reliable
change in the improvement direction and therefore were unlikely to be counted in the
clinically significant improvement group. Therefore, the finding that 73 percent of the IPT-B
group had made a reliable change on the BDI-II by the end of two-month follow up is, at
best a conservative conclusion.
Despite multiple measures sometimes presenting a discordant picture of change, findings
from the Ogles et al. (1995) study and the present study provide hope that clinical
significance, as measured by multiple methods can be quite precise. When limited to three
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outcome measures appropriate for assessing change after treatment (as in the present study)
for depression, the agreement among measures is impressive.
4.43 Overall Impression of Improvement in terms ofSeverity ofDepression and Summary
ofEffects oflPT-B
One final method of definition of a 'successful treatment' was through application of criteria
as outlined by Warren (1994). When applied to the results of the present study, in terms of
symptom reduction on both versions of the RHRSD, it was revealed that when clinician
rated, 65 percent of the IPT-B group reached criteria for success by 2-month follow-up
versus 39 percent in the control group. When self-rated, 54 percent of the IPT-B group
reached criteria for success by two-month follow-up, compared to only 39 percent control
group. By Warren's (1994) criteria therefore, IPT-B can certainly be defined as a successful
treatment for the majority of patients presenting to Primary Care in the present study and
certainly more successful in terms of reduction of symptoms of depression than the waiting
list control group. It is interesting to note that application of Warren's criteria for success
appears to be stricter than the Jacobson method for clinically significant change as although
still substantial, less patients reached criteria for success according to Warren than they did
when using Jacobson's method. Therefore, in the future, it is recommended that not only
should the Jacobson method be employed to define clinically significant change but if using
the RHRSD, the more stringent criteria ofWarren (1994) should also be employed.
Results from the effects on the IPT-B treatment calculations, according to Greenhalgh
(1997), demonstrated that when clinically significant change (Jacobson and Truax, 1991)
was used as the outcome event, the number needed to treat (NNT) was less than one. As the
number needed to treat was so small, the intervention of IPT-B is considered to be
worthwhile.
When the results of the severity of depression were examined in greater depth, Post Hoc
analyses for the BDI-II demonstrated that although there were significant differences
between baseline and two-month follow up for the control group, in both samples, the
differences were not as great as those described for the IPT-B group. One possibility for
these findings is that the results within the control group are a reflection of spontaneous
recovery over time, which will occur in some patients without any intervention (Roth and
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Fonagy, 1996). It is argued that the rate of observed spontaneous recovery will depend on
the point in time, over the natural cycling of a disorder, at which treatment is offered.
Spontaneous recovery may be seen as a reflection of the natural history of major depressive
disorder and highlights one of the problems faced by the current trial: to demonstrate that
the treatment of IPT-B had a gain beyond the natural recovery, which it did through the
significant differences obtained between the IPT-B group and the control group, on severity
of depression outcome.
4.5 SECONDARY ANALYSES ASSOCIATED WITH SEVERITY OF DEPRESSION
In an effort to understand the variability of response to treatment for depression, patient
characteristics have received much attention, with little consistency in the findings. Elkin et
al. (1989) in the original NIMH TDCRP found that marital status was significantly related to
outcome and better outcome has been reported in patients in a long standing relationship or
married (e.g., Elkin, 1994; Elkin, Parloff, Hadley and Autry, 1985). Marital status was not
related to outcome in the present study, which was not as expected given the evidence that
marital relationships have a high correlation with and etiological implication for the onset of
depression and have also been demonstrated to have an effect on patients' responsiveness to
and maintenance of treatment gains (Rounsaville, Weissman, Prusoff and Hercet-Barob,
1979; Rounsaville, Prusoff and Weissman, 1980). One possible explanation for this finding
is the high proportion of married participants in the study; more than 60 percent of
participants in each group, in both samples were married. The data however, does not
differentiate those participants who were in marital conflict and indeed, the categorisation of
'married' assumes a harmonious partnership. In the future, categorisation of the 'marrieds'
should be those who describe themselves as in a harmonious relationship and those who
describe themselves as in a relationship of conflict.
4.51 Predictors ofOutcomefor Severity ofDepression
The only patient characteristic to demonstrate a linear relationship with outcome was that of
initial severity of depression, therefore in order to determine whether the initial severity of
depression could predict outcome, the following ways of quantifying outcome were used:
(1) Reliable Change Index (Jacobson and Truax, 1991) i.e. how much a patient had changed
from baseline to both end of treatment and 2-month follow up, employing the Reliable
Change statistic for both BDI-II and RHRSD and (2) Severity of depression, as measured by
BDI-II and RHRSD at end of treatment and 2-month follow up.
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The results for the two major severity of depression outcome measures demonstrated that the
only predictors of reliable change, as a result of IPT-B, are their respective baseline
measures which is an important finding, particularly for those in Primary Care. The BDI-II is
a relatively straight forward questionnaire for the patient to complete and could be
administered by the GP when considering a patient for a course of IPT-B. The baseline score
could be used to predict the reliable change. It is argued that the clinician administered
RHRSD is too time consuming for the GP to administer but would be part of the process of
IPT-B during the initial stages and could therefore be used by the IPT-B therapist to predict
reliable change. The result of this finding, it is argued, will enable the IPT-B Therapist to
adopt a hopeful, supportive and active stance, particularly with those who are more severely
depressed, as they can expect the most change.
The results from the second measures of outcome allowed the judgement that self report on
the BDI-II at baseline was a significant predictor of severity at follow up, therefore, not only
does the BDI-II predict reliable change, it will also predict severity of outcome. The results
for the clinician version of the RHRSD were not as positive and indeed, the findings in the
present study indicate that severity of outcome cannot be predicted using the clinician
version of the RHRSD.
4.52 Predictors ofOutcome and Future Research
In the future, any research concerning IPT-B should take account of the existing literature
with regards to factors which have been demonstrated to be related to outcome with IPT:
Factor Associated with Outcome in terms of
Improved Symptomatology
Author(S) and Year of Publication
•• " ' :
Severity of depressive symptoms Brugha et al. (1990); Ramana et al. (1995)
Patient contribution to the alliance and the
perceived quality of the therapeutic relationship
Zuroff et al. (2000)
Functional disability Coryell, Endicott, and Keller (1990)
Medical comorbidity George, Blazer, Hughes and Fowler (1989);
Keitner, Ryan, Miller, Kohn and Epstein (1991)
Personality pathology Shea, Widiger and Klein (1993); Ezquiaga,
Garcia, Bravo and Pallares (1998); Patience,
McGuire, Scott and Freeman (1995)
Psychosocial factors such as the occurrence of
stressful life events
Monroe, Kupfer and Frank (1992); Vallejo,
Gasto, Catalan, Bulbena and Menchon (1991).
Social support George, Blazer, Hughes, & Fowler, (1989);
Veiel, Kuhner, Brill and Ihle (1992)
Patient's belief about the controllability of their
health
Reynaert, Janne, Vause, Zdanowicz and Lejeune
(1995)
Table 17.0: Clinical Factors Associated with Outcome from Major Depressive Disorder
88
CHAPTER 4: DISCUSSION: PART (1)
Severity of Depression
It is also advised that a measure of therapist competence, both as a check for integrity of the
independent variable and for its potential as a predictor variable in analyses of outcome, be
included in any future research involving IPT-B (Shaw et al. 1999).
It is important to consider that the majority of studies which have examined recovery from
depression have been conducted with psychiatric samples. Until recently, few investigations
had examined clinical characteristics or psychosocial factors associated with treatment
outcome in the Primary Care population and even fewer have examined those factors within
the Primary Care population within the NHS in the UK. The studies cited above suggest that
similar clinical factors such as depressive severity, disability and medical and psychiatric
comorbidity are associated with treatment outcome in both depressed Primary Care and
psychiatric patients.
An understanding of the patient factors which are associated with or even predict good
outcome for specific treatments will permit clinicians to customise depression interventions
to particular patient profiles and to minimise relapse or recurrence. Certainly, in the future,
any trial using IPT-B should take account of both clinical and psychosocial factors and
perhaps beliefs about health (Brown et al. 2000) to determine if any are associated with or
can predict outcome. Brown et al. (2000) stated that in their sample of Primary Care patients
(from the US) health beliefs were the only significant predictor of symptom reduction for
patients in the IPT group. In the present study, baseline severity of depressive symptoms was
found to be the only significant predictor of symptom reduction.
89
CHAPTER 4: DISCUSSION: PART(l)
Severity of Depression
4.6 IMPLICATIONS OF THF, MAIN FINDINGS OF SEVERITY OF DEPRESSION
FOR SERVICE DELIVERY
A number of questions are raised by the findings from the present study, in terms of the
direct implications for service delivery. With regards to the severity of depressive symptoms,
it is possible that when a brief time limit is imposed as in IPT-B, the rate of therapeutic
change is accelerated, as has previously been suggested by Eckert (1993). It is possible that
change occurred within the IPT-B group due to high levels of therapist activity, establishing
specific and limited clear goals within the IPT-B model, maintaining a clear, collaboratively
agreed focus and setting an explicit time limit from the start of therapy (Reynolds et al.
(1996). Although these features have previously been described as potential catalysts of
change for brief therapy (Davanloo, 1978; Malan, 1976; Mann and Goldman, 1982 and
Sifneos, 1979) they are also very clear features of the IPT-B model, in terms of the overall
characteristics and non-specific factors (Table 3.0). These features, although highlighted in
the IPT-B model, are not specific to IPT-B, therefore from the results obtained, we cannot
determine whether it is IPT-B per se that is creating the change, but we can conclude that the
8 sessions of therapeutic contact is more effective at reducing symptoms of depression than
waiting list control. Further research to determine the specificity of the model of IPT-B is
now called for, as within the present design, there is an obvious lack of comparison group for
specificity. Indeed, the comments made above with regards to accelerated time limits could
also be applied to the CBT model of depression. In order to examine the possible differential
acceleration of changes in psychotherapy, further research including CBT with 8 and 16
sessions is now called for, as is discussed in terms of further research.
According to DeRubeis and Crits-Christoph (1998), a psychotherapeutic approach can only
be termed 'efficacious' if it (a) leads to a reduction or remission of the disorder at a rate
higher than that occurring with the passage of time or (b) outperforms an alternative active
treatment. The present study certainly met the first criteria, as it was originally designed to
do, but not the specificity criteria.
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4.7 QUALITY OF INTERPERSONAL RELATIONSHIPS: PRIMARY ANALYSES as
related to Hypotheses 2 and 3(b)
The following section offers an interpretation of the findings of the primary analyses as
related to the main hypotheses: 2 and 3(b) with regards to the quality of interpersonal
relationships using outcome measures for both samples including:
(1) SOS-B
(2) WHOQOL-Bref
4.71 Quality of Interpersonal Relationships: Hypotheses 2 and 3(h)
Research Hypothesis 2: The adapted version of IPT to IPT-B is effective in improving the
quality of interpersonal relationships when compared to waiting list control
Research Hypothesis 3(b): The adapted version of IPT to IPT-B is effective over time in
terms of improving the quality of interpersonal relationships when compared to waiting list
control.
There is evidence that the original model of IPT has an effect on social adjustment that goes
beyond the effects of drugs and that builds over time, following treatment termination
(Weissman et al. 1974, 1981) and the results obtained in the present study would appear to
support that observation. The perceived quality of interpersonal relationships was examined
through the use of SOS-B and the social relationships domain of the WHOQOL-Bref, with a
result of a clear effect with time in both sample populations. Indeed, it was a consistent
finding that the passage of time alone had the main effect, in terms of improving the quality
of interpersonal relationships. As there were no significant differences reported between the
two groups for either emotional or practical support (SOS-B) or for the quality of social
relationships (WHOQOL), both research hypotheses 2 and 3(b) were rejected.
A possible explanation for the lack of differences between the two groups, with regards to
the quality of interpersonal relationships, is that the follow-up time period may have been too
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short to determine any real changes within the patients' interpersonal world. What remains
unclear from the results is whether the differences obtained over time would continue in the
IPT-B group and gradually level off in the control group, as has been suggested, for example
by Weissman et al.( 1981). Not only is the intervention time very brief (8 weeks) but so too is
the follow-up period, therefore although one of the main aims of IPT is to improve the
quality of interpersonal functioning, perhaps within the IPT-B model the aim should rather
be to improve the interpersonal functioning over time as would be determined through
longer follow-up (approximately 6 months).
4.8 SECONDARY ANALYSES
The remaining three domains of quality of life were analysed as secondary analyses, as they
did not directly relate to the main research hypotheses.
4.81 Psychological, Environmental and Physical Capacity Domains of the WHOQOL-Brcf
Within the psychological domain, there were clear differences found between the two
groups, in both samples, which demonstrated that those in the IPT-B group reported a
significantly better quality of life within this domain after intervention. Indeed, within the
completer sample, IPT-B was effective over time in terms of improving the perceived quality
of life within the psychological domain, when compared to waiting list controls; this result
was not unexpected, as with any psychological intervention, the quality of life in the
psychological domain would be expected to improve.
The environmental and physical capacity domains were not as definite though; improvement
in the environment and/or physical capacity would not necessarily be expected to be
associated with a psychological intervention. Within the environmental domain, the findings
suggest clear differences over time showing that as time progresses, the subsequent
perceived quality of life within this domain improves. Within the completer sample, not only
was there a clear difference between the two groups, but IPT-B was shown to be effective
over time in terms of improving the perceived quality of life when compared to waiting list
controls.
In terms of the physical capacity domain, results demonstrated clear differences over time,
within both samples, again showing that as time progresses, the subsequent perceived quality
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of life within this domain improves. Within the intention-to-treat sample, significant
differences between the two groups showed that those in the IPT-B group reported
significantly better quality of life within the physical capacity domain than those in the
control group, after intervention.
Therefore, IPT-B can be observed to be associated with a difference in the reported
perceived quality of life within the psychological, environmental and physical capacity
domains. One possible explanation for these findings, despite neither the environment nor
physical capacity being a goal of IPT-B, is that those who are more depressed are unable to
take pleasure in their environment and therefore perceive the quality of it to be negative. As
the severity of depression decreases, mood lifts and energy levels improve, patients may be
able to take more interest in their environment, and therefore perceive the quality of it to be
improving. The same hypothesis could also be applied to physical capacity; as depression
severity decreases, energy levels improve and the patient is able to move around without
expending as much energy as when severely depressed and therefore perhaps perceive their
physical capacity to have improved.
Therefore, not only is IPT-B associated with a positive effect on depressive symptoms in the
short term, it can also be associated with a positive influence on the patient's perception of
the quality of their environment, physical capacity and psychological well-being (as there
were significant differences observed between the two groups for each of these domains). In
the future, it would be interesting to observe those patients who have made reliable
improvement, using Jacobson's reliable change index (Jacobson and Truax, 1991) to
determine whether greater reliable change in depressive symptomatology is associated with
greater improvement in quality of life, in terms of perceived environment, physical capacity
and psychological well-being. As discussed earlier, this would also act as a response to the
call for data on quality of life (Gladis et al. 1999) and perhaps become one of the central
outcome measures as suggested by Chambless and Ollendick (2001).
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PART (Tt
4.9 ECONOMIC EVALUATION
The economic evaluation was carried out in response to the following suggestion:
"We believe that any judgement of the clinical significance of treatment effects is best made
in the context of treatment costs. The mostpractical treatments will be those with benefit-to-
cost ratios that are higher than those ofother available treatments."
DeRubeis and Crits-Christoph (1998)p38
4.91 Discussion ofSensitivity Analysis
The main assumption that was made in the economic evaluation, was the number of Clinical
Psychology sessions required to deliver CBT; the assumption was that 18 sessions would be
necessary. When this number was varied between 16 and 20, under sensitivity analysis, it did
not effect the direction of the outcome of the cost effectiveness analysis, indicating that the
results are robust to changes in this major variable.
In addition, the effect of adding the cost of antidepressant drugs to the IPT-B costs was
explored and it too did not effect the direction of outcome of the cost effectiveness analysis.
The outcome measure of BDI-II was chosen, as published data existed, which were directly
comparable to the data collected for the current study. It must be noted, however that the
success rate, as indicated by BDI-II was considerably lower than that indicated by other
outcome measures, thus providing a conservative measure of cost effectiveness. The cost
effectiveness of CBT is £2820 compared to £1335 for IPT-B, demonstrating the superior
cost effectiveness of IPT-B. It should be noted that this economic evaluation has been carried
out from the perspective of the NHS only. If it had been within the scope of the study to
adopt a societal perspective, it would have been necessary to include the costs to the patients
and to the economy, as well as to the NHS. Effectively, this would make IPT-B even more
cost effective, as it is delivered over a considerably shorter period of time, therefore
inconveniencing the patients must less and returning them to full functioning earlier.
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5.0 STRENGTHS AND WEAKNESSES OF THE PRESENT STUDY
5.01 Summary ofthe Strengths ofthe Present Study
The major strengths of the present study can be summarised as follows:
1. The adaptation of 1PT to IPT-B was carefully planned and executed according to
suggestions made byWilfley et cd. (1998) and subsequently compared to both IPC and IPT.
2. Positive results from the initial pilot case-study provided justification for the present
study.
3. Sources of potential systematic bias (defined as anything that erroneously influences the
conclusions about the groups and distorts comparisons) were acknowledged and avoided
whenever possible. The aim in the present study was for the two groups to bo as similar as
possible, except for the particular difference being examined (intervention of IPT-B) which
was confirmed through initial statistical analysis which revealed no significant differences
between the treatment group and the control group at baseline for the major outcome
measures, for either of the sample populations. Sources of bias were checked and monitored
according to advice provided by Greenhalgh (1997) shown in Figure 5.0.
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Figure 5.0: Sources of Potential Bias
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4. Effect size estimates were employed to supplement the traditional statistical analyses
conducted and therefore provided a richer understanding of the treatment effects.
5. Examination of the clinical significance of the results and comparison with results
obtained from a reanalysis of the NIMH TDCRP data (Ogles et al. 1995) allowed the
judgement that the changes made within the present study, in terms of severity of depressive
symptoms, were reliable.
6. Examination of two sample populations, i.e. completer and intention-to-treat, ensured
that an accurate representation of the findings was delivered. Simply ignoring patients who
drop out from a clinical trial will bias the results, usually in favour of the intervention. It is
therefore standard practice to analyse the results on an intention to treat basis (Stewart and
Parmar, 1996).
7. The economic evaluation, which was conducted alongside the study, has ensured that
IPT-B is now one of the more practical treatments, according to DeRubeis and Crits-
Christoph (1998). Economic evaluations are beginning to occur more frequently within
psychotherapy outcome research and presumably will become standard practice in the future.
The economic evaluation conducted alongside the present study will allow comparison with
other psychotherapy outcome trials in the future.
8. The detailed case-studies of'successful' and 'unsuccessful' IPT-B (Appendix 2.0) provide
information about the benefits and problems of IPT-B treatment in clinical practice.
5.02 Summary of the Weaknesses of the Present Study
The following have been identified as potential weaknesses of the present study:
1. Within the present design, there is an obvious lack of comparison group for specificity.
According to DeRubeis and Crits-Christoph (1998), a psychotherapeutic approach can only
be termed 'efficacious' if it (a) leads to a reduction or remission of the disorder at a rate
higher than that occurring with the passage of time or (b) outperforms an alternative active
treatment. The present study certainly met the first criteria but not the specificity criteria.
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2. The lack of stratification of atypical features of depression was considered to be a
potential weakness of the present study, as there are reports of differential response to
pharmacotherapy versus psychotherapy (Sotsky, 1997).
3. The lack of consistent completion of patient dairies (to account for external bias) was
considered as a weakness of the present study but as highlighted earlier, concerns about
compliance with paper diaries are justified (Stone et al. 2002) and is not a reflection of this
particular study but is a common finding in other health care settings and in other research
trials. It is therefore proposed that different methods of obtaining that information be piloted,
such as adding a 5-minute 'diary completion' section to either the beginning or end of the
session for each arm of future trials.
4. The lack of blind ratings is a clear weakness and source of potential bias in the present
study but given the resource implications, it was considered that in this preliminary stage of
examination of IPT-B, the benefits outweighed the costs.
5. There was only one therapist involved in the delivery of IPT-B, however as described
above, given the resource implications it was the only feasible design and attempts were
made to overcome this potential source of bias, through the employment of an independent
rater of audiotaped therapy sessions.
5.03 Summary ofFactors Considered to be both a Strength AND a Weakness
1. It is generally accepted that the only satisfactory method of assigning treatments in a
clinical trial is by randomisation however, there is also an argument that because patients in
treatment in the community are not randomly assigned to treatment, the results are unlikely
to generalise to clinical practice. There are, of course both advantages and disadvantages to
the process of randomisation, for example, it may rule out selection bias as a threat to
internal validity and it allows the use of the statistical theory of error. The process of
randomisation however, does not take account of patient choice (Brewin and Bradley, 1989)
which is a clear weakness.
2. Therapist integrity and adherence to the model of IPT-B was monitored and rated by an
experienced objective Clinical Psychologist (trained in IPT) through audio-taped sessions.
Although this may be considered one of the sources of strength of the study, in clinical
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practice, it would be unusual to audiotape every session and formally rate adherence to the
model, therefore this actually had an effect of potentially limiting the generalisability of the
results and thus becoming a weakness.
3. The use of specific manuals within the present study will ensure that the results are
capable of replication and are "necessary to provide an operational definition of the
intervention under study" (Chambless and Ollendick, 2001) but in terms of the
generalisability of the results there are two main arguments: (1) Seligman (1996) and
Garfield (1996) suggest that therapists in the community (in the US) do not follow manuals
and therefore the results are not generalisable. Indeed, according to Addis and Krasnow
(2000), nearly half of licensed psychologists in the US never use manuals in their clinical
work. (2) Without a manual to describe what the treatment entails, clinicians are unable to
determine the similarity of their own practice. In terms of generalisable knowledge, it is
therefore meaningless to say that a treatment works without being able to say what that
treatment is (Chambless and Ollendick, 2001). This is a controversial issue in psychotherapy
research and interestingly, Chambless and Ollendick (2001) have recently reported that there
is no data to support the assertion that manualisation of psychotherapeutic treatment is
detrimental to patients.
As Fonagy (1999) has mentioned in his psychodynamic perspective on the general
acceptance of treatment manuals, some clinicians react negatively to such, perhaps
perceiving a threat to their independence of practice. Indeed, Bohart, O'Hara and Leitner
(1998) stated that the therapist is a "...disciplined improvisational artist, not a manual-driven
technician" (pi45). Some other authors perceive manualisation as being more positive:
Wilson (1998) stated that "...use of standardised, manual based treatments in clinical
practice represents a new and evolving development with far-reaching implications for the
field of psychotherapy" (p363). In terms of the present study, it was considered to be
meaningless to report any data concerning an adapted model of IPT, without stating exactly
what such a treatment entailed and without providing direct comparisons with other models
(IPT and IPC). All of the above strengths and weaknesses represent the balance between
high internal vs external validity and are summarised in Appendix 14.0.
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Perhaps the most important question to be asked of any study, whereby a treatment has been
adapted to a new format however is: will this treatment be of use to other clients and
clinicians, i.e. will this treatment generalise?
5.1 GENERALISATIONS AND IMPLICATIONS OF THE MAIN FINDINGS TO
THE PROFESSIONAL CONTEXT
5.11 Generalisations ofMain Findings
The most obvious limitation of the present study is that it is not clear if the results from this
study would be relevant to other cases, not randomised to a controlled trial. This concerns
the external validity or generalisation of findings from the experiment, so that it can be
answered empirically. The present study considered two domains to which the findings of
the study may be generalisable:
5.111 Population validity: to which members of which population is IPT-B useful or
applicable?
Results indicate that the original model of IPT can be adapted to a briefer format, IPT-B, and
used within Primary Care. Results also demonstrate that IPT-B is effective in reducing
symptoms of depression. The procedure proved to be useful for those patients presenting to
their GP who considered depressive symptoms as their main problem (see inclusion and
exclusion criteria) and were willing to undergo a process of randomisation for the trial.
5.112 Ecological validity: how far can these findings be replicated with different
experimenters, settings and measurement procedures?
To date, all reported adaptations of IPT have used trained IPT therapists. In the early stages
of the adaptation, the results of this study can only be applied to those trained in IPT. The
therapy took place in Primary Care and therefore, the results cannot be said to be applicable
to other settings as yet.
5.12 Implications ofMain Findings
The overarching research question which was posed at the beginning of the present study
was: Can Interpersonal Psychotherapy ofDepression (IPT) be adapted to be briefer (IPT B)
within a Primary Care setting and still remain effective in terms ofreducing the symptoms of
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depression and improving the quality of interpersonal relationships? From the results
presented, the following implications for clinical practice can be made:
1. IPT can be adapted to be a briefer model of IPT-B.
2. IPT-B can be employed with patients who present to their GP (in Primary Care in
the UK) with a primary diagnosis of major depressive disorder.
3. Patients who receive IPT-B can expect to make an improvement in terms of reducing
the presenting symptoms of depression.
4. Patients who are more severely depressed can expect to make more substantial
improvements, in terms of reducing their symptoms of depression, after IPT-B
treatment than those who are less severely depressed.
5. The initial severity of depression will predict reliable change as a result of IPT-B.
6. IPT-B is considerably more cost effective than an estimated routine treatment of
CBT.
7. In order to achieve one success with IPT-B, the number needed to treat was less than
one patient, which is considered to be extremely small.
8. Training in IPT may include a section on adapted models (as discussed earlier) and
include IPT-B and the altered time limits.
5.2 LIMITATIONS OF THE PRESENT STUDY and PSYCHOTHERAPY
RESEARCH IN GENERAL
The following section is a brief discussion of a selection of the wider issues, considered to be
of most relevance to the present study. The issues presented here may also be considered as
limitations within the present study and within psychotherapy research in general.
5.21 The Issue ofAttrition
Elkin et al. (1989) found that their Early Terminators were more severely depressed at intake
than patients who completed treatment which was not found in the present study. Indeed,
only 4 patients dropped out of treatment, all of whom had received at least 4 sessions of IPT-
B and only one of whom was severely depressed at intake. The present study attempted to
take account of those patients who dropped out through use of the intention-to-treat sample.
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5.22 Length ofFollow Up
An interesting observation is that the greatest change in the present study was demonstrated
through self-report on the RHRSD, whereby 73 percent of patients rated themselves as
making a clinically significant change, on a reduction of depressive symptom basis, by 2-
month follow up. In the IPT-B intervention group, all initial changes observed at the end of
treatment were maintained through to 2-month follow up. Roth and Fonagy (1996) however,
state that the effectiveness of a treatment cannot be judged simply by the management of an
index episode; reduction in relapse is a more pertinent and informative guide to success.
They also suggest that long term follow-up of at least 2 years would be necessary to provide
a conclusive result that is not confounded with the natural history of Major Depressive
Disorder.
The brief 2-month follow up period did not allow sufficient time to determine if IPT-B had
any impact on the quality of interpersonal relationships or indeed, if treatment gains were
maintained.
5.23 Use ofDSM-1VDiagnosisfor Major Depressive Disorder (MDD)
As most recent research on outcome employs DSM as the basis for patient selection, so too
did the present study. Use of diagnostic labels to select patients however, has the potential to
create an illusion of homogeneity, which often fails to mirror the complexity of clinical work
(Roth and Fonagy, 1996). There are advantages to using the DSM system, in particular, its
operationalised criteria, which provides a clear conceptual framework. The use of diagnostic
labels in the majority of outcome studies also increases the potential to make generalisations.
It is argued here that without some categorisation, synthesis of evidence would be extremely
difficult, if not impossible. Despite the limitations of the DSM criteria however, a feasible
alternative has yet to be suggested.
Therefore, the use of diagnostic labels, as assigned through the use of DSM criteria, raises
the question of diagnostic homogeneity i.e. was the sample diagnostically homogenous?
All patients certainly reached criteria for major depressive disorder (MDD), according to
DSM-IV, but some patients also reached criteria for dysthymic disorder (10 percent of total
sample population were diagnosed with MDD superimposed on dysthymic disorder). The
same proportion of patients were diagnosed with comorbid generalised anxiety disorder (10
percent), which in itself raises the issue of comorbidity and the related issue of whether or
not atypical features of major depressive disorder should have been identified. Stewart,
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Garfinkel, Nunes, Donovan and Klein (1998) stated that comparisons of treatments may be
misleading if studies do not account for diagnostic subtype. However, they also concluded
that the NIMH
TDCRP data did not show differential treatment effects within the psychotherapies, for
patients with and without atypical features. This finding may have been due to small sample
size and therefore, it is the recommendation that any future trial with IPT-B differentiates the
sample prospectively, rigorously applying DSM-IV criteria for atypical features of
depression.
5.3 RECOMMENDATIONS FOR FURTHER RESEARCH
5.3 / Efficacious method versus effectiveness studies: the balance between strict conditions
and 'real life'
Efficacy studies refer to well-controlled outcome research in which the treatment groups are
compared to a control group and/or to another treatment group under strict experimental
conditions. Such studies require quite rigid scientific control, with the treatment groups
differing only in the specific factor of interest. It can be appreciated that while efficacy
studies are necessary sub-components of therapy, and for the testing of scientific theories,
they provide little information about the benefits and problems of treatment in routine
clinical practice, which the present study sought to determine. Indeed, the real benefits and
problems of IPT-B came from the detailed case studies (Appendix 2.0).
The present study design is certainly not reflective of routine clinical care, i.e. patients are
not routinely randomised into two groups; therapy is not routinely manualised; adherence to
a model of therapy is not routine clinical practice; a predetermined number of sessions is not
routine clinical practice and inclusion criteria are not routinely applied to each patient.
Patients do not routinely agree to maintain a stable dose of antidepressants during therapy as
they agreed to in the present study. However, despite these differences between routine
clinical practice and the present study, the design was not as rigorous as would be found in a
Randomised Controlled Trial, which can be expensive, time-consuming and clinically
invasive.
In the consideration of future studies of IPT-B, it is important to acknowledge some of the
potential disadvantages of the 'Gold Standard' Randomised Controlled Trial as follows:
102
CHAPTER 4: DISCUSSION: PART (3)
1. The method used to randomise may allow the clinician to know in advance to which
group the patient is going to be allocated (imperfect randomisation).
2. All eligible patients may not be subjected to randomisation (selection bias).
3. A high number of patients may refuse to enter the randomisation procedure.
4. It may be difficult to achieve genuine independence of assessment in long-term
psychological interventions and assessors will not be blind as to which group the patients
have been assigned. In terms of the present study, the assessor was certainly not blind to the
treatment group.
5. An RCT requires a sample which is as homogeneous as possible (i.e. meeting criteria for
a single diagnostic category) and the identification of a main target outcome. These criteria
would exclude all patients with co-morbid disorders which again, certainly was not the case
in the present study and is certainly not a true reflection of patients presenting to Primary
Care. As the RCT requires a highly selected population with a given condition, it makes the
RCT sample unrepresentative of the population treated in clinical practice. Therefore results
from the RCT cannot be translated into clinical recommendations as they pertain to an
unrepresentative sample. The sample in the present study were certainly more representative
of the clinical sample presenting to the GP's as the entry criteria were, by design, less rigid
than a full RCT would demand.
6. In a full RCT, there would be different therapists employed to deliver the therapy of each
arm of the trial The strict requirement of the RCT would demand that therapists be of
comparable experience and all trained in the delivery of manualised treatment. Assessing
video or audio recordings would then ensure treatment adherence.
Despite arguments from Seligman (1996) that effectiveness studies are important sources of
information for empirically validating treatments and that data derived from such may be
more persuasive than efficacy studies, it is recommended that IPT-B be subjected to a
comparative RCT. As Shapiro (1989) stated, outcome research design is about compromises,
which are based on the explicit understanding of the implications of the choices made. It is
now recommended that, despite the limitations, an RCT should be conducted, using the
design as depicted in Figure 6.0.
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Figure 6.0: Future Comparative Psychotherapy Trial Incorporating IPT-B
Elkin (1999) has argued that outcome research needs to provide critical information about
the therapists carrying out the treatment including the nature of the overall therapist sample,
variability in therapist efficacy, therapist characteristics, training and supervision, and
adherence and competence in carrying out the treatment.
It is also recommended that in the future the IPT-B manual (IPT-B) could be adapted to two
forms: (1) Clinician IPT-B manual; (2) Patient IPT-B manual. The patient manual could be
sent out prior to treatment as is currently occurring in a study in Melbourne, Australia
whereby the Patient Guide with monitoring forms (Weissman, 1995) is sent to the patient
before treatment begins in order to maximise the efficiency of therapist/patient contact; this
would appear to make sense given the time limited nature of the IPT-B. Indeed, the design
currently being considered is to examine the effectiveness of Guided CBT (using Mind Over
Mood, Greenberger and Padesky, 1995) versus Guided IPT, using both 16 and 8 session
protocols.
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Blatt et al. (2000) suggest that the evaluation of broader life functioning and the meaning
and value that treatment has for the patient in a variety of areas will be important in the
future. They suggest that the findings may identify some of the mechanisms that could delay
or prevent relapse or suggest a possible sequence to therapeutic change. Symptom reduction
may be an important first step in therapeutic change but equally important may be the
subsequent consolidation of feeling more able to cope with life situations and various
potential depressogenic life stressors. Treatment should not only reduce symptoms but also
the vulnerability to subsequent potentially disruptive experiences. Both of these dimensions
need to be assessed when comparing the effects of different types of therapeutic intervention
(Zuroff, Blatt, Sanislow, Bondi, and Pilkonis, 1999).
One final suggestion for future research is to address changes in clients' attachment styles
over the course of the time-limited therapy; this would seem to be particularly relevant given
that Attachment Theory, as developed by Bowlby (1969), provides a major theoretical
source for understanding depression in an interpersonal context and is central to
Interpersonal Psychotherapy for Depression. To date, this has not been attempted as an
empirical investigation with patients as part of a programme of CBT or IPT but has recently
been attempted with those undergoing time-limited dynamic psychotherapy (Travis, Binder,
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An Adaptation of Interpersonal Psychotherapy for Depression within
Primary Care (IPT-Brief):
A randomised trial ofIPT-B versus waiting list control in the treatment of
Major Depressive Disorder
APPENDIX 1.0
DSM-IV DIAGNOSTIC CRITERIA FOR MAJOR DEPRESSIVE DISORDER
(American Psychiatric Association, 1994).
A. Five (or more) of the following symptoms have been present nearly every day during the
same two-week period and represent a change from previous functioning: at least one of the
symptoms is either (1) depressed mood or (2) loss of interest or pleasure
1. depressed mood most of the day, nearly every day, as indicated by either subjective report (e.g.
feels sad or empty) or observation made by others (e.g. appears tearful)
2. markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly
every day (as indicated by either subjective account or observation made by others)
3. significant weight loss when not dieting or weight gain (e.g. a change ofmore than 5% of body
weight in a month), or decrease or increase in appetite nearly every day.
4. insomnia or hypersomnia nearly every day
5. psychomotor agitation or retardation nearly every day (observable by others, not merely subjective
feelings of restlessness or being slowed down)
6. fatigue or loss of energy nearly every day
7. feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) nearly
every day (not merely self-reproach or guilt about being sick)
8. diminished ability to think or concentrate, or indecisiveness, nearly every day (either by subjective
account or as observed by others)
9. recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specific
plan, or a suicide attempt or a specific plan for committing suicide
B. The symptoms do not meet criteria for a Mixed Episode.
C. The symptoms cause clinically significant distress or impairment in social, occupational, or
other important areas of functioning.
D. The symptoms are not due to the direct physiological effects of a substance (e.g., a drug of
abuse, a medication) or a general medical condition (e.g., hypothyroidism).
E. The symptoms are nor better accounted for by Bereavement i.e., after the loss of a loved one,
the symptoms persist for longer than 2 months or are characterised by marked functional
impairment, morbid preoccupation and worthlessness, suicidal ideation, psychotic symptoms, or
psychomotor retardation
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APPENDIX 2.0 ILLUSTRATIVE CASE STUDIES IAN (IK) and LINDA (LN)
The following is a description of two individual cases, chosen as detailed illustrative
examples of IPT-B as an intervention utilising the Role Transition focus area. Using the
single case design, Ian, who received therapy (IPT-B) showed overall considerable
improvement whereas Linda, who also received IPT-B did not show overall improvement,
either subjectively or objectively. In both cases, there were 3 follow-up assessments, which
enriched the quality of the data. The design for the two case studies was as follows:
8 sessions Assessment 2 w Assessment 3 w Assessment 4
IPT-B
Including baseline assessment End of treatment Follow-up 2 Follow-up 3
2 months post end 4 months post end
2.1 PRESENTING PROBLEM/PATIENT DESCRIPTION OF IAN: Successful
Treatment
Ian was a 53 year-old self-employed mechanic, who had separated from his second wife
(DK) 6 months prior to presentation. Ian had 2 children from his first marriage of 25 years.
He sought treatment as he recognised the symptoms of depression from an episode 10 years
prior to presentation, coinciding with the time he separated from his first wife. Depressive
symptoms were first reviewed with Ian. He complained of a clear onset of symptoms such as
depressed mood, markedly diminished interest and pleasure in daily activities, feelings of
worthlessness and excessive guilt, lack of energy, insomnia, diminished ability to
concentrate and decreased appetite. Ian met DSM-IV criteria for MDD and had a Revised
Hamilton Depressive Rating Scale score of 19, characterised as "major depression." Ian's
symptoms were discussed with him at the first session when he was clear that the onset of
depression had occurred at approximately the time of separation from his second wife.
2.11 Case Formulation for Ian
1PT Session 3: A Role Transition
The primary goal of the third session was to discuss a formulation with Ian, outline the
treatment goals and reiterate how IPT-B is conducted. Ian's difficulties were formulated
within a Role Transition Focus: making the transition from being part of a married couple to
being single man again. Ian's symptoms of depression were conceptualised as being
maintained by his difficulty in accepting the role change. We spent time exploring what was
lost when Ian's second marriage ended and the unexpressed emotion which accompanied the
transition. The goals of a role transition guided the treatment formulation and the therapeutic
process, as such:
1. Facilitation of mourning and acceptance of the loss of the old role of husband and
provider.
2. Helping Ian to regard the new role of single man, as more positive.
3. Helping Ian to restore self-esteem by developing a sense of mastery regarding the
demands of the new role (Klerman et al. 1984).
Ian appeared to be extremely motivated to change and from the outset and appeared to be
determined to improve. He took on board the model of therapy and suggestions made
regarding asking others for help. Ian's symptoms gradually improved on a weekly basis
(measured objectively using BDI-II); he was able to verbalise his needs and to prioritise his
recovery. By the end of therapy, Ian was aware of times when it was acceptable to ask others
for help; this was perhaps the single most important shift in Ian's thinking as a result of
therapy. Initially, Ian would have perceived that to ask other people for help in any way
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would have been evidence of "weakness" and therefore was to be avoided at all costs.
Indeed, coming to therapy was an extremely difficult decision and process for Ian.
The focus of our work was maintained in the present and in the future, in terms of ways that
Ian could manage his symptoms more effectively and ways to improve his social network.
Indeed, it would appear that Ian had a wide and caring network of people whom he could
call on to support him in many different ways, reflected in the objective measures of change,
for example the Significant Others Scale (Power et al. 1988) and the WHOQOL (1996).
Throughout treatment, Ian was periodically reminded of the number of remaining sessions
and the 3 follow-up sessions (end of treatment; 2-month and 4-month follow-up). In IPT-B
there is an explicit discussion of termination issues, as the prospect of ending therapy is
perceived as being a time of potential mourning and therefore may be unsettling. The ending
however is also viewed as an opportunity to model a "successful ending." With Ian, gains
were attributed to him, progress was documented and confidence in dealing with future
problems was reinforced. By the final session, Ian was doing considerably better, as is
reflected in all the objective measures of change.
2.12 Summaryfor Ian
Ian presented to Primary Care with a clear onset of depressive symptoms, significant enough
to reach a diagnosis of Major Depressive Disorder according to DSM-IV Criteria, the time of
which coincided with the break up of his second marriage. The IPT-B model appeared to 'fit'
with Ian's experience of depression and the time limited, focussed nature of our work
together appeared to have a significant impact on Ian's interpersonal functioning and quality
of life. As discussed earlier, the assignment of the "sick role" with the diagnosis of
depression served to "normalise" Ian's experience and demonstrated to him that we were
talking about the same "illness". It also demonstrated, at the outset, the possibilities for
recovery and allowed the therapist to hold the positive stance advocated by the IPT model
(Klerman et al. 1984).
2.2 PRESENTING PROBLEM/PATIENT DESCRIPTION OF LINDA: Unsuccessful
Treatment
Linda was a 51 year-old, married mother of 2 adult females. She sought treatment as she felt
that although she had had a "lifetime oftroubles" she did not want to get any older and not be
able "to do things that she [I] wanted to do." Linda complained of depressed mood, loss of
appetite and energy, insomnia, inability to concentrate, feelings of worthlessness and "feeling
sick all the time." Linda was unable to describe a clear onset of symptoms and according to
DSM-IV criteria was diagnosed as having Major Depressive Disorder superimposed on
Dysthymic Disorder. According to Linda, she had experienced problems since she was 7
years old and indeed was treated with psychiatric help from the age of 9-15 years. Linda left
school at 15 years old and did not receive any further help until she was 40 years old, at
which time she sought help for depressive symptoms; she was given therapeutic input by a
clinical psychologist, which terminated when the psychologist left her post. At baseline
assessment, Linda's Revised Hamilton Depressive Rating Scale score was 25, which is
characterised as "major depression"; she denied any suicidal ideation.
2.21 Case Formulation
IPTSession 3: A Role Transition
The primary goal of the third session was exactly the same with Linda as it was with Ian, i.e
to discuss the formulation, outline the treatment goals and reiterate how IPT-B is conducted.
Linda's presenting problems were formulated as being a difficulty associated with making a
transition from a lifetime of feeling unwell ("feeling sick all the time") to feeling well.
Linda's symptoms of depression were conceptualised as being maintained by her inability to
accept a loss of the "sick role." We spent time exploring what a loss of the "sick role" would
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mean to Linda and exploring giving Linda a "sick role" as part of IPT-B. The goals of the
role transition guided the treatment formulation and the therapeutic process, as described
earlier for Ian.
It became clear that Linda had learnt to adopt a "sick role" early on in life, as had her own
mother. As time progressed, the "sick role" became more adaptive and actually served to
help Linda to get her needs met as a young child. Linda continued into her adult life with the
same role, which had served her well until she reached an age whereby it became
increasingly clear that her "sick role" was actually stopping her from doing the things that
she wanted to do. Linda discovered that those around her (family and friends) were
becoming less inclined to legitimise her "sickness" as she was quite clearly not following the
culturally determined conventions of being ill, such as trying to regain health as quickly as
possible, or accepting help in overcoming the illness (Christopoulos, 2001). As she tried to
lose her familiar role, she realised that she was unable to change. The process of trying to
make that transition had become increasingly difficult and there was a great deal of failure
associated with the concept of change for Linda. Although there were no clear precipitants to
the current episode of depression, we formulated the precipitant as an increase in age
associated with a fear that she would be unable to achieve some of her ambitions, however
small they may seem. Our attention became focussed on the possibilities for the future in
terms of making a transition to a life of not "feeling sick" and especially the meaning of the
loss of the old role for Linda. By the final session of IPT-B, Linda's subjective and objective
reports demonstrated no improvement in either the severity of the symptoms of depression or
in the quality of her interpersonal relationships. The goals of IPT-B were not achieved with
Linda by session 8 or by follow-up. It was hypothesised that Linda's attempts at engaging in
therapy were indeed her attempts at trying to legitimise her familiar sick role, both for
herself and her family, but also discovered that through that process, there was also the
process of accepting help to overcome the depression.
2.22 Summaryfor Linda
Linda presented to Primary Care with a 2-year-plus period of Dysthymic Disorder with a
superimposed Major Depressive Disorder (MDD). The presenting symptoms of depression
began approximately one year prior to presentation and coincided with Linda's 50th birthday.
Linda was unable to associate her symptoms with a clear precipitant to the MDD but was
able to accept that her increasing age (and associated losses) did have an impact on her
mood. The IPT-B model did not have an impact on Linda's presenting problems and indeed,
the brief time-limited nature of the intervention was perhaps one of the problems, as
highlighted by her belief that her problems were "...too longstanding." Due to the chronic
nature of Linda's difficulties and the severity of depression at follow-up, she agreed to
continue with further psychological intervention after the final follow-up. Linda continues to
in treatment in the Department of Clinical Psychology.
2.3 AIM 1: TO DETERMINE WHETHER IPT-B IS EFFECTIVE IN REDUCING
THE SYMPTOMS OF DEPRESSION IN IAN and LINDA
2.31 RevisedHamilton Rating Scalefor Depression: Clinician Version (Warren, 1994)
Table 18.0 gives the means and standard deviations of the RHRSD Total Score for the
verification group (Warren, 1994) and normative data for non-depressed adults. Table 19.0
gives the Total Raw Score for pre-treatment and post-treatment (0, 2 and 4 months) obtained
with Ian and Linda. The scores were used to determine an initial diagnosis and to compare
pre and post-treatment using criteria as suggested by Jacobson and Truax (1991)'.
1 Jacobson & Truax (1991) suggest criteria for the evaluation of clinically significant changes in psychotherapy.
The authors suggest that if normative data aer available for a non-dysfunctional population and/or a dysfunctional
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RHRSD Observer Depressed Adults 17.2 7.3 8.3 5.2
verification (171)
sample Self-report Depressed Adults 17.9 8.8 10.8 7.9
(Warren, 1994) (paper) (168)
Fava, KelLindaer, Observer Non-depressed 6.1 5.1
Munari, & Pavan Adults
(1982)
Robbins, Alessi, Self-report Non-depressed 16.0 8.7
& Colfer (1985) (paper) Adults















RHRSD Observer IAN 19 oJ 0 2
Self-report
(paper)
IAN 31 22 6 6
RHRSD Observer LINDA 25 21 23 22
Self-report
(paper)
LINDA 28 26 27 26
Table 19.0: Raw Scores obtained with IAN and LINDA for the Revised Hamilton Rating Scale
for Depression.2
Patients are typically characterised as experiencing Minor Depression with a Total RHRSD
Score of 11-16; Major Depression with a score of 17-25 and Severe Depression with a score
of greater than or equal to 26. The initial assessments provided an 'observer rated' RHRSD
Total Score of 19 for Ian and 25 for Linda, both of which fell within the range of major
depression (17-25). Warren (1994) suggests that on the RHRSD, a post-treatment score of 10
or less or a decrease by 1/3 in initial severity is considered to represent successful treatment
response over the short term (0-6 months).
For Ian, the Total Raw Score decreased by 16 (greater than 1/3 in initial severity and below
the cut-off score of 10) immediately post treatment. At 2 and 4 months follow-up the Total
Raw Score decreased by 19 and 17 respectively (from baseline data). Using The Jacobson
and Truax (1991) criteria for clinically significant changes in psychotherapy, the level of
functioning after treatment placed Ian closer to the mean of the functional group (non-
depressed adults) than the mean of depressed adults after treatment on both forms of the
group for the standardisation measures, there are three criteria by which clinical significance may be
operationalised:
The level of functioning after treatment should fall outside the range of the dysfunctional population (+2 S.D
in the direction of the normal referenced group).
The level of functioning should fall within the range of the non-dysfunctional group.
The level of functioning should place the client closer to the mean of the functional group than the mean of
the dysfunctional group.
2 The conventional way of reporting Hamilton Ratings is in terms of raw scores.
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RHRSD (Tablel9.0). Indeed, examining the clinical significance of change with reference to
the present study population, Ian's scores on both versions of the RHRSD were clinically
significant, according to Jacobson and Truax, (1991, Table 20.0).
As a statistical measure of whether Ian improved over the course of treatment, Jacobson's
Reliable Change Index: RCI was employed (Jacobson and Truax, 1991). The RCI
determines whether the observed change is greater than the change which would be expected
on the basis of the error in the measure. The results demonstrated that at all 3 follow-up
times, the RCI exceeded 1.96 and therefore we can be reasonably confident that the
improved status was not just due to the inherent unreliability of the test (RCI at end of
treatment=3.87; at 2-month follow-up=4.6 and at 4-month follow-up=4.12, Appendix 13.0).
Graph 11.0 depicts Ian's baseline and follow-up data for clinician and self-rated versions of
the RHRSD. With Linda, the RCI was carried out as a statistical measure to confirm no
significant change for the major outcome measure of the RHRSD (Appendix 13.0).
2.32 Revised Hamilton Rating Scale for Depression: Self-Report Inventory (Warren, 1994)
Ian initially scored 31, indicating a more severe depression, particularly when compared with
the norms in Table 18.0. Ratings for both baseline assessment and follow-up were low for
inconsistency suggesting that Ian rated himself consistently throughout (see Graph 11.0).
The Reliable Change Indices were calculated as being RCI at end of treatment=1.91; at 2-
month foIlow-up=5.32 and at 4-month follow-up=5.32. 2 and 4-month follow-up data
indicate that the improved status was not just due to the possible unreliability of the test
(Appendix 13.0). For Linda, the RCI confirmed no significant change for the Self-Report
version of the RHRSD.
2.33 Beck Depression Inventory - II (Beck, 1996)
At baseline assessment, Ian rated with moderate depression on the BDI-II = 27 (Beck, 1996)
and throughout treatment, scores decreased in severity (see Graph 11.0). Results reflected
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Graph 11.0 BDI-II Scores and Pre & Post Treatment RHRSD (clinician rated) and RHRSD (self
report) Scores for IAN
The Reliable Change Index was calculated as being RCI=2.75 at the end of treatment;
RCI=5.28 at 2 months follow-up and RCI=5.50 at 4 months follow-up (Appendix 13.0) all of
which exceed 1.96 and therefore, with reasonable confidence, it can be stated that the
improved status was not just due to the possible unreliability of the test.
At baseline assessment, Linda rated with severe depression on the BDI-II = 37 (Beck, 1996)
and throughout treatment, scores remained fairly stable in terms of severity (see Graph 12.0).
By session 8, results reflected severe depression according to the BDI-II. RCI for Linda at


















Graph 12.0 BDI-II Scores and Pre & Post Treatment RHRSD (clinician rated) and RHRSD (self
report) Scores for LINDA
2.34 Summary ofClinically Significant Changes (according to Jacobson and Truax, 1991)
On all three major measures of outcome, RHRSD (both versions) and BDI-II, Ian
demonstrated clinically significant improvement when compared to normative data and
when compared to the present study population (Table 20.0). Linda did not demonstrate any
such improvement when compared to either study population or normative data.























Table 20.0: Demonstration of Clinical Significance According to Jacobson and Truax (1991)
Criteria for the Evaluation of Changes in Psychotherapy.
viii
APPENDIX 2.0
2.4 AIM 2: TO DETERMINE WHETHER IPT-B IS EFFECTIVE IN IMPROVING
THE QUALITY OF INTERPERSONAL RELATIONSHIPS
2.41 Significant Others Scale (Power, Champion andAris, 1988) for IAN andLINDA
Results indicated that at baseline, Ian initially reported a fairly high discrepancy between the
actual and ideal levels of both emotional and practical support, especially when compared to
those for depressed and non-depressed normative samples (Graph 13.0). Over time, the
discrepancy reported between actual and ideal levels of emotional and practical support had
decreased to less than that reported by non depressed normative samples.
Social Support Functions
(Actual emotional & practical (AE,AP) Ideal
emotional & practical (IE,IP) and discrepency
(DE.DP))
Graph 13.0 Mean SOS Scores with IAN and Normative Samples
In terms of Significant Others for Linda, she reported an initial decrease in the discrepancy
between the ideal and actual emotional support, however by 2-month follow-up this
discrepancy had widened and did not return to the level initially reported (Graph 14.0). For
practical support, the discrepancy changed from baseline to end of treatment (3 .0 to 0.2) and
by 2-month follow-up had increased to 1.6 and remained stable at 4 month follow-up. At
baseline, Linda's overall ideal levels for both emotional and practical support were higher
than either the depressed group or the non-depressed group supporting the suggestion that
depressed patients typically have high or unrealistic expectations of themselves and of other




(Actual emotional & practical (AE,AP) Ideal
emotional & practical (IE,IP) and discrepency
(DE.DP))
Graph 14.0 Mean SOS with LINDA and Normative Samples
2.42 World Health Organisation Quality ofLife Scale (WHOQOL-BREF)
Four domain scores were derived, denoting Ian's perception of quality of life in each
particular domain. Results demonstrated that the lowest scores at baseline assessment (using
percentage of the highest possible score) were 'Psychological' and 'Social Relationships'
(indicating lowest quality, as scores are scaled in a positive direction). Scores from baseline
were compared with scores at follow-up to demonstrate any improvement in perception of
quality of life within each of the four domains. By follow-up assessment 3 (4 months post
end of treatment), Ian scored 100% of the highest possible score for the 'Psychological
Domain
Domain Highest LAN's Raw Score LAN's Score




B/L FU1 FU2 Ft 3 B/L FUI FU2 F13
Physical Capacity 35 22 24 31 34 62.8 68.5 88.5 97.1
Psychological 30 10 15 25 30 33.3 50 83.3 100
Social relationships 15 7 8 8 11 46.7 53.3 53.3 73.3
Environmental 40 37 34 34 38 92.5 85 85 95




Graph 15.0 WHOQOL-Brcf Version for IAN
Results demonstrate that Ian's perception of quality of life improved over the course of
treatment and at the end of treatment and continued to improve over 4 months follow-up.
Results for Linda demonstrated little change over treatment and at follow-up (Graph 16.0).
Capacity
Domain




Two of the most interesting results from the Session Impact Scale (Elliot and Wexler, 1994)
were obtained with questions 2 and 6: "I realised something new about someone else; I feel
that my therapist understands me " respectively. The scale scores from 1 -5 with 1 = not at all
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Graph 17.0: BDI-II Scores for Case Studies (IAN and LINDA) with Session Impact Scale
Question 2: "I realised something new about someone else "
Results indicated that as treatment progressed over time, Ian reported that he was beginning
to realise something new about someone else - a sense of "newness" had to be present. With
this sense of newness, the reported severity of depression had decreased (BDI-II = 15) at
session 8 (this questionnaire was not administered at the 2 and 4 month follow-up interviews,
as it applied to the therapeutic interaction). Session 7 coincided with Christmas and Ian's
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Graph 18.0 BDI-II with Session Impact Scale Question 6: "I feel that my therapist understands
Results indicated that as treatment progressed over time, the severity of depression for Ian
decreased with a reported increase in feeling more understood by the therapist. Results from
the contact and support suggested that Ian did not receive any kind of external support
throughout the course of treatment. Linda showed very little variation with regards to feeling
Xll
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understood by the therapist and therefore this particular factor could be interpreted as being
less important to the recovery process for Linda.
2.6 DISCUSSION OF THE TWO SINGLE CASE STUDIES
Evaluation of the single-case data was carried out according to both clinical and
experimental criteria whereby clinical criteria answers the question: Has the patient
achieved an acceptable level of improvement? Experimental criteria concern the confidence
which one may have in the belief that the intervention produced any observed effect.
For the 'successful treatment' case, the results obtained from the RHRSD at baseline
assessment and follow-up, indicated a marked decrease in the severity of depression over
time (immediately following treatment, 2 and 4 months post treatment). According to both
Jacobson and Trux's (1991) and Warren's (1994) criteria for judging success, Ian did
achieve an acceptable level of improvement and certainly made a clinically significant
change over time. Results demonstrated that Ian's scores fell within the range of the non-
dysfunctional group (using both normative data and the study population data as the
dysfunctional group) and indeed were lower than the cut-off as sited by Warren (1994), as
being an indicator of success at 2 and 4 months follow-up. There were no reported changes
for Linda in the RHRSD and therefore she cannot be said to have achieved an acceptable
level of improvement.
In terms of experimental criteria, Jacobson's Reliable Change Index applied to Ian's data
allowed the judgement that in the Clinician Version of the RHRSD, the improved status was
not just due to the possible unreliability of the test nor to regression to the mean at 4 month
follow-up. Therefore, we can be confident that the change occurred in Ian as a result of
therapy and not as a result of testing, reactivity, regression or maturation (as discussed
earlier).
Ian reported that all depressive symptoms had decreased both in terms of quantity and
severity. One of the primary aims of IPT-B was to reduce the symptoms of depression and
given the results presented for Ian, this aim was certainly achieved on both clinical and
experimental criteria at 4 months follow-up. Given the results presented for Linda, this aim
was clearly not achieved on either clinical or experimental grounds.
Perhaps one of the most interesting results for Ian, was the change in discrepancy score over
time with regards to the discrepancy between ideal and actual emotional and practical social
support. Over time, the discrepancy reported decreased to less than that reported by non
depressed normative samples. The model of therapy (IPT-B) focused on expectations of self
and others, particularly during the session whereby an interpersonal inventory was
completed. Perhaps this session in particular was most meaningful in helping Ian to
challenge some of his expectations. When the comparison is made between what might be
considered successful versus unsuccessful treatment, it is clear from the results that Linda
was unable to sustain the changes that she had made over the course of therapy. Also, despite
Linda's discrepancy score for emotional and practical social support changing over the
course of time, this did not appear to have any impact on her mood, as reflected objectively
through the BDI-II score.
A more in-depth examination of the initial ideal reported levels of emotional and practical
support reveals a potential difference between what may have contributed towards the
success or not (in terms of outcome) for the present study. Ian initially reported that his ideal
levels of both practical and emotional support were less than he was actually receiving at
baseline (i.e. Ian actually wanted to receive less support than he was getting) whereas Linda
perceived herself as not receiving enough support, either practically or emotionally. This
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may be a reflection of Ian's initial belief that it was not such a good idea to ask others for
help. Perhaps one of the most therapeutic components of IPT-B for Ian was his
acknowledgement that he did need help from other people and that it was beneficial to ask
for it (in terms of having a positive impact on his mood). As time progressed, Ian responded
that his ideal emotional and practical support was increasing, i.e. it was becoming more
acceptable for him to need and therefore ask for others' help, thus having an impact on his
mood as reflected through the BDI-II and RHRSD. Although Linda made changes in her
social world which contributed towards her perception of the discrepancy between ideal and
actual levels of both emotional and practical support reducing over time, she was unable to
sustain these changes which perhaps was reflected in her mood (BDI-II and RHRSD).
Ian reported a marked increase in all four domains of quality of life which indicated that as
therapy progressed, he perceived an improved quality of life. Linda however reported a
decrease in her perceived quality of life and in the Physical Capacity Domain, this actually
decreased for every assessment. As an interesting point, Linda noted no change in the quality
of her social relationships over the course of therapy and over 4-month follow-up, perhaps
again reflected in her low mood and subsequent severity of depression.
Treatment specific measures were also completed post-treatment by the therapist in order to
assess adherence to the IPT-B model. Throughout treatment for both Ian and Linda, it was
determined that the therapist did adhere to the IPT-B model. Tapes were rated by a trained
supervisor in IPT to provide an objective independent rating of adherence to IPT-B; ratings
reflected that the therapist was indeed adhering to the model.
External contact was also assessed in order to minimise effects from any external source.
Throughout treatment Ian did not contact any external agency and therefore any external bias
which may have produced an effect during therapy can be excluded. Linda did however
contact external agencies and as such external bias may have been introduced to her ratings.
Linda contacted the following over the course of therapy:
1. aromatherapist




Initial severity of depressive
symptoms
'Moderate' according to BDI-II (27) 'Severe' according to BDI-II (37)
Sex Male Female
Marital Status Recently separated from 2nd wife Married
Chronicity of problems Clear and recent onset of
depressive symptoms
Chronic (more than 10 years)
nature of symptoms
Ideals with regard to emotional
and practical support from
others.
Ian initially did not expect or desire
help from others but slowly began
to use his social support network
appropriately.
Linda initially perceived that others
did not give as much social support
as she needed. Initial ideal levels of
social support were high perhaps
reflecting unrealistic expectations
of others.
External Bias No reported external agencies
involved in care of Ian over the
course of IPT-B
Different external agencies
involved as described above
Table 22.0: Summary of Major Differences between 'Successful' and 'Unsuccessful' Treatment
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SOVflJDARl 111-S (AN LINDA , '
Age 53 51
Employment status Full time Full time
Children 2 adult children in regular contact 2 adult children in regular contact
Table 23.0: Summary ofMajor Similarities between 'Successful' and 'Unsuccessful' Treatment
From the similarities and differences between the two case studies presented (Tables 20.0
and 21.0) as illustrative examples of'successful' IPT-B and 'unsuccessful' IPT-B, it would
appear that the differences between Ian and Linda have contributed to a greater extent to the
outcome than the similarities. The results of these two case studies should also be viewed in
relation to the larger picture of the full study and in terms of clinical significance using the
primary outcome measures of RHRSD (both clinician-rated and self-report versions). For the
clinician-rated version, 66% of the IPT-B Treatment Group reached Jacobson and Truax's
(1991) criteria for clinically significant change by 2-month follow up whilst 73% reached the
same criteria on the self report version of the RHRSD.
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IPT ADAPTATIONS: MANUALS AVAILABLE
'
MANUAL AU 1 IIOR(S) SOURCF
Maintenance IPT for
Recurrent Major Depression
Frank, E., Kupfer, D.J., Cornes,
C. & Morris, S,M.
In Klerman, G.L. and





IPT for Dysthymic Disorder
(IPT-D)






Mufson, L., Moreau, D.,




(Chapter 13). New York:
Guilford Press
IPT for Late-Life Depression Frank, E., Frank, N., Cornes, C.,
Imber, D., Miller, M.D., Morris,
S.M. and Reynolds, C.F. III.
In Klerman, G.L. and





Conjoint IPT for Depressed
Patients with Marital Disputes
(IPT-CM)
Weissman, M.M. and Klerman,
G.L.
In Klerman, G.L. and





IPT for Bipolar Disorder
(Interpersonal Social Rhythms
Therapy)
Frank, E. Unpublished: contact Professor
of Psychiatry, Western
Psychiatric Institute and Clinic,
3811 O'Hara Street, Pittsburgh,
PA 15213.
IPT for Primary Care and
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IPT for Substance Abuse Rounsaville, B.J. & Carroll, K. Interpersonal Psychotherapy for
patients who abuse drugs. In
Klerman, G.L. and Weissman,




IPT for Bulimia Nervosa Individual format: Fairburn, C.,
Interpersonal Psychotherapy for
Bulimia Nervosa.
Fairburn In Klerman, G.L. and





Group format (IPT-G): Wilfley,
D.E. Interperosnal
Psychotherapy Adaptedfor
Group (IPT-G) andfro the
Treatment ofBinge Eating
Disorder.
Wilfley - Yale Binge Eating
Tratment Study, unpublished
(1993).
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DEVELOPMENT OF IPT-B TREATMENT MANUAL
Taken from Weissman et al. (2000)
STEP
from Weissman et al., (2000)
DESCRIPTION OF RESPONSE
from present author
Clinical experience, with both IPT and with
the treatment population in question, is a
prerequisite to developing a manual. The
researcher should be certified in IPT and
familiar with the target illness and its
treatment approaches.
The present author has been trained in IPT
and was familiar with the target illness and its
treatment approaches.
A needs assessment may be carried out of the
population under study.
Within Primary Care (in Fife), patients
treated for depression are seen for an average
of 6-8 sessions, mainly using the Cognitive
Behavioural Model for Depression (Beck et
al., 1979).
Modifications of IPT derived from the needs
assessment can be addressed in the manual
through the development of case vignettes
and scripts.
IPT was adapted to IPT-B utilising advice
from Wilfley et al., (1998) on how to adapt a
treatment and comparisons drawn with IPC
(Interpersonal Counselling).
Once a manual has been developed, it
deserves to be tested before being used in a
treatment trial. Pilot cases may bring to light
problems with the manual, or raise new
issues that should be added to it.
IPT-B was used with a single case (DF) and
is discussed at length in the Methods Chapter.
Problems were raised and changed for the
current trial.
The goal is to have a manual that is
sufficiently comprehensive that it influences
therapists.
Results from the pilot Case Study indicated
IPT-B to be used within a larger N.
The next stage in the process is to use IPT-B
manual with other therapists currently having




DETAILED DESCRIPTION OF PRELIMINARY STAGE: THE SINGLE CASE STUDY
The single case-study design (characterised by repeated measures of a quantitative variable
on a single case) was employed as it offered a method of investigating fluctuations in
behaviour and symptoms over time - the effects of the treatment, IPT-B, were judged against
these fluctuations. The design was a non-randomised, one-group experimental design, in
which the individual participant (DF) served as her own control.
The design for the single case was based on the AB design whereby A and B represented a
series of repeated observations under 2 conditions:
1. Baseline (A)
2. Treatment (B)
By taking repeated measurements, testing, reactivity, regression and maturation were
assessed and controlled.3 Each of these threats would be expected to produce a systematic
trend in the sequence of baseline data points. The effectiveness of the treatment, IPT-B, was
judged by the extent to which the data points shifted when the intervention was introduced,
and by whether the change was sustained throughout the intervention.
DF was assessed at 0 and 6 months post-treatment, in order to determine whether any
observed changes were sustained post intervention.
To some extent the AB design can provide a control for the effects of history. If the client's
(DF) behaviour was reasonably stable during baseline and treatment phases, despite the
documented presence of various extraneous events, it is not unreasonable to infer that any
major change occurring at the time of introducing treatment is due to the treatment. In order
to determine whether any other contact with external agencies could have influenced the
results by producing a therapeutic effect, DF completed the 'Contact and Support'
questionnaire on a weekly basis.
A combination of sufficient data points, careful documentation of treatment and extra-
treatment events, and systematic and cautious analyses of variability and change justified the
use of the AB design in the pilot study. A combination of the above features enabled the
inference to be made that the treatment caused an effect (i.e. it increased the internal validity
of the study). All of the points raised above (including Kazdin's (1981) characteristics that
improve the credibility of the single case study4) were taken into account in the original
design of the study.
The Procedure with the Single Case
A contract was discussed with DF with an agreement for 8 sessions and 2 review sessions.
The first review session was scheduled for immediately post-treatment (0 months) and the
second review was scheduled for 6 months post-treatment as time permitted. DF also gave
her permission to be audiotaped for future research purposes and for rating adherence to the
IPT-B model.
3
Testing is the general name given to effects, which can occur when subjects are measured repeatedly. Each
measure is likely to show different specific effects of testing. People may learn to 'fake good' or 'bad' on
symptoms checklists. Measurement may also be reactive so that the very act of measurement provokes a
significant change in the subject's behaviour. Reactivity usually declines in time so that changes between 2
occasions may not be due to a 'true' change but merely to a decrease in reactivity. Reactivity is a significant
feature but it can usually be removed by taking repeated measures, which are expected to stabilise after some
time.
4
Systematic, quantitative (versus anecdotal) data; multiple assessments of change over time; change in
previously chronic or stable problems; immediate or marked effects following the intervention.
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During treatment, individual targets were assessed using the following:
1. Beck Depression Inventory II (Beck, 1996).
2. Session Impact Scale (Elliot and Wexler, 1994) adapted format to assess 6 key areas of the
impact of therapy.
3. Contact and Support Scale to assess any external contributors to differences in DF's
presentation.
Immediately post session, the following questionnaires were completed by the therapist
(Rounsaville et al., 1986):
1. Checklist and Rating Form: either initial sessions or termination.
2. Therapist Strategy Form and Role Transitions Rating Form.
3. Process Rating Form.
4. Overall Therapy Rating Form.
IPT-B - The manualfor the single case
The manual is structured as follows:
1. Outline of the structure of IPT-B in three phases: assessment, middle and termination.
2. Overview of the sessions.
3. Session by session account with possible agendas to follow (detailing specific strategies).
The pilot study manual was developed for the particular focus chosen with the single case
(DF) and therefore incorporated a focus of'Role Transition'.
DF: The Single Case
The initial criteria for inclusion in the study included a referral for depression with no other
Axis I or II criteria mentioned in the referral letter. DF was the single case who reached a
diagnosis of Major Depressive Episode, as rated by the Revised Hamilton Rating Scale for
Depression (Warren, 1994), according to DSM-IV (APA, 1994) criteria.
DF was a 27-year-old, married woman with a 2-year-old daughter who presented with a clear
onset of depressive symptoms.
Using the single case design, DF, who received IPT-B, showed overall considerable
improvement.
INDIVIDUAL RESULTS FOR DF
Evaluation of the single-case data was carried out according to both clinical and
experimental criteria whereby clinical criteria answers the question: Has the patient
achieved an acceptable level of improvement? Experimental criteria concern the confidence
which one may have in the belief that the intervention produced any observed effect.
GlobalMeasures
Results obtained from both the clinical interview and the self-report problem inventory of the
RHRSD at baseline assessment and follow up, indicated a marked decrease in the severity of
depression over time (immediately following treatment and 6 months post treatment).
According to both Jacobson and Trux's (1991) and Warren's (1994) criteria forjudging
success, DF did achieve an acceptable level of improvement. Results demonstrated that DF's
scores fell within the range of the non-dysfunctional group and indeed were lower than the
cut-off as sited by Warren (1994) as being an indicator of success.
In terms of experimental criteria, Jacobson's Reliable Change Index allowed the judgement
that in the Clinician Version of the RHRSD, the improved status was not just due to the
xx
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possible unreliability of the test nor to regression to the mean. Therefore, we can be
confident that the change occurred in DF as a result of therapy and not as a result of testing,
reactivity, regression or maturation (as discussed earlier).
DF reported that all depressive symptoms had decreased both in terms of quantity and
severity. One of the primary aims of IPT-B was to reduce the symptoms of depression.
Given the results presented, this aim was certainly achieved on both clinical and
experimental criteria for immediately post treatment. The results at 6 month follow up
cannot be reported as being due to treatment given that at approximately 4 months post
treatment, DF returned to her GP stating that she was 'feeling rather down". DF was
prescribed antidepressants (Paroxetene) and therefore, all 6 month follow up data has to be
interpreted with caution. It does, however, provide an important suggestion for further
research with IPT-B. Within the present study there were no follow up 'floating sessions'
which could be taken at the patient's discretion, due to time limitations. In further studies, it
would be highly recommended that 2 floating sessions in the 6 months post treatment were
built in to therapy to encourage use of the strategies of IPT-B in the first instance rather than
an immediate transfer to prescribed medication.
SOS - B Version
Perhaps the most interesting result was the change in discrepancy score over time with
regards to the discrepancy between ideal and actualpractical support - DF rated initially that
she was actually receiving too much practical support. The model of therapy (IPT-B)
focused on expectations of self and others, particularly during the session whereby an
interpersonal inventory was completed. Perhaps this session in particular was most
meaningful in helping DF to challenge some of her expectations. When the results for
Session Impact Scale are examined, it was after this particular session that DF rated the
question "Realised something new about myself" highest.
WHO-QOL-Bref Version
In terms of quality of life, as perceived by DF, there was a marked increase in scores over all
4 domains, indicating that as therapy progressed, DF perceived that she had an improved
quality of life across all domains.
Another particularly interesting finding was that at follow up, DF chose to rate 3 extra key
people in her life, perhaps as a direct result of drawing out an Interpersonal Inventory and
examining the opportunities available in DF's social network.
Individual Targets
In terms of improving the quality of data obtained, standardised measures of change were
employed throughout therapy. The BDI-II was administered on a weekly basis and results
clearly indicated a decrease in severity of reported depressive symptoms over time. Again, 6
month data has to be interpreted with caution due to effects of antidepressant medication.
Therapeutic Process
Results indicated that as DF's symptoms of depression decreased, perceptions of feeling
understood by the therapist and realising something new about someone else, increased.
Treatment specific measures were also completed post-treatment by the therapist in order to
assess adherence to the IPT-B model. Throughout treatment, it was determined that the
therapist did adhere to the IPT-B model. The limitation was that the therapist completed her
own ratings and therefore could not control for bias. In the future, tapes would be passed
onto a trained supervisor in IPT to rate the adherence of the therapist.
External contact was also assessed in order to minimise effects from any external source.
Throughout treatment, DF did not contact any external agency and therefore any external
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bias which may have produced an effect during therapy can be excluded. As stated earlier, 6
month data should be interpreted with caution due to an external bias of antidepressant
medication taken approximately 4 months post treatment.
Generalisation ofFindings
Perhaps the most important question to be asked of any study whereby a treatment has been
adapted to a new format is: will this treatment be ofuse to other clients and clinicians?
The most obvious limitation in studying a single-case is that it is not clear if the results from
this case would be relevant to other cases. This concerns external validity or generalisation
of findings from an experiment, so that it can be answered empirically. The present study
considered 3 domains to which the findings of the case study may be generalisable:
1. Population validity: to which members of which populations is this procedure useful or
applicable?
Initially, results would indicate that the model of IPT can indeed be adapted to a briefer
format and used within Primary Care. Results also indicate that the model is effective
(initially, in the short term) in reducing symptoms of depression and improving the quality of
interpersonal relationships with patients presenting with mild-moderate depression.
2. Ecological validity: howfar can these findings be replicated with different experimenters,
settings and measurementprocedures?
To date, all reported adaptations of IPT have used trained IPT therapists. In the early stages
of the adaptation, the results of this study can only be applied to those trained in IPT. The
therapy took place in Primary Care and therefore, the results cannot be said to be applicable
to other settings as yet.
3. Manipulation or construct validity (Cook & Campbell 1979): will a conceptually similar
intervention have the same effect?
A clinical replication series (Barlow & Hersen, 1984) may be conducted in the future to
determine external validity of the therapy.
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patients who are in distress and
have symptoms due to current
stresses in their lives.
Developed for clinical
depression.
Patient reaches full criteria for
major depression.
Patient may have diagnosable
psychiatric symptoms that do
not meet established criteria for
psychiatric disorders. The
patient is viewed as a person in
distress & experiencing
symptoms & is not viewed as a
patient with a specific
psychiatric diagnosis.









- to reduce symptoms of
depression;
- to improve social and IP
functioning.
Goals of treatment:
- to reduce stress;
- to enhance social functioning
through the encouragement of
self reliance;
- to reduce inappropriate5
healthcare utilisation (based on
the premise that use of a
Healthcare system is a major
mode of coping with stressors in
the environment).
Goals of treatment:
- to reduce symptoms of
depression;
- to improve social and IP
functioning.
3 phases of treatment (detailed
in the Comprehensive Guide to
IPT (Weissman et al 2000)
including case examples).
3 phases of treatment (detailed
explicitly in a manual with
precise written instructions).
3 phases of treatment (detailed
in the IPT-B manual). Agendas
feature as a guide.
16 sessions to be taken over 20
weeks.
6 sessions to be taken over 8
weeks.
8 sessions to be taken over 10
weeks.
Each session lasts 1 hour. Each session lasts 30 minutes
(first session lasts 1 hour).
Each session lasts 1 hour.
Is administered by trained
professionals in IPT.
Can be administered by a non-
mental health professional.
Is administered by trained
professional in IPT.
Specific homework does not
feature.
Homework features. Homework features.
Primary measure of symptoms
is BDI-II.
Primary measure of symptoms
is GHQ.
Primary measure of symptoms
is BDI-II.
5 The IPC manual differentiates between inappropriate utilisation of the healthcare system (in the US)
both from the perspective of the individual and society as a whole. It could be argued that despite our




SIMILARITIES BETWEEN IPT, IPC AND IPT-B
IPC and IPT-B are derived directly from interpersonal psychotherapy (IPT; Klerman
etal. 1984).
The IPT manual was used as a general guide in developing both IPC and IPT-B.
IPT, IPC & IPT-B are not aimed at personality or character change.
IPT & IPT-B are not concerned with origin of depressive symptoms but uses their
connection with IP problems as treatment focus. IPC is not concerned with the origins
of the stress symptoms but again, uses their connection with IP problems with the
"here and now" focus.
Treatment focuses on elucidating patterns in interpersonal relations and linking recent
IP events to recent mood.
IPT, IPC & IPT-B are all conceptualised at 3 levels: strategies for specific tasks,
techniques & therapeutic stance.
Therapist adopts a hopeful, supportive, non-neutral and active stance (i.e. patient
advocate).6
Target of interventions in IPT, IPC & IPT-B is face-to-face interactions with
significant others.
Specific techniques are the same across all 3 modes of therapy including: reassurance,
clarification, improving communication (frequently by encouraging patients to tell
others how they feel), testing perceptions and performance through IP contact (similar
to CBT) and decision analysis.
Main task of the therapist is to ensure that the patient remains focused in the
identified problem area(s), gains a better understanding of them and attempts to
change the problem area(s).
Therapeutic relationship is not interpreted as transference.
Interpretation of dreams is not attempted.
Therapy does not attempt to uncover deeply unconscious conflicted areas.
Therapeutic relationship is not a friendship.
6 "In adapting a treatment, it is important to identify the therapist and patient roles in the specified
treatment and how changing the therapeutic [time] may alter them." (Wilfley et al 1998)
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TREATMENT COMPARISONS BETWEEN IPT, IPC AND IPT-B





Discussion of diagnosis of
depression.






chronology of the symptoms
in relation to recent life
events and stress
Determine who the key
people are that the patient
may be having difficulties
with (similar to the
Interpersonal Inventory but
less detailed and less
emphasis appears to be
placed on the drawing out of
such).
Patient's distress





4. loneliness & social
isolation
Stated as not being mutually




relationships & patterns of
social functioning - also
potential sources are
identified.)
Any changes in IP
relationships close to the
onset of depression are
highlighted - to inform for
future focus & to establish a
context in which the
depressive symptoms will be
understood.
Therapist links the patient's
depression to his or her IP





Discussion of diagnosis of
depression.






relationships & patterns of
social functioning - also
potential sources are
identified.) This will be
written by the patient i. e an
autobiographical statement.
Any changes in IP
relationships close to the
onset of depression are
highlighted - to inform for
future focus & to establish a
context in which the
depressive symptoms will be
understood.
Therapist links the patient's
depression to his or her IP




PHASE 2 - IPT Sessions 5-12 IPC Sessions 3&4 IPT-B Sessions 3-6
Middle
Application of techniques as Encouragement of patient's Application of techniques as
described by Klerman et al., capacity for coping with the described by Klerman et al.,
1984. Focus on one of four problem area (as defined 1984. Focus on one of four
IP problem areas: above) IP problem areas:
1. grief following death of 1. grief following death of
a loved one (abnormal a loved one (abnormal
grief reaction). grief reaction).
2. Role disputes (conflict 2. Role disputes (conflict
with significant with significant
persons) persons)
3. Role transitions 3. Role transitions
(changed life situations) (changed life situations)





PHASE 3 IPT Sessions 13-16 IPC Sessions 5&6 IPT-B Sessions 7&8
Termination
Recognition and Encouragement of use of Recognition and
consolidation of treatment improved modes of coping consolidation of treatment
gains with these problems gains
Discussion of preventative Facilitation of independence Discussion of preventative
measures for the future measures for the future
Patient is urged to continue Termination - 2 weeks after Patient is urged to continue
until treatment is complete session 5. until treatment is complete
at 16 sessions.
If the patient is sufficiently
improvedfollowing any
session, they are urged not
to continue with therapy.
at 8 sessions.
IPC is described in a manual which gives direct and explicit instructions for what the
health care professional should say in any given different scenario. IPT-B does not give
such explicit instructions but offers agendas to be followed. Specific instructions are given
only at the feedback of the formulation session whereby the focus is agreed upon between












e.g. BDI-II; Contact & Support
Session Impact Scale
e.g. personal questionnaire
measures & ratings of
subjective states taken weekly &
baseline.
Process
Taken more frequently than
individual target measures to track
changes within a single session.
7
Although self report measures of symptom intensity may be subject to instrumentation effects, in the present




Elliot and Wexler, 1994
1. Realised something new about myself
As a result of the session, I now have a new insight about myself or have understood something new about me; I
see a new connection or see why I did or felt something. (Note: there must be a sense of "newness" as a result of
something which happened during the session).
12 3 4 5
Not at all Slightly Somewhat Pretty Much Very Much
2. Realised something new about someone else
As a result of the session, 1 now have a new insight about another person or have understood something new
about someone else or people in general. (A sense of "newness" should be present).
1 2 3 4 5
Not at all Slightly Somewhat Pretty Much Very Much
3. More bothered by unpleasant thoughts and/or feelings, or more likely to push them away.
The session has made me think of uncomfortable or painful ideas, memories, or feelings that weren't helpful; it
made me push certain thoughts of feelings away or avoid them.
1 2 3 4 5
Not at all Slightly Somewhat Pretty Much Very Much
4. Feel attacked or that my therapist doesn't care
As a result of the session, I now feel criticised, judged or put down by my therapist; I feel she is cold, bored or
doesn't care about me.
1 2 3 4 5
Not at all Slightly Somewhat Pretty Much Very Much
5. Impatient or doubting of therapy.
As a result of the session, I now feel more bored or impatient with the progress of therapy or with having to go
over the same old things over and over again; 1 have started to feel more that my therapy is pointless or not going
anywhere.
1 2 3 4 5
Not at all Slightly Somewhat Pretty Much Very Much
6. Feel my therapist understands me
As a result of the session, I now feel more deeply understood, that someone else (my therapist) really understands
what is going on with me or what I'm like as a person.
12 3 4 5
Not at all Slightly Somewhat Pretty Much Very Much
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Diary for use in IPTStudy
An Adaptation of Interpersonal Psychotherapy for Depression within Primary Care
Please record details of all contact with your GP and details of the kind of support you have received:
1. I have been to see my GP (record number of times):






















































































2. What medications are you taking (just write "same" if it doesn't change over the weeks)




















































3. Have you met with any other health care professional (e.g. dietician, Physiotherapist) Record date
and who you saw:
Week 1 Week 2 Week 3 Week 4 Week 5 Week 6
Date: Date: Date: Date: Date: Date:
Who I saw: Who I saw: Who I saw: Who I saw: Who I saw: Who I saw:
Week 7 Week 8 Week 9 Week 10 Week 11 Week 12
Date: Date: Date: Date: Date: Date:
Who I saw: Who I saw: Who 1 saw: Who I saw: Who I saw: Who 1 saw:
4. Have you had any contact with or received any treatment from anyone else (e.g. Aromatherapist,
Reflexologist)
Week 1 Week 2 Week 3 Week 4 Week 5 Week 6
Date: Date: Date: Date: Date: Date:
Who I saw: Who I saw: Who I saw: Who I saw: Who 1 saw: Who I saw:
Week 7 Week 8 Week 9 Week 10 Week 11 Week 12
Date: Date: Date: Date: Date: Date:
Who I saw: Who I saw: Who I saw: Who I saw: Who I saw: Who I saw:
5. Have you made any lifestyle changes (diet, exercise, moved house, changed job?)
xxx
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INITIAL SESSION(S) CHECKLIST AND RATING FORM
Rounsaville et al. (1986)
TASKS QUALITY
Yes No Rec Excellent Poor
Inquire re: chief complaint &
depressive symptoms
1 2 3 i 2 3 4 5 6 7
History of current depressive episode 1 2 3 i 2 3 4 5 6 7
Brief Social History 1 2 3 i 2 3 4 5 6 7
Inquire re: patient's expectations re
psychotherapy
1 2 3 i 2 3 4 5 6 7
Explanation of IPT/Basic assumptions 1 2 3 i 2 3 4 5 6 7
Translation of chief complaint
(depressive symptoms) into
interpersonal context
1 2 3 i 2 3 4 5 6 7
Reassurance re: positive prognosis 1 2 3 i 2 3 4 5 6 7
Explanation of IPT techniques 1 2 3 i 2 3 4 5 6 7
Contract setting (admin, details, length,
frequency and duration of sessions &
treatment, appointment times)
1 2 3 i 2 3 4 5 6 7
Interpersonal inventory 1 2 3 i 2 3 4 5 6 7
Feedback IPT formulation/Identify
focus
1 2 3 i 2 3 4 5 6 7
Contract setting re: treatment goals 1 2 3 i 2 3 4 5 6 7
Exploration of therapist & patient tasks
working towards treatment goals
1 2 3 i 2 3 4 5 6 7
Therapist Behvaiour Quality
Excellent Poor
Appropriate activity level 1 2 3 4 5 6 7
Appropriate degree of 1 2 3 4 5 6 7
supportiveness




TERMINATION SESSION(S) CHECKLIST AND RATING FORM
Rounsaville et al. (1986)
TASKS QUALITY
Yes No Rec Excellent Poor
Explicit discussion of the end of
treatment
1 2 3 1 2 3 4 5 6 7
Elicit/discuss patient's reaction to
termination
1 2 3 1 2 3 4 5 6 7
Acknowledgement of the end of
treatment as a time of potential grieving
1 2 3 1 2 3 4 5 6 7
Help patient move toward a recognition
of his/her independent competence
1 2 3 1 2 3 4 5 6 7
Review the course of treatment &
progress with the patient
1 2 3 1 2 3 4 5 6 7
Patient given the opportunity to
evaluate the treatment & assess future
needs
1 2 3 1 2 3 4 5 6 7
Assess with patient early warning
signals, & discuss procedures for re¬
entry into treatment if necessary




Rounsaville et al. (1986)
TRANSITION FOCUS
Goal Directed Activity yes no rec Excellent Poor
Review depressive symptoms 1 2 3 1 2 3 4 5 6 7
Relate depressive symptoms to
difficulty in coping with some
recent life change
1 2 3 1 2 3 4 5 6 7
Review positive and negative
aspects of old role and possible new
ones
1 2 3 1 2 3 4 5 6 7
Explore feelings about what is lost 1 2 3 1 2 3 4 5 6 7
Explore feelings about the change
itself
1 2 3 1 2 3 4 5 6 7
Explore opportunities in the new
role.
1 2 3 1 2 3 4 5 6 7
Realistic evaluation ofwhat is lost 1 2 3 1 2 3 4 5 6 7
Encourage appropriate release of
affect
1 2 3 1 2 3 4 5 6 7
Encourage development of social
support system and new skills
called for in new role
1 2 3 1 2 3 4 5 6 7
GRIEF FOCUS
Goal Directed Activity yes no rec Excellent Poor
Review depressive symptoms 1 2 3 1 2 3 4 5 6 7
Relate depressive symptoms to
death of significant other
1 2 3 1 2 3 4 5 6 7
Reconstruct the patient's
relationship with the deceased
1 2 3 1 2 3 4 5 6 7
Describe the sequence and
consequences of events just prior
to, during, and after the death.
1 2 3 1 2 3 4 5 6 7
Explore associated feelings
(negative as well as positive)
1 2 3 1 2 3 4 5 6 7
Consider possible ways of
becoming involved with others.
1 2 3 1 2 3 4 5 6 7
DISPUTE FOCUS
Goal Directed Activity yes no rec Excellent Poor
Review depressive symptoms 1 2 3 1 2 3 4 5 6 7
Relate depressive symptoms' onset
to overt or covert dispute with
significant other and with whom
patient is currently involved.
1 2 3 1 2 3 4 5 6 7




1 2 3 1 2 3 4 5 6 7
Understand how nonreciprocal role
expectations relate to dispute
1 2 3 1 2 3 4 5 6 7
Are there parallels in other
relationships?
1 2 3 1 2 3 4 5 6 7




Rounsaville et al. (1986)
PROCESS QUALITY




1 2 3 1 2 3 4 5 6 7
Administartive details 1 2 3 1 2 3 4 5 6 7
Encourage expression of affect;
inquiry into sensitive areas;
acceptance/acknowldement of
affect; inquiry into feeling
associated with content





1 2 3 1 2 3 4 5 6 7
Communication analysis 1 2 3 . 1 2 3 4 5 6 7
Use of the therapeutic relationship 1 2 3 1 2 3 4 5 6 7
Directive techniques, advice giving,
limit setting, education, modelling,
direct help
1 2 3 1 2 3 4 5 6 7
Decision analysis 1 2 3 1 2 ">J 4 5 6 7
Use of significant other 1 2 tJ 1 2 3 4 5 6 7
Other 1 2 3 1 2 3 4 5 6 7
Non IPT techniques e.g.
behaviouristic, overly
psychoanalytic
1 2 3 1 2 3 4 5 6 7
Problems with doing therapy Client Therapist
Yes No Yes No
Lateness 1 2 1 2
Missed appointments 1 2 1 2
Changed topic/tangential 1 2 1 2
Direct un-cooperativeness 1 2 1 2
Excessive dependency/demands 1 2 1 2
Suicide threats 1 2 1 2
Early termination Threats 1 2 1 2
Distorted view of therapist 1 2 1 2
Impersonal Presentation 1 2 1 2
Other 1 2 1 2
OVERALL THERAPIST RATING FORM
yes no rec Excellent Poor
Therapist's skill at helping patient
with intimate self disclosure
1 2 3 1 2 3 4 5 6 7
Therapist's ability to tend to the
therapeutic relationship
1 2 3 1 2 3 4 5 6 7
Therapist's ability to focus session
on appropriate topic
1 2 3 1 2 3 4 5 6 7
Therapist's ability to maintain
appropriate therapeutic stance
1 2 3 1 2 3 4 5 6 7
Overall quality of the session 1 2 3 1 2 3 4 5 6 7






THE STRUCTURE OF IPT-B
1PT-B is based on the premise that symptoms of depression (IPC = psychological distress) regardless
of biological vulnerability or personality, occur in a psychosocial and interpersonal context and is
defined as occurring in 3 phases: Assessment; Middle; Termination
The structure for IPT-B has been directly derived from IPT for Depression (Klerman et al 1984)
OUTLINE SESSION 1: INITIATING IPT-B
Dealing with the Depression
Review of depressive symptoms using DSM-IV criteria
Give the syndrome a name
Explain depression and the treatment
Sick role given with positive emphasis on recovery
Relate Depression to Interpersonal Context
Review current and past interpersonal relationships as they relate to current depressive symptoms.
Review will be carried out as a homework task by patient to include the following:
■ nature of interaction with significant persons
■ expectations of patient and significant persons from each other and whether these have
been fulfilled
■ satisfying and unsatisfying aspects of the relationships
■ changes the patient wants in the relationship
OUTLINE SESSION 2
Identification ofMajor Problem Area
Determine the problem area related to current depression and set treatment goals
Review of Interpersonal Inventory
Determine which relationship or aspect of a relationship is related to the depression and what might
change it.
Explain the IPT-B Concepts and Contract
Outline your understanding of the problem.
Agree on treatment goals (which problem area will be the focus).
Describe procedures of IPT-B: "here and now" focus, need for patient to discuss important concerns;
review of current interpersonal relations (to be carried out by patient at home),
Discussion of practical aspects of treatment
Length: 1 hour sessions (10 minutes at beginning to complete BDI-II).
Frequency: once a week for 8 weeks.
Times.
Policy for missed appointments: every week will be counted as a session so that the therapy must be
completed within 8 weeks.





Each Problem area has a set ofgoals and strategies as outlined by Klerman et al (1984).
OUTLINE SESSIONS 7-8 Termination of Treatment
Explicit discussion of termination
Acknowledgement that termination is a time of grieving
Moves toward patient recognition of independent competence
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DETAILED MANUAL SESSION 1
The first session is used to establish rapport with the patient. During this session, the following should
be included (therapist 'checklist & rating' forms should act as a checklist at the end of every session):
Before patient is seen, ask to complete BDI-II
What has caused the need for treatment? What has been going on in the patient's life that has caused
the needfor treatment and WHO was around (interpersonal context)
Recent history of depressive condition including a review of past episodes and of particular
interpersonal precipitants and/or consequences of the depression and ways in which previous
depressive episodes have been resolved.
Review of depressive symptoms using the Hamilton Rating Scale as a basis
Depression diagnosis given using DSM-IV criteria
Suicidal intent must be carefully assessed using BPS guidelines
Education re depressive condition i.e. depression is common with approximately 3-4% ofthe adult
population at any one time in UK being diagnosable. Depression does respond to treatment and
therefore the outlook is excellent.
Sick Role given:
Which demanding activities can the patient cut back on?
Which pleasurable activities can the patient increase?
Who can help out?
Ifpatient had a broken leg, who would help?
What would they do to help?
What things didpatient used to enjoy which they have done less ofrecently?
Timetable daily activities to take into account typical symptom pattern
Relate depression to interpersonal context through a review of current and past interpersonal
relationships as they relate to current depressive symptoms using Interpersonal Inventory as a basis
for patient to carry out at home.
Something small and manageable i.e task agreed upon to gain sense of achievement
Initial discussion of practical aspects of treatment - 8 sessions for an hour a week - these should be
booked in advance if at all possible.
At the end of the session, ask patient to complete the following questionnaires
Other contact questionnaire
Patient rating scale
**Complete Therapist checklist and Rating Scale
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DIAGNOSTIC CRITERIA FROM DSM-IV (APA, 1994)
Major Depressive Episode
depressed mood most of the day, nearly every day, as indicated by either subjective report (e.g. feels
sad or empty) or observation made by others (e.g. appears tearful)
markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly every
day (as indicated by either subjective account or observation made by others)
significant weight loss when not dieting or weight gain (e.g. a change ofmore than 5% of body
weight in a month), or decrease or increase in appetite nearly every day.
insomnia or hypersomnia nearly every day
psychomotor agitation or retardation nearly every day (observable by others, not merely subjective
feelings of restlessness or being slowed down)
fatigue or loss of energy nearly every day
feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) nearly every
day (not merely self-reproach or guilt about being sick)
diminished ability to think or concentrate, or indecisiveness, nearly every day (either by subjective
account or as observed by others)
recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specific plan,














Before patient is seen, ask to complete BDI-II
Symptoms of depression over past week reviewed using DSM-IV criteria - interpersonally (how have
symptoms of depression influenced relationships?)
Expectations of therapy discussed
Explanation of IPT/basic assumptions - relationships are central to the experience, from our
experience ofdoing this with others, 1PT works. Reassurance re: positive aspects.
Review of Interpersonal Inventory
Determine which relationship or aspect of a relationship is related to the depression and what might
change it
Discuss major problem area related to current depression (this is in preparation to determine IPT
formulation and identify potentialfocusfor therapy with the patient).
Discuss therapist and patient tasks working towards goals (therapist task is to keep patientfocused
with regards to focus agreed' andpatient task is to bring to therapy areas they wish to discuss
pertinent to their depressive symptoms, particularly things that affect them emotionally)
Review of practical aspects of treatment i.e. length, times, frequency & policy for missed
appointments.
At the end of the session, ask patient to complete the following questionnaires
'Other contact' questionnaire
'Patient rating scale'




Beforepatient is seen, ask to complete BDI-II
Symptoms of depression over past week reviewed using DSM-1V criteria - interpersonally (how have
symptoms of depression influenced relationships?)
Problem area identified with patient from last week - introducing the focus:
SESSION J - INIRODUL'ING BOLE TRANSITIONS
Do you remember that at the beginning I said that although the causes ofdepression arc unknown, it
is frequently associated with problems in interpersonal relationships. Problems in relating to others
may bring on depression in some people whilst for others the symptoms of depression prevent them
from dealing as successfully as they usually do. In this treatment, wc will try to discover what you
want and needfrom others and help you learn how to get it. You have mentionedpreviously that you
do have problems and I think that will be ways in which we can help you to learn how to deal with
more effectively.
Over the last 2 sessions, it seems to me that you have described a clear onset ofyour depression
around about the time that but you also have described that you were feeling this way before and that
perhaps the transition from is more important. You have told me about
episodes in your life that have been very difficultfor you including
In IPT, we try to get you back to feeling how you were before the onset of your depression and
therefore it is very important that we spell out exactly what we are going to try to do here.
We will be discussing your life as it is right now, and reviewing your relationships with important
people in your life. We will also be looking at what it was like for you in the old role and what your
feelings are about what has been lost and whatyourfeelings are about what has been gained.
I'd like to discuss with you the areas you describe as related to your depression.
One is the kind of transition you've madefrom
The second issue is how your feelings ofdepression may have been emphasised
Ifwe are agreed, I'd like to tell you how wc will proceed. Your task will be to talk about things that
concern you, particularly things that affect you emotionally. We will be concentrating on the issues I
described above but there may be other issues which are important, please feel free to raise them - I
will be interested not only in what happened but also your feelings about these events. It is your
responsibility to select topics which are most important to you.
STRATEGIES: (Not all strategies to be attempted at each session - only those that are appropriate)
Bi /?trv/Vif1 daptussive symptoms
■ Relate depressive symptoms to difficulty in coping with recent life change
■ Review positive and negative aspects ofold and new roles
■ Explorefeeling about what is lost
■ Explore feelings about the change itself
■ Explore opportunities in new role
■ Realistically evaluate what is lost Encourage appropriate release ofaffect
M Encoutuge development ofsocial support system and of new skills calledfor in new rote
Treatment goals set: reiterate goals of IPT-B plus feedback of formulation/ identification of focus
area: aim for pre-morbid functioning; what has been lost? For each problem area, what is the best
xli
APPENDIX 11.0
possible outcome, the most expectable outcome and the worst outcome? Who do you want a more
intimate relationship with? One goal agreed on was to try to work out what has been happening with
relationships and why you have found it difficult to be close to people and to try to help you find and
establish more satisfying relationships.
What do you need to be doing to make those friends?
What are the areas that you are doing it all alone?
Questions for homework & ask patient to write a summary of their understanding of their depressive
symptoms (see homework sheet for session 3)
At the end of the session, ask patient to complete the following questionnaires Other contact
questionnaire
Patient rating scale
**Complete Therapist checklist and Rating Scale
TASK FOR END OF SESSION 3
What does the change in role mean to you?
When you , how did your life change?
What important people were left behind?
How did you feel in this new role?
Tell me about what it was like in the old role?
What were the good things?
What were the bad things?
What did you like?
What did you not like?
How did it feel to give that up?
Tell me about the details of - how did you feel in the new situation?
What was it like at first?
What is required of you now?
How hard is it?
What is going well?
What is going badly?
Feelings about the change - guilt....
Ifpossible, try to write a summary ofyour understanding ofwhat was happening in your life around
about when you became depressed - who was around and how you were feeling - really try to define
your feelings here.
SESSION 4
Before patient is seen, ask to complete BDI-II
Use the following strategies for sessions 3-6 (not all at every session):
STRATEGIES:
■ Review depressive symptoms using DSM-IV criteria
■ Relate depressive symptoms to difficulty in coping with recent life change
■ Review positive and negative aspects ofold and new roles
■ Explorefeeling about what is lost
■ Explore feelings about the change itself
■ Explore opportunities in new role
■ Realistically evaluate what is lost Encourage appropriate release ofaffect
» Encourage development ofsocial support system and ofnew skills calledfor in new role
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At the end of the session, ask patient to complete the following questionnaires
Other contact questionnaire; Patient rating scale **Complete Therapist checklist and Rating Scale
SESSIONS 5 & 6
Before patient is seen, ask to complete BDI-II
STRATEGIES: (Not all strategies to be attempted at each session - only those that are appropriate)
■ Review depressive symptoms
■ Relate depressive symptoms to difficulty in coping with recent life change
■ Review positive and negative aspects ofold and new roles
■ Explorefeeling about what is lost
■ Explore feelings about the change itself
■ Explore opportunities in new role
■ Realistically evaluate what is lost Encourage appropriate release ofaffect
■ Encourage development ofsocial support system and ofnew skills calledfor in new role
At the end of the session, ask patient to complete the following questionnaires
Other contact questionnaire
Patient rating scale
**Complete Therapist checklist and Rating Scale
SESSION 7
Before patient is seen, ask to complete BDI-II
Review of depressive symptoms using DSM-IV criteria over past week
Explicit discussion of the end of treatment - possible return ofsymptoms - normal - anxiety raised?
Make the distinction between loss and relapse - we have the opportunity to model a successful ending
and discussingfeelings with regards to that.
Explicit discussion of 8-12 months post therapy, there is the opportunity to see changes in the
interpersonal world of the patient - this gives the chance to experience success.
Help patient move toward a recognition of his/her independent competence.
Review of course of treatment and progress with the patient
Patient given the opportunity to evaluate future needs
At the end of the session, ask patient to complete the following questionnaires Other contact
questionnaire, Patient rating scale **Complete Therapist checklist and Rating ScalE
SESSION 8 - FINAL SESSION
Before patient is seen, ask to complete BDI-II
Review of depressive symptoms using DSM-IV criteria
Assess with patient early warning signals, and discuss procedures for re-entry into treatment if
necessary
At the end of the session, ask patient to complete the following questionnaires: Quality ofLife
Questionnaire - WHO Briefversion; Significant others scale; HAM-D-R; SCID;
Other contact questionnaire
Patient rating scale










DETAILED MANUAL SESSION 1
The first session is used to establish rapport with the patient. During this session, the following should
be included (therapist 'checklist & rating' forms should act as a checklist at the end of every session):
Before patient is seen, ask to complete BDI-II
1. What has caused the need for treatment? What has been going on in the patient's life that has
caused the needfor treatment and WHO was around (interpersonal context)
2. Recent history of depressive condition including a review of past episodes and of particular
interpersonal precipitants and/or consequences of the depression and ways in which previous
depressive episodes have been resolved.
3. Review of depressive symptoms using the Hamilton Rating Scale as a basis
4. Depression diagnosis given using DSM-IV criteria
5. Suicidal intent must be carefully assessed using BPS guidelines
6. Education re depressive condition i.e. depression is common with approximately 3-4% ofthe adult
population at any one time in UK being diagnosable. Depression does respond to treatment and
therefore the outlook is excellent.
7. Sick Role given:
Which demanding activities can the patient cut back on?
Which pleasurable activities can the patient increase?
Who can help out?
Ifpatient had a broken leg, who would help?
What would they do to help?
What things didpatient used to enjoy which they have done less ofrecently?
Timetable daily activities to take into account typical symptom pattern
7. Relate depression to interpersonal context through a review of current and past interpersonal
relationships as they relate to current depressive symptoms using Interpersonal Inventory as a
basis for patient to carry out at home.
8. Something small and manageable i.e task agreed upon to gain sense of achievement
9. Initial discussion of practical aspects of treatment - 8 sessions for an hour a week - these should be
booked in advance if at all possible.
10. At the end of the session, ask patient to complete the following questionnaires
Other contact questionnaire
Patient rating scale




Before patient is seen, ask to complete BDI-I1
1. Symptoms of depression over past week reviewed using DSM-IV criteria - interpersonally (how
have symptoms of depression influenced relationships?)
2. Expectations of therapy discussed
3. Explanation of IPT/basic assumptions - relationships are central to the experience, from our
experience ofdoing this with others, 1PT works. Reassurance re: positive aspects.
4. Review of Interpersonal Inventory Highly important to obtain a history of significant
relationships with those who are now dead or otherwise absent. This should include the
circumstances of the death and the patient's behavioural and emotional reaction to it.
5. Determine which relationship or aspect of a relationship is related to the depression and what
might change it
6. Discuss major problem area related to current depression (this is in preparation to determine IPT
formulation and identify potentialfocusfor therapy with the patient).
To diagnose abnormal grief: I notice thatyou don't mention your mother when discussing your
parents. Has anyone you've been close to died recently? Couldyou tell me about the death? When?
Where? What circumstances? How did itfeel when you learned of the death? How were you the
nextfew weeks? Didyou carry on as usual?
7. Discuss therapist and patient tasks working towards goals (therapist task is to keep patient focused
with regards to focus agreed' andpatient task is to bring to therapy areas they wish to discuss
pertinent to their depressive symptoms, particularly things that affect them emotionally)
8. Review of practical aspects of treatment i.e. length, times, frequency & policy for missed
appointments.
9. At the end of the session, ask patient to complete the following questionnaires
'Other contact' questionnaire
'Patient rating scale'




Beforepatient is seen, ask to complete BDI-II
1. Symptoms of depression over past week reviewed using DSM-IV criteria - interpersonally (how
have symptoms of depression influenced relationships?)
2. Problem area identified with patient from last week - introducing the focus:
SESSION 3 - INTRODUCING GRIEF FOCUS
Do you remember that at the beginning I said that although the causes ofdepression are unknown, it
is frequently associated with problems in interpersonal relationships. Problems in relating to others
may bring on depression in some people whilst for others the symptoms of depression prevent them
from dealing as successfully as they usually do. In this treatment, we will try to discover what you
want and needfrom others and help you learn how to get it. You have mentioned previously that you
do have problems and I think that will be ways in which we can help you to learn how to deal with
more effectively.
Over the last 2 sessions, it seems to me that you have described a clear onset ofyour depression
around but you also have described that you were feeling this way
before and that perhaps the loss of is more important. You have told me
about episodes in your life that have been very difficultfor you including
In IPT, we try to get you back to feeling how you were before the onset ofyour depression and
therefore it is very important that we spell out exactly what we are going to try to do here.
We will be discussing your life as it is right now, and reviewing your relationships with important
people in your life.
I'd like to discuss with you the areas you describe as related to your depression.
Ifwe are agreed, I'd like to tell you how we will proceed. Your task will be to talk about things that
concern you, particularly things that affect you emotionally. We will be concentrating on the issues I
described above but there may be other issues which are important, please feel free to raise them I
will be interested not only in what happened but also your feelings about these events. It is your
responsibility to select topics which are most important to you.
STRATEGIES: (Not all strategies to he attempted at each session - only those that are appropriate)
Review depressive symptoms
... . . ' , . ... .
Relate depressive symptoms to death ofsignificant other
Reconstruct the patient's relationship with the deceased
Describe the sequence and consequences of events justprior to, during, and after the death.
Explore associatedfeelings (negative as well as positive)
Consider possible ways ofbecoming involved with others.
3. Treatment goals set: reiterate goals of IPT-B plus feedback of formulation/ identification of focus
area: aim for pre-morbid functioning. For each problem area, what is the best possible outcome,
the most expectable outcome and the worst outcome? Who do you want a more intimate
relationship with? One goal agreed on was to try to work out what has been happening with
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relationships and why you have found it difficult to be close to people and to try to help you find
and establish more satisfying relationships.
What do yon need to be doing to make those friends?
What are the areas that you are doing it all alone?
4. Questions for homework & ask patient to write a summary of their understanding of their
depressive symptoms (see homework sheet for session 3)
5. At the end of the session, ask patient to complete the following questionnaires Other contact
questionnaire
Patient rating scale
**Complete Therapist checklist and Rating Scale
TASK FOR END OF SESSION 3
1. What does the loss mean to you?
2. When you lost , how did your life change?
3. What were the ups and downs of you relationship with How did you feel in this new role?
4. What were the good things?
5. What were the bad things?
6. What did you like?
7. What did you not like?
8. What is your life like now?
9. How have you tried to make up for the loss?
10. Who are your friends?
11. What activities might be enjoyable?
12. Tell me about the details of - how did you feel in the new situation?
13. What was it like at first?
14. What is required of you now?
15. How hard is it?
16. What is going well?
17. What is going badly?
18. Feelings about the loss - guilt....
If possible, try to write a summary of your understanding of what was happening in your life around





Before patient is seen, ask to complete BDI-II
1. Use the following strategies for sessions 3-6 (not all at every session):
STRATEGIES: (Not all strategies to be attempted at each session only those that are appropriate)
Review depressive symptoms
Relate depressive symptoms to death ofsignificant other
Reconstruct the patient's relationship with the deceased
Describe the sequence and consequences ofevents justprior to, during, and after the death.
Explore associatedfeelings (negative as well as positive)
Considerpossible ways ofbecoming involved with others.
2. At the end of the session, ask patient to complete the following questionnaires
Other contact questionnaire
Patient rating scale
**Complete Therapist checklist and Rating Scale
SESSIONS 5 & 6
Before patient is seen, ask to complete BDI-II
STRATEGIES: (Not all strategies to be attempted at each session - only those that are appropriate)
Review depressive symptoms
Reluie depressive symptoms to death ofsignificant other
Reconstruct thepatient's relationship with the deceased
Describe the sequence and consequences ofevents justprior to, during, and after the death.
Explore associatedfeelings (negative as well us positive)
Consider possible ways ofbecoming involved with others.
2. At the end of the session, ask patient to complete the following questionnaires Other contact
questionnaire
Patient rating scale
**Complete Therapist checklist and Rating Scale
SESSION 7
Before patient is seen, ask to complete BDI-II
1. Review of depressive symptoms using DSM-IV criteria over past week
2. Explicit discussion of the end of treatment - possible return ofsymptoms - normal - anxiety
raised? Make the distinction between loss and relapse - we have the opportunity to model a
successful ending and discussingfeelings with regards to that.
3. Explicit discussion of 8-12 months post therapy, there is the opportunity to see changes in the
interpersonal world of the patient - this gives the chance to experience success.
4. Help patient move toward a recognition of his/her independent competence.
5. Review of course of treatment and progress with the patient
6. Patient given the opportunity to evaluate future needs
7. At the end of the session, ask patient to complete the following questionnaires Other contact
questionnaire; Patient rating scale **Complete Therapist checklist and Rating Scale
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SESSION 8 - FINAL SESSION
Before patient is seen, ask to complete BDI-II
1. Review of depressive symptoms using DSM-IV criteria
2. Assess with patient early warning signals, and discuss procedures for re-entry into treatment if
necessary
3. At the end of the session, ask patient to complete the following questionnaires











DETAILED MANUAL SESSION 1
The first session is used to establish rapport with the patient. During this session, the following should
be included (therapist 'checklist & rating' forms should act as a checklist at the end of every session):
Before patient is seen, ask to complete BDI-I1
What has caused the need for treatment? What has been going on in the patient's life that has caused
the needfor treatment and WHO was around (interpersonal context)
Recent history of depressive condition including a review of past episodes and of particular
interpersonal precipitants and/or consequences of the depression and ways in which previous
depressive episodes have been resolved.
Review of depressive symptoms using the Hamilton Rating Scale as a basis
Depression diagnosis given using DSM-1V criteria
Suicidal intent must be carefully assessed using BPS guidelines
Education re depressive condition i.e. depression is common with approximately 3-4% of the adult
population at any one time in UK being diagnosable. Depression does respond to treatment and
therefore the outlook is excellent.
Sick Role given:
Which demanding activities can the patient cut back on?
Which pleasurable activities can the patient increase?
Who can help out?
Ifpatient had a broken leg, who would help?
What would they do to help?
What things didpatient used to enjoy which they have done less ofrecently?
Timetable daily activities to take into account typical symptom pattern
Relate depression to interpersonal context through a review of current and past interpersonal
relationships as they relate to current depressive symptoms using Interpersonal Inventory as a basis
for patient to carry out at home.
Something small and manageable i.e task agreed upon to gain sense of achievement
Initial discussion of practical aspects of treatment - 8 sessions for an hour a week - these should be
booked in advance if at all possible.
At the end of the session, ask patient to complete the following questionnaires
Other contact questionnaire
Patient rating scale




Before patient is seen, ask to complete BDI-II
Symptoms of depression over past week reviewed using DSM-IV criteria - interpersonally (how have
symptoms of depression influenced relationships?)
Expectations of therapy discussed
Explanation of IPT/basic assumptions - relationships are central to the experience, from our
experience ofdoing this with others, IPTworks. Reassurance re: positive aspects.
Review of Interpersonal Inventory
Determine which relationship or aspect of a relationship is related to the depression and what might
change it
Discuss major problem area related to current depression {this is in preparation to determine IPT
formulation and identify potentialfocusfor therapy with the patient). Patient must give evidence of
overt or covert conflicts with a significant other
(Goals: if dispute, identify dispute, choose plan of action, modify expectations or faulty
communication to bring about a satisfactory resolution)
Discuss therapist and patient tasks working towards goals {therapist task is to keep patient focused
with regards to focus agreed' andpatient task is to bring to therapy areas they wish to discuss
pertinent to their depressive symptoms, particularly things that affect them emotionally)
Review of practical aspects of treatment i.e. length, times, frequency & policy for missed
appointments.
At the end of the session, ask patient to complete the following questionnaires
'Other contact' questionnaire
'Patient rating scale'




Before patient is seen, ask to complete BDI-II
Symptoms of depression over past week reviewed using DSM-IV criteria - interpersonally (how have
symptoms of depression influenced relationships?)
Problem area identified with patient from last week - introducing the focus:
SESSION 3 - INTRODUCING DISPUTES FOCUS
Do you remember that at the beginning I said that although the causes ofdepression arc unknown, it
is frequently associated with problems in interpersonal relationships. Problems in relating to others
may bring on depression in some people whilst for others the symptoms of depression prevent them
from dealing as successfully as they usually do. In this treatment, we will try to discover what you
want and needfrom others and help you learn how to get it. You have mentionedpreviously that you
do have problems and I think that will be ways in which we can help you to learn how to deal with
more effectively.
Over the last 2 sessions, it seems to me that you have described a clear onset ofyour depression
around but you also have described that you were feeling this way
before and that perhaps the is more important. You ha\>e told me about
episodes in your life that have been very difficult for you including
In IPT, we try to get you back to feeling how you were before the onset ofyour depression and
therefore it is very important that we spell out exactly what we are going to try to do here.
We will be discussing your life as it is right now, and reviewing your relationships with important
people in your life.
I'd like to discuss with you the areas you describe as related to your depression.
Ifwe are agreed, I'd like to tell you how we will proceed. Your task will be to talk about things that
concern you, particularly things that affect you emotionally. We will be concentrating on the issues I
described above but there may be other issues which are important, please feel free to raise them ■ I
will be interested not only in what happened but also your feelings about these events. It is your
responsibility to select topics which are most important to you.
STRATEGIES: (Not all strategies to be attempted at each session - only those that are appropriate)
■ Review depressive symptoms
■ Relate depressive symptoms' onset to overt or covert dispute with significant other and with
whom patient is currently involved.
■ Determine stage ofdispute:
d. Renegotiation (calm down participants to facilitate resolution)
e. Impasse (increase disharmony in order to reopen negotiation)
f. Dissolution (assist mourning)
■ Understand how nonrcciprocal role expectations relate to dispute:
a. What are the issues in the dispute?
b. What are the differences in expectations and values?
c. What are the options?
d. What is the likelihood offinding alternatives?
e. What resources are available to bring about change in the relationship?
■ Are there parallels in other relationships?
a. What is thepatient gaining?
b. What unspoken assumptions lie behind thepatient's behaviour?
M How is the dispute perpetuated?
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APPENDIX 11.2
Treatment goals set: reiterate goals of IPT-B plus feedback of formulation/ identification of focus
area: aim for pre-morbid functioning. For each problem area, what is the best possible outcome, the
most expectable outcome and the worst outcome? Who do you want a more intimate relationship
with? One goal agreed on was to try to work out what has been happening with relationships and why
you have found it difficult to be close to people and to try to help you find and establish more
satisfying relationships.
What do you need to be doing to make those friends?
What are the areas thatyou are doing it all alone?
Questions for homework & ask patient to write a summary of their understanding of their depressive
symptoms (see homework sheet for session 3)
At the end of the session, ask patient to complete the following questionnaires Other contact
questionnaire; Patient rating scale **Complete Therapist checklist and Rating Scale
TASK FOR END OF SESSION 3
1. What does the dispute mean to you?
2. What do you want/expect from this relationship?
3. What does the significant other wants/expect from this relationship?
4. What are the options?
5. What is the likelihood of finding alternatives?
6. What resources are available to bring about change in the relationship?
7. What were the ups and downs of you relationship with What were the good things?
8. What were the bad things?
9. What did you like?
10. What did you not like?
11. What is your life like now?
12. Who are your friends?
13. Tell me about the details of
14. What was it like at first?
15. What is required of you now?
16. How hard is it?
17. What is going well?
18. What is going badly?
19. Feelings about the dispute - guilt....
If possible, try to write a summary of your understanding of what was happening in your life around





Before patient is seen, ask to complete BDI-II
Use the following strategies for sessions 3-6 (not all at every session):
STRA TEGIES: (Not all strategies to be attempted at each session - only those that are appropriate)
■ Review depressive symptoms
■ Relute depressive symptoms' onset to overt or covert dispute with significant other and with
whom patient is currently involved.
■ Determine stage ofdispute:
g. Renegotiation (calm down participants to facilitate resolution)
h. Impasse (increase disharmony in order to reopen negotiation)
i. Dissolution (assist mourning)
■ Understand how nonrcciprocal role expectations relate to dispute:
f. What are the issues in the dispute?
g. What are the differences in expectations and values?
h. What are the options?
i. What is the likelihood ofJindmg alternatives?
j. What resources are available to bring about change in the relationship?
■ Are thereparallels in other relationships?
c. What is thepatient gaining?
d. What unspoken assumptions lie behind the patient's behaviour?
■ How is the dispute perpetuated?
At the end of the session, ask patient to complete the following questionnaires
Other contact questionnaire; Patient rating scale", **Complete Therapist checklist and Rating Scale
SESSIONS 5 & 6
Before patient is seen, ask to complete BDI-II
STRA TEGIES: (Not all strategies to be attempted at each session - only those that are appropriate)
■ Review depressive symptoms
■ Relate depressive symptoms' onset to overt or covert dispute with significant other and with
whom patient is currently involved.
■ Determine stage ofdispute:
j. Renegotiation (calm down participants to facilitate resolution)
k. Impasse (increase disharmony in order to reopen negotiation)
I. Dissolution (assist mourning)
* Understand how nonreciprocul role expectations relate to dispute:
k. What are the issues in the dispute?
I. What are the differences in expectations and values?
m. What are the options?
it. What is the likelihood offinding alternatives?
o. What resources are available to bring about change in the relationship?
■ Are there parallels in other relationships?
e. What is the patient gaining?
f. What unspoken assumptions lie behind the patient's behaviour?
■ How is the dispute perpetuated?
At the end of the session, ask patient to complete the following questionnaires Other contact




Before patient is seen, ask to complete BDI-II
Review of depressive symptoms using DSM-IV criteria over past week
Explicit discussion of the end of treatment - possible return ofsymptoms - normal - anxiety raised?
Make the distinction between loss and relapse - we have the opportunity to model a successful ending
and discussingfeelings with regards to that.
Explicit discussion of 8-12 months post therapy, there is the opportunity to see changes in the
interpersonal world of the patient - this gives the chance to experience success.
Help patient move toward a recognition of his/her independent competence.
Review of course of treatment and progress with the patient
Patient given the opportunity to evaluate future needs
At the end of the session, ask patient to complete the following questionnaires Other contact
questionnaire; Patient rating scale **Complete Therapist checklist and Rating Scale
SESSION 8 - FINAL SESSION
Before patient is seen, ask to complete BDI-II
Review of depressive symptoms using DSM-IV criteria
Assess with patient early warning signals, and discuss procedures for re-entry into treatment if
necessary
At the end of the session, ask patient to complete the following questionnaires







**Complete Therapist checklist and Rating Scale
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RELIABLE CHANGE INDEX USING POPULATION IN THE TEST DATA
Reliable Change Index (RCI) = (xi - x>)/ (SEDIFF)
RHRSDEND RHRSD 2 RHRSD END RHRSD 2 BDI-Il BDI-I12
(»r Month (or Month END (of Month
Treatment) Follow-up Treatment) Follow-up Treatment) Follow-up
RCI RCI RCI RCI RC RCI
SED= SED= SED= SED= SED= SED-
:: ,=L |„/2(,S7- i ..... i ,/?(.<?/.! ' ■ /?(■«••■) If .. JUSE,). : 7x^)1 ""»»
f |V = 4.13 = 4.13 = 4.70 = 4.70 = 4.36 = 4.36
Observer Observer Self Report Self Report Self Report Self Report
I 2.17* 2.18* 2.77* 2.76* 6.65* 6.65*
2 1.45 -1.45 -1.49 -1.49 1.15 1.15
3 1.21 1.21 -0.64 -0.64 1.83 1.83
4 2.66* 2.66* 2.13* 2.13* 4.59* 4.59*
5 0 -2.66 -0.43 0.85 -0.23 -0.23
6 3.63* 3.63* 1.06 1.06 0.69 0.69
7 0 -0.48 -0.85 0.85 0 0
8 4.6* 4.6* 2.76* 2.76* 5.05* 5.05*
9 0 0 0.21 -0.85 1.15 0.46
10 0 0 -2.13 -2.73 2.29* 2.29*
11 0 0 0 0 0 0
12 0 0.73 0 0 0.23 0.69
13 0 0 0 0 0 0
14 -0.48 -0.48 0 0 0.92 0.92
15 0.48 3.63* 0.42 4.25* 5.5* 9.86*
16 0.24 0.48 0.85 1.49 -0.46 0.92
17 2.18* 2.13* 1.7 1.7 2.29* 2.29*
18 0 0.24 1.7 2.98* 2.29* 1.38
19 0.24 0.73 0.64 0.64 1.38 -0.46
20 0 0 0 0 0 0
21 -0.24 0 1.06 0.85 3.44* 1.38
22 0 0 0.21 0.21 0 0
23 0.24 0.24 3.19* 3.19* 2.98* 2.98*
24 0 0 0 0 6.42* 6.42*
25 3.87* 4.6* 1.91 5.32* 2.75* 0.69
26 2.18* 2.18* 1.49 1.49 0.92 0.92
27 1.21 1.94 -1.7 -0.85 1.15 1.15
28 1.21 1.21 2.98* 3.62* 6.19* 6.88*
29 1.69 1.69 0.42 0.42 1.38 1.38
30 0.73 0.73 1.06 1.49 2.06* 1.83
31 4.84* 5.33* 3.4* 3.4* 2.75* 4.36*
32 0 0 0 0 0.23 0.23
33 3.87* 4.84* 1.91 3.19* 5.73* 5.96*
34 1.94 0.24 1.06 -0.21 0.46 0.23
35 6.78* 6.78* 3.19* 3.19* 5.96* 5.96*
36 4.12* 4.36* 4.04* 4.25* 3.21* 4.82*
37 0.73 0.73 0.42 0.42 4.82* 4.82*
38 0.24 4.6* 2.98* 4.25* 2.52* 2.98*
39 3.34* 3.39* 2.98* 2.76* 1.61 2.29*
40 0 0 0 0 2.75* 2.75*
41 0 0 0 0 6.88* 6.88*
42 -0.24 -0.24 -1.06 -1.06 -5.05 -5.05
43 2.18 2.18* 2.13* 2.13* 1.38 1.15
44 0.24 -0.24 -0.21 -0.21 1.38 2.29*
45 3.63* 3.63* 3.19* 3.19* 4.82* 4.81*
46 0 3.39* -0.64 3.83* -0.23 4.81*
47 1.69 1.69 2.98* 2.98* 3.44* 3.44*
48 0 0 0 0 2.06* 2.06*
49 2.18* 2.18* 5.96* 6.8* 8.72* 8.94*
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*>1.96 therefore improved status is not just due to inherent unreliability of test
1-23 = Waiting List Control Group
24-49 = IPT-B Intervention Group
Those highlighted refer to Intent to Treat Group
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APPENDIX 13.0
JACOBSON'S RELIABLE CHANGE INDEX
Reliable Change Index (RCI) = (x\ — Xi)/ (SEDIFF)
Using comparisons with Fava et al, (1982) normative data - see Table 18.0
Standard error ofmeasurement of a score (SEM) = Sx 7(1 — r„)
Sx = Standard deviation of the population in the test
r» = reliability of the test
Standard error of a difference score (SEDIFF) =
Reliable Change Index (RCI) = (x, - Xi) / (SEDIFF)
X i = pre-treatment score
~
post-treatment score
The critical value for the RCI to be statistically significant = 1.96
REVISED HAMILTON RATING FOR DEPRESSION : IK and LN
CLINICIAN VERSION
CLINICAL INTERVIEW at 3 follow up times (end of treatment; 2 and 4 month follow up)
Mean = 6.1 (SEM) = Sx yj(\-ra)
Sx = 6.53 (SEM) = 6.53 7(1-0.8) = 2.92
TV = 0.8 (SEDIFF) = ^2(SEs,)i.






RCI end 2 month
follow up
RCI 2 mo 4 month
follow up
KCI 4 mo
IK 19 3 3.87* 0 4.60* 2 4.12*
LN 25 21 0.97 23 0.48 22 0.73
* Exceeds 1.96 therefore improved status is not just due to inherent unreliability of test
REVISED HAMILTON RATING FOR DEPRESSION : IK & LN
SELF REPORTPROBLEM INVENTOR Y
Reliable Change Index (RCI) = (xi - X2)/ (SEDIFF)
(SEM) = Sx 7(1 ~tE)
(SEM) = 7.4 7(1 - 0.8) = 3.31
(SEDIFF) = 72(SEff












RCI end 2 month
follow up
RCI 2 mo 4 month
follow up
RCI 4 mo
IK 31 22 1.91 6 5.32* 6 5.32*
LN 28 26 0.42 27 0.21 27 0.21
*Exceeds 1.96 therefore improved status is not just due to inherent unreliability of test
BECK DEPRESSION INVENTORY II: IK
Reliable Change Index (RCI) = (xi — X2)/ (SEDIFF)
Mean = 7.65 (SEM) = Sx ^(1 -r„)
Sx= 11.64 (SEM) = 11.64 ^(1 - 0.93) = 3.08
r„ = 0.93 (SEDIFF) = -J2(SE.\,)2












RCI 2 mo 4 month
follow up
RCI 4 mo
IK 27 15 2.75* 4 5.28* 3 5.50*
LN 37 31 1.38 30 1.61 31 1.38
* Exceeds 1.96 therefore improved status is not just due to inherent unreliability of test
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APPENDIX 14.0
SUMMARY OF THE MAJOR STRENGTHS AND WEAKNESSES OF THE
PRESENT STUDY
STRENGTHS WEAKNESSES
- ■;» » ™
STRENGTHS & WEAKNESSES
The design of the study:
STRENGTH WEAKNESS
Original adaptation carefully
planned & executed with
comparisons drawn between
IPC and IPT.




treatments in a clinical
trial is by randomisation
Results are unlikely to
generalise to clinical
practice
IPT-B initial tested on a pilot
case-study








Systematic bias avoided Lack of compliance with
patient diaries (to account
for external bias)
Specific manuals ensure
results are capable of
replication AND it is
considered meaningless
to report any data
concerning an adapted




As therapists do not follow
manuals in community
results are not generalisable
Examination and
interpretation of the effect
size as a measure of
improvement




Published data were used to
estimate the relative cost
effectiveness ofCBT
Examination the clinical
significance of the findings
Two sample populations:
completer and intention-to-
treat, stratified for severity
of depression
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